| Speaker |
Date Time |
Session |
Role |
Description |
| Anne L. Abbott, MD, PhD, FRACP |
11/18/2025 7:50 AM |
10 |
Presenter |
What Facts Would Be Needed To Change My View That All ACS Patients Are Best Treated Medically: Why The CMS Decision To Reimburse Carotid Stenting (CAS) For ACS Patients Was Based On The Wrong Comparative Data (CAS vs CEA When It Should Have Been CAS vs Medical Treatment) |
| Dorothy B. Abel, BSBME |
11/19/2025 5:28 PM |
38 |
Presenter |
Different Perspectives From Industry And The FDA Regarding The Importance Of Innovation, Engineering And Financial Rewards That Influence Innovation |
| Cherrie Z. Abraham, MD |
11/20/2025 10:26 AM |
57 |
Presenter |
Gore TAMBE Endograft For The Treatment Of Complex AAAs And TAAAs: Indications, Advantages, Limitations And Technical Tips |
| Cherrie Z. Abraham, MD |
11/18/2025 1:00 PM |
13 |
Presenter |
The Cost Of Artificial Intelligence (AI) In Medicine: Boldly Or Foolishly Going Where No One Has Gone: Will The Benefits Be Worth The Cost |
| Cherrie Z. Abraham, MD |
11/19/2025 4:24 PM |
45 |
Presenter |
Complex Endovascular Aneurysm Repair In Cases With Compromised Iliac Access: Technical Tips |
| Ali F. AbuRahma, MD |
11/21/2025 10:30 AM |
82 |
Presenter |
Update On International Guidelines For Carotid Disease: Why They Are Still Imperfect |
| Ali F. AbuRahma, MD |
11/21/2025 4:06 PM |
85 |
Presenter |
When A Duplex Scan Detects Subclavian Steal, Symptomatic Or Asymptomatic, What Is The Natural History And How Should It Be Managed |
| Ali F. AbuRahma, MD |
11/21/2025 8:48 AM |
80 |
Presenter |
The Effect Of Calcium Burden (Circumference, Thickness, Length) On The Early And Late Outcomes Of TCAR: How Best To Optimize The Treatment For Each Of These |
| Ali F. AbuRahma, MD |
11/21/2025 |
84, |
Session
Moderator |
MORE HOT CAROTID TOPICS: TREATMENT IN 2025 OF EXTRACRANIAL CAROTID ANEURYSMS, RECURRENT STENOSIS, WEBS, ETC. |
| Zach AbuRahma, DO |
11/21/2025 11:24 AM |
82 |
Presenter |
CEA vs TCAR In A Single Center Propensity Matched Study: 30-Day Outcomes Of The Two Treatments Are Similar: Why Is TCAR Mortality Higher At 2 Years |
| Zach AbuRahma, DO |
11/21/2025 |
86, |
Session
Moderator |
NEW CONCEPTS AND NEW DEVELOPMENTS IN PERCUTANEOUS ACCESS CLOSURE AND WOUND CARE |
| Christopher J. Abularrage, MD |
11/22/2025 7:12 AM |
106 |
Presenter |
When Is Primary Amputation The Best Treatment For Patients With CLTI: It Is Currently Very Rare But There Are Valid Indications |
| Christopher J. Abularrage, MD |
11/19/2025 8:35 AM |
24 |
Presenter |
When Should Coronary Drug-Eluting Stents (DESs) Be Used To Treat Vein Bypass Stenoses And When Should They Not Be: Which Stent Is Best |
| Joshua D. Adams, MD |
11/18/2025 11:42 AM |
12 |
Presenter |
Covered Endovascular Reconstruction Of The Iliac Bifurcation (CERIB) For Treatment Of Aortoiliac Occlusive Disease With Hypogastric Preservation: How To Do It: Advantages And Results |
| Joshua D. Adams, MD |
11/19/2025 4:42 PM |
46 |
Presenter |
How To Perform F/EVAR With Full Renal Perfusion In Patients With An Early Renal Artery Bifurcation |
| Mark A. Adelman, MD |
11/20/2025 |
59, |
Session
Moderator |
UPDATED INFORMATION ON LOWER EXTREMITY PROSTHETIC GRAFTS (SEE ALSO SESSION 28) AND RE-ENTRY DEVICES |
| Mark A. Adelman, MD |
11/21/2025 |
92, |
Session
Moderator |
NEW DEVELOPMENTS IN THE TREATMENT OF THORACIC OUTLET SYNDROMES (TOSs)
|
| Mark A. Adelman, MD |
11/22/2025 |
109, |
Session
Moderator |
AORTIC AND CAROTID TOPICS TOO IMPORTANT TO MISS |
| Fabiola Aguilera, MD |
11/22/2025 2:58 PM |
115 |
Presenter |
Is Botulinum Toxin Effective Treatment For Digital Ischemia |
| Sam S. Ahn, MD, FACS, MBA |
11/21/2025 7:22 AM |
87 |
Presenter |
Repair Of Popliteal Artery Aneurysms With Bare Metal Stents: Which Stent Is Best: Proof That It Works And That It Can Be Done Successfully And Effectively As An Outpatient Procedure |
| Francesco A. Aiello, MD |
11/19/2025 4:10 PM |
37 |
Presenter |
Academic Vascular Surgery Groups Can And Must Design, Implement, And Execute Adding An OBL To Their Practice: Do It Or Die |
| Jean-Marc Alsac, MD, PhD |
11/18/2025 10:42 AM |
4 |
Presenter |
Aortic Endograft Coverage With TBADs: Should It Be Short Covering Only The Entry Tear Or Long Covering As Much Of The Dissected Aorta As Possible: Advantages And Limitations Of Each |
| Jean-Marc Alsac, MD, PhD |
11/19/2025 2:42 PM |
44 |
Presenter |
Results Of The STABILISE Technique In Patients With Connective Tissue Disorder Related TBADs: When Can It Work And When Is It Contraindicated |
| Jean-Marc Alsac, MD, PhD |
11/18/2025 9:32 AM |
3 |
Presenter |
What Is The STABILISE Technique For Treating Acute And Chronic TBADs By Disrupting The Intimal Flap And Overdilating The Distal Bare Stent: Updated Results, And When Should It Be The Treatment Of Choice |
| Ali Amin, MD, RVT, FACS, FACC |
11/19/2025 11:06 AM |
26 |
Presenter |
12 Commandments For A Successful BTK Intervention In Patients With CLTI |
| Ali Amin, MD, RVT, FACS, FACC |
11/20/2025 1:36 PM |
59 |
Presenter |
Re-Entry Devices Are Currently Almost Never Necessary: Techniques To Treat Lower Extremity Lesions Successfully Without Them: When Might They Be Needed |
| Ali Amin, MD, RVT, FACS, FACC |
11/20/2025 5:16 PM |
54 |
Presenter |
Techniques To Minimize Radiation Exposure And Contrast Use To Reduce Nephropathy: CO2 Angiography Is Unnecessary |
| Ali Amin, MD, RVT, FACS, FACC |
11/22/2025 7:48 AM |
106 |
Presenter |
With Prograde CFA Punctures, How To Easily Get The Guidewire Down The SFA Rather Than The Deep Femoral |
| Max Amor, MD |
11/21/2025 10:54 AM |
82 |
Presenter |
Value Of IVL (Shockwave-J&J) For CAS Or TCAR In Heavily Calcified Lesions: How To Do It Safely And Technical Tips: Limitations And Precautions |
| Max Amor, MD |
11/21/2025 7:54 AM |
80 |
Presenter |
Long-Term Results Of Micromesh Stents Show Their Value In Carotid Artery Stenting (CAS): What Are The Differences In The 3 Micromesh Stents And Do They Matter |
| Gary M. Ansel, MD |
11/19/2025 2:54 PM |
36 |
Presenter |
Principles Physicians Need To Consider When Innovating Medical Devices: It's More Than Securing Intellectual Property |
| Gary M. Ansel, MD |
11/18/2025 7:20 AM |
9 |
Presenter |
The Sentante Robotic System Allows For Remote Endovascular Procedures: How Does It Work: Other Advantages And Limitations |
| Gary M. Ansel, MD |
11/18/2025 9:15 AM |
17 |
Presenter |
Large Bore Aspiration Thrombectomy—Tips, Tricks And Pearls |
| Gary M. Ansel, MD |
11/21/2025 9:53 AM |
81 |
Presenter |
How Patient Selection And Operator Skill May Influence Carotid Trial Results With TCAR And TFCAS: How May They Overshadow Other Factors And Render Trials Misleading |
| Gary M. Ansel, MD |
11/18/2025 |
21, |
Session
Moderator |
HOT NEW TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE AND ITS TREATMENTS |
| Michele Antonello, MD, PhD |
11/19/2025 10:28 AM |
41 |
Presenter |
An Off-The-Shelf (OTS) Inner Branched Endograft (E-nside From Artivion) For The Treatment Of Juxtarenal And Pararenal Aortic Aneurysms: Advantages, Limitations, Technical Tips And Results From A Multicenter Italian Registry |
| Michele Antonello, MD, PhD |
11/20/2025 11:10 AM |
58 |
Presenter |
Updated European Experience With The Gore Single Branch Endograft For The Treatment Of Lesions In Or Near The Aortic Arch: What Makes It Different, Advantages And Results |
| George A. Antoniou, MD, PhD, MSc, FEBVS |
11/19/2025 1:06 PM |
43 |
Presenter |
Diabetes Reduces The Growth Rate Of Abdominal Aortic Aneurysms: From A Large Meta-Analysis: What Is The Mechanism |
| George A. Antoniou, MD, PhD, MSc, FEBVS |
11/18/2025 2:52 PM |
6 |
Presenter |
EVAR 2 Is No Longer A Relevant RCT: Outcomes Of EVAR In Over 18,000 High-Risk Patients Ineligible For Open Repair Shows That EVAR Is Justified In Some: When Is This So |
| Frank R. Arko, MD |
11/20/2025 11:40 AM |
58 |
Presenter |
Current US Status And Results With The RelayPro NBS Endograft For TEVAR: Advantages And Limitations |
| Frank R. Arko, MD |
11/19/2025 5:38 PM |
30 |
Presenter |
What Is New With Penumbra Indigo Clot Aspiration Systems: Improved Mechanical Catheter And Computer Based Clot Removal Indigo Systems: New Size Catheters For The Treatment Of Acute Arterial Clot: How The Systems Works And Why They Improve Clot Removal In Various Vascular Beds: Is Open Surgery Ever Needed |
| Frank R. Arko, MD |
11/20/2025 5:43 PM |
63 |
Presenter |
Fibered And Non-Fibered Coil Embolism Technology: Which Type Of Coils Are Best For Different Indications: When Are Liquid Agents Best |
| Frank R. Arko, MD |
11/20/2025 |
63, |
Session
Moderator |
NEW OR IMPROVED ENDOVASCULAR DEVICES FOR CLOT REMOVAL OR EMBOLIZATION (SEE ALSO SESSION 30)
|
| Zachary M. Arthurs, MD |
11/20/2025 11:37 AM |
50 |
Presenter |
New Developments In Isolated Limb Perfusion To Enable Traumatically Amputated Limb Reimplantation |
| Enrico Ascher, MD |
11/19/2025 11:18 AM |
34 |
Presenter |
DEBATE: Why Vascular Surgeons And Vascular Specialists Should Unionize: It Will Solve Many Of The Problems They Currently Face Due To Hospital Administrators |
| Enrico Ascher, MD |
11/21/2025 11:42 AM |
82 |
Presenter |
Minimal Incision CEA (MICE) vs TCAR: Technical Tips For MICE, Cost Effectiveness, Advantages And Limitations Of Both |
| Enrico Ascher, MD |
11/18/2025 6:47 AM |
9 |
Presenter |
Opening Remarks |
| Enrico Ascher, MD |
11/22/2025 7:00 AM |
106 |
Presenter |
How To Do Bypass Surgery To Heavily Non-Compressible Calcified Target Arteries |
| Enrico Ascher, MD |
11/21/2025 7:04 AM |
87 |
Presenter |
Small Asymptomatic Popliteal Aneurysms: What Factors Determine Whether They Should Be Treated Invasively Or Observed: If Invasively, When Endo When Open |
| Enrico Ascher, MD |
11/22/2025 8:44 AM |
107 |
Presenter |
Successful Bypasses To Foot Arteries And Their Branches Allowed Limb Salvage In What Were Thought To Be 'No Option For Treatment' CLTI Patients |
| Enrico Ascher, MD |
11/19/2025 |
23, |
Session
Moderator |
GENERALITIES IN THE TREATMENT OF LOWER EXTREMITY OCCLUSIVE DISEASE, CLTI AND THEIR MEDICAL TREATMENT: SOME NEW CONCEPTS
|
| Enrico Ascher, MD |
11/22/2025 |
109, |
Session
Moderator |
AORTIC AND CAROTID TOPICS TOO IMPORTANT TO MISS |
| Bernadette Aulivola, MD |
11/18/2025 5:30 PM |
16 |
Presenter |
Technical Tips And Precautions For Safe And Effective Anterior Spine Exposure: What Hemorrhagic Complications Can Occur And How Are They Best Managed |
| Martin J. Austermann, MD |
11/21/2025 1:00 PM |
91 |
Presenter |
Recorded Cases Showing Different Endovascular Techniques For Repair Of Late EVAR Failures |
| Martin J. Austermann, MD |
11/20/2025 8:57 AM |
48 |
Presenter |
Which Bridging Covered Stents Or Stent-Grafts Work Best For F/B/EVAR: A European Perspective: Why Renal Artery Bridging Stent-Grafts Are The Achilles Heel In B/EVAR And What To Do About It |
| Martin J. Austermann, MD |
11/21/2025 |
91, |
Session
Moderator |
CHALLENGING RECORDED LIVE CASES FROM MÜNSTER, GERMANY |
| Hamdy Awad, MD |
11/21/2025 6:40 AM |
79 |
Presenter |
How MRI Can Help Guide Treatment To Prevent SCI And Determine SCI Prognosis After Thoracic Aortic Aneurysm And TAAA Repairs (Endo And Open) |
| Faisal Aziz, MD |
11/19/2025 1:48 PM |
43 |
Presenter |
Advantages And Disadvantage Of Local Anesthesia For EVAR: How To Use It Safely And With Adjuncts: It Is Particularly Valuable In Octogenarians |
| Ali Azizzadeh, MD |
11/21/2025 4:36 PM |
94 |
Presenter |
Classification And Management Of BTAI: An Update From The Revised SVS Clinical Practice Guidelines: When Is Medical Management The Best Treatment |
| Nobuyoshi Azuma, MD |
11/18/2025 3:00 PM |
21 |
Presenter |
After CLTI Invasive Treatment For One Limb, Adverse Ischemic Limb Events In The Contralateral Limb Are Common Requiring Careful Observation And Often Invasive Treatment: Based On Data From The SPINACH Trial |
| Sateesh C. Babu, MD |
11/21/2025 9:02 AM |
88 |
Presenter |
Infected Axillary Artery Prosthetic Graft Stumps: How Best To Deal With Them Without Total Graft Excision |
| Sateesh C. Babu, MD |
11/20/2025 |
60, |
Session
Moderator |
NEW OR IMPROVED ENDOVASCULAR DEVICES FOR LOWER EXTREMITY TREATMENTS: ATHERECTOMY, STENTS, ACCESSORIES, ETC. (SEE ALSO SESSIONS 23-27)
|
| Martin R. Back, MD |
11/18/2025 4:56 PM |
8 |
Presenter |
With Acute Type A Dissections And Severe SMA Malperfusion, What Is The Optimal Treatment Sequence: When Should Descending Aortic TEVAR To Restore SMA Flow Precede Open Repair Of The Ascending Aorta |
| Martin R. Back, MD |
11/21/2025 7:16 AM |
87 |
Presenter |
With Popliteal Artery Aneurysms, Why After 20 Years Of Selective Endograft Treatment Do I Now Favor Open Repair In Most Patients: Which Ones Still Get An Endograft |
| Charles J. Bailey, MD |
11/20/2025 2:30 PM |
60 |
Presenter |
Why The Zilver PTX DES (Cook) Is A Durable Effective Treatment For Long FemPop Lesions: Based On Worldwide Trials And Experience: DES Choice (Zilver PTX And Eluvia – Boston Scientific) Can Impact Patient Well Being: 3-Year Results From The REAL-DES Trial |
| Charles J. Bailey, MD |
11/21/2025 9:00 AM |
80 |
Presenter |
DEBATE: Why We Do NOT Need An RCT Comparing TCAR With Other Treatments: Real-World Data Prove Its Safety, Efficacy, And Superiority As A Treatment For Carotid Stenosis |
| Jonathan Bath, MD |
11/20/2025 2:42 PM |
52 |
Presenter |
Laser In Situ F/EVAR Is The Procedure Of Choice For Complex Ruptured Complex AAAs Or TAAAs: Technical Tips, Endografts To Use, Advantages And Limitations |
| Iris Baumgartner, MD |
11/18/2025 4:06 PM |
21 |
Presenter |
DEBATE: All CLTI Patients Should Undergo Endovascular Treatment As The First Procedure: What Is The Role For Bypass Surgery |
| Hernan A. Bazan, MD, DFSVS, FACS |
11/19/2025 7:54 AM |
32 |
Presenter |
What Are The Molecular Mechanisms Underlying Carotid And Coronary Plaque Rupture: Can They Be Modified By Drugs In The Future |
| Hernan A. Bazan, MD, DFSVS, FACS |
11/18/2025 9:34 AM |
11 |
Presenter |
Frailty Scores And Other Variables Impact The Outcomes Of Urgent Carotid Interventions In Acute Stroke Patients: A Comprehensive Analysis Of Risk And Prognosis Shows That Stroke Severity Is The Most Important Determining Factor |
| Robert E. Beasley, MD, FSIR, FSCAI |
11/19/2025 11:24 AM |
26 |
Presenter |
Patency And Wound Healing Results Of The 3-French Compatible Microstent (From Micro Medical) Compare Favorably With POBA For BTK Lesions: From The STAND RCT: Antegrade And Retrograde Insertions Are Possible |
| Robert E. Beasley, MD, FSIR, FSCAI |
11/20/2025 2:00 PM |
60 |
Presenter |
Managing Complex Lower Extremity Disease: Experience With The Revolution Atherectomy System (From Rex Medical): Advantages And Experience |
| Robert E. Beasley, MD, FSIR, FSCAI |
11/20/2025 3:42 PM |
61 |
Presenter |
The Ultrascore Scoring Balloons (From BD) For PTA: How Does It Work: Advantages, Clinical Experience And Current Status |
| Robert E. Beasley, MD, FSIR, FSCAI |
11/19/2025 8:29 AM |
24 |
Presenter |
Update On The BioMimics 3D Spiral Flow Stent (From Veryan Medical): How Does It Work And Is Its Patency Equal To That Of DESs |
| Adam Beck, MD |
11/18/2025 10:02 AM |
3 |
Presenter |
US And European Experience With The Terumo Relay Aortic Ascending Aorta Endovascular Graft: What Makes It Different And Experience To Date |
| Adam Beck, MD |
11/18/2025 1:48 PM |
5 |
Presenter |
Computer Analysis Of CT Factors Determining AAA Wall Weakness/Strength Of Areas In AAAs Predicts Rupture Risk Independent Of Size And Post EVAR Neck Behavior: The ViTAA System |
| Adam Beck, MD |
11/21/2025 7:40 AM |
79 |
Presenter |
What Does The US Aortic Research Consortium (ARC) Tell Us About SCI And CSF Drainage: Decreased Prophylactic Use Of The Latter Seems Beneficial Except For A Few High-Risk Patients: Therapeutic Use Continues To Have Value |
| Adam Beck, MD |
11/21/2025 |
79, |
Session
Moderator |
PROGRESS IN THE PREVENTION AND TREATMENT OF SPINAL CORD ISCHEMIA (SCI) ASSOCIATED WITH THE TREATMENT OF THORACIC, THORACOABDOMINAL AND COMPLEX ABDOMINAL ANEURYSMS |
| Jean Pierre Becquemin, MD, FRCS |
11/20/2025 11:28 AM |
58 |
Presenter |
Valiant Captiva (Medtronic) For TEVAR: Advantages, Limitations And 5-Year Results For Various Aortic Lesions |
| Jean Pierre Becquemin, MD, FRCS |
11/18/2025 11:36 AM |
4 |
Presenter |
With TBADs What Is The Best Technique To Close The False Lumen: TEVAR, Petticoat, Stabilize, Candyplug Or Knickerbocker, Embolization (By What Method), Septotomy (By What Method): How To Decide |
| Jean Pierre Becquemin, MD, FRCS |
11/18/2025 2:46 PM |
6 |
Presenter |
Colonic Ischemia Following EVAR Repair: Current Concepts About Etiology, Diagnosis, Prevention, Treatment And Outcomes |
| Christian A. Behrendt, MD |
11/18/2025 1:48 PM |
13 |
Presenter |
Why Best Medical Therapies (BMTs) Are Not Working Well In Lower Extremity Arterial Occlusive Disease Patients Despite Excessive Healthcare Expenditure: How Can AI Remedy The Situation |
| Christian A. Behrendt, MD |
11/19/2025 4:12 PM |
29 |
Presenter |
The Reason Why The Apparently Opposite Results From BEST-CLI And BASIL 2 Are Actually Consistent And Reflect Everyday Clinical Practice: As Shown By Results From A Large Multicenter Prospective Cohort Study |
| James F. Benenati, MD |
11/20/2025 |
63, |
Session
Moderator |
NEW OR IMPROVED ENDOVASCULAR DEVICES FOR CLOT REMOVAL OR EMBOLIZATION (SEE ALSO SESSION 30)
|
| George L. Berdejo, BA, RVT, FSVU |
11/22/2025 9:05 AM |
110 |
Presenter |
Volumetric Access Flow: Challenges And Pitfalls |
| George L. Berdejo, BA, RVT, FSVU |
11/21/2025 |
85, |
Session
Moderator |
MORE HOT AND CONTROVERSIAL CAROTID TOPICS |
| Ramon Berguer, MD, PhD |
11/18/2025 11:00 AM |
4 |
Presenter |
Current Status Of A Catheter Aortic Septotomy Device For Treating Aortic Dissections By Cutting The Septum From Below: How Does It Work And Advantages: Limitations To Other Septotomies That Cut The Septum From Above |
| Ramon Berguer, MD, PhD |
11/19/2025 |
39, |
Session
Moderator |
MORE TOPICS RELATED TO THE THORACIC AORTA, AORTIC DISSECTIONS, INFLAMMATORY ANEURYSMS AND THEIR TREATMENT |
| Todd Berland, MD |
11/22/2025 7:06 AM |
106 |
Presenter |
Antegrade Via The SFA vs Pedal Access: Technical Tips And When To Use Each |
| Colin D. Bicknell, MD, FRCS |
11/19/2025 1:18 PM |
43 |
Presenter |
How Do Arterial Blood Pressure Levels Influence AAA Growth Rates: Does Controlling The Blood Pressure Slow Growth Rates |
| Colin D. Bicknell, MD, FRCS |
11/18/2025 4:14 PM |
7 |
Presenter |
Stenting (Open vs Covered) Of Visceral Branches For TEVAR In Uncomplicated Type B Aortic Dissections (uTBADs): When Is It Necessary And How Does It Improve Results (From The EARNEST Trial) |
| Jean Bismuth, MD |
11/18/2025 11:48 AM |
12 |
Presenter |
Real-World Evaluation Of The Covered Endovascular Revascularization Of The Aortic Bifurcation (CERAB) Technique For Treating Complex AIOD: Indications, Advantages, Limitations And Stent-Graft Choice |
| Jean Bismuth, MD |
11/18/2025 2:24 PM |
14 |
Presenter |
Leaders Have To Lead: This Is True In Vascular Surgery And Everything Else: Why Lack Of Leadership In Vascular Surgery Has Resulted In Our Remaining A Subordinate Subservient Subspecialty: Why Has It Happened And What Can Be Done About It |
| Jean Bismuth, MD |
11/18/2025 2:40 PM |
20 |
Presenter |
Remote Wireless Monitoring (IntelVasc) Of Any Lower Extremity Vascular Treatment: How Does It Work And How Can It Help Patients |
| Martin Björck, MD, PhD |
11/20/2025 1:24 PM |
51 |
Presenter |
Update On Advances In Treatment Of Abdominal Compartment Syndrome Associated With Ruptured AAAs: When And How Can It Be Treated Medically And When Must The Abdomen Be Opened |
| Martin Björck, MD, PhD |
11/19/2025 2:48 PM |
44 |
Presenter |
Medical Treatment Of Patients With Vascular Ehlers Danlos Syndrome: How Does Celiprolol (A Beta Blocker) Treatment Work And How Does It Help |
| Martin Björck, MD, PhD |
11/19/2025 4:06 PM |
29 |
Presenter |
How Can We Understand And Best Use The Diverging Results Of The BEST-CLI, BASIL 2, And BASIL 3 RCTs For The Treatment Of CTLI Patients |
| James H. Black, III, MD |
11/19/2025 2:36 PM |
44 |
Presenter |
Endovascular (Endograft) Therapy For Marfan And Other CTDs: When Is It Indicated As The Primary Treatment Or After Failed Open Repair And When Is It Not: Is It Time For A Guideline Change |
| James H. Black, III, MD |
11/20/2025 7:38 AM |
47 |
Presenter |
Current Concepts In The Treatment Of Vascular Ehlers Danlos Syndrome (EDS): How To Make Treatment Outcomes And Operations For Complications Successful: Technical Tips |
| James H. Black, III, MD |
11/18/2025 |
16, |
Session
Moderator |
PROGRESS IN THE TREATMENT OF AORTIC COARCTATIONS AND EXPERT TECHNICAL SKILLS FOR OPEN VASCULAR OPERATIONS |
| James H. Black, III, MD |
11/19/2025 |
44, |
Session
Moderator |
MORE NEW DEVELOPMENTS IN AAAs: ENDOVASCULAR TREATMENTS WITH HERITABLE AORTIC DISEASE (CONNECTIVE TISSUE GENETIC DISORDERS - CTDs): HOW DOES INTRASAC THROMBUS LOAD AFFECT AAA BEHAVIOR AND PROGNOSIS AFTER EVAR |
| Jan D. Blankensteijn, MD |
11/18/2025 1:30 PM |
5 |
Presenter |
If Type 2 Endoleaks, Which Are Common After EVAR, Are So Dangerous, Where Are All The Post EVAR Rupture From Them: Maybe They Aren't So Dangerous: When Must They Be Treated |
| Jan D. Blankensteijn, MD |
11/20/2025 |
49, |
Session
Moderator |
MORE PROGRESS IN F/B/EVAR AND PARALLEL GRAFTS FOR COMPLEX AAAs AND TAAAs; AND RELATED TOPICS |
| John Blebea, MD, MBA |
11/19/2025 7:59 AM |
24 |
Presenter |
Management Of Atherectomy Failures: What Are The Causes: Are They More Common In OBLs And How Are They Related To Over Usage |
| Erwin Blessing, MD |
11/18/2025 1:24 PM |
19 |
Presenter |
Technical Tips Of Deep Venous Arterialization (DVA): To Make It Work What Are The Critically Important Aspects Of Care Which Start After The Procedure |
| Erwin Blessing, MD |
11/18/2025 5:36 PM |
22 |
Presenter |
Retrograde Recanalization Of Lower Extremity Occlusive Lesions: Technical Tips, Complications And How To Be Successful Even After Removal Of The SFA |
| Erwin Blessing, MD |
11/19/2025 7:10 AM |
23 |
Presenter |
Technical Tips For Vessel Prep Prior To The Use Of DCBs And DESs: It Is Different And Not Simple: How To Do It And Why Is It Important |
| Erwin Blessing, MD |
11/19/2025 8:23 AM |
24 |
Presenter |
Advantages And Limitations Of Supera Vasculomimetic (VMI Stents) For Complex Fem-Pop Occlusive Lesions: They Even Work In The Subintimal Position: When Are They The Best Treatment |
| George Blessios, MD |
11/22/2025 2:15 PM |
114 |
Presenter |
Extended Applications Of The VasQ Device For Creating Hemodialysis Access |
| Dittmar Boeckler, MD |
11/21/2025 4:00 PM |
94 |
Presenter |
Vascular Injuries After Blunt Abdominal Trauma: Diagnosis And Management: When Endo, When Open Treatment |
| Dittmar Boeckler, MD |
11/18/2025 4:08 PM |
7 |
Presenter |
Long-Term Outcomes Of Endovascular Treatment For TBADs: Failure Modes: What Secondary Interventions Are Required: Is Late Graft Migration An Issue |
| Dittmar Boeckler, MD |
11/20/2025 7:14 AM |
47 |
Presenter |
The Role Of The Vascular Surgeon In Treating Perinatal Hemorrhage: Endovascular Iliac Balloon Occlusion Can Be Life Saving: How And Where Balloons Should Be Placed |
| Dittmar Boeckler, MD |
11/18/2025 |
6, |
Session
Moderator |
MORE ABOUT AAAs AND EVAR, STANDARD AND COMPLEX: UPDATES ON PHYSICIAN MODIFIED ENDOGRAFTS (PMEGs) AND GUIDELINES
|
| Michel J. Bosiers, MD |
11/20/2025 2:42 PM |
60 |
Presenter |
3-Year Results With Another Drug Eluting Bioresorbable Stent (Motiv From REVA) To Treat BTK Lesions: How Is This Device Different, Advantages And Limitations |
| Michel J. Bosiers, MD |
11/18/2025 5:24 PM |
22 |
Presenter |
3- Year Outcomes Of The MOTIV Drug Eluting Bioresorbable Scaffold (Reva Medical) To Treat BTK Artery Lesions |
| Michel J. Bosiers, MD |
11/20/2025 9:20 AM |
57 |
Presenter |
Comparative Analysis Of The Results Of Various Off-The-Shelf (OTS) Devices For Treating TAAAs |
| Lee Bouwman, MD, PhD |
11/20/2025 10:08 AM |
57 |
Presenter |
What Are Semi Branches In The Artivion Inner Branched Custom-Made Aortic Endograft (E-xtra Design MultiBranch) For Pararenal Aneurysms And How Do They Reduce Aortic Coverage: Advantages, Limitations And Results |
| Lee Bouwman, MD, PhD |
11/19/2025 11:04 AM |
42 |
Presenter |
Advantages And Current Status Of The Artivion IBD Device For Treating Common And Internal Iliac Artery Aneurysms: From The PLIANT II Multicenter Study: When Will This Device Be Available In The US |
| Lee Bouwman, MD, PhD |
11/18/2025 4:30 PM |
22 |
Presenter |
Value Of Microcirculatory Resistance (IMR), Optical Coherence Tomography (OCT), BTK-Flow Reserve And Fractional Flow Reserve (FFR) In BTK Lesions: How To Perform These Measurements |
| Jonathan R. Boyle, MD, MA (Cantab) FRCS |
11/18/2025 2:40 PM |
6 |
Presenter |
Are Re-Intervention Rates After EVAR Influenced By Device Type And Manufacturer: What Is The Mechanism Responsible For Differences |
| Jonathan R. Boyle, MD, MA (Cantab) FRCS |
11/19/2025 6:58 AM |
23 |
Presenter |
How Does Early Intervention For Critical Limb Threatening Ischemia (CLTI) Save Legs And Lives: The Earlier Ischemia Is Corrected The Better |
| Andrew W. Bradbury, MD, FRCSEd |
11/19/2025 3:48 PM |
29 |
Presenter |
New Findings And Interpretations From The BASIL 2 And BASIL 3 RCTs: What They Tell Us That Is Helpful And What They Don't |
| Daniela Branzan, MD |
11/19/2025 1:30 PM |
35 |
Presentation
Moderator |
PROGRAM TO BE DETERMINED |
| Daniela Branzan, MD |
11/19/2025 5:30 PM |
46 |
Presenter |
Value Of Preemptive Embolization Of AAA Side Branches (IMA And Lumbars) Prior To EVAR: Objective Evidence That It Prevents Sac Enlargement: When Is It Necessary And When Not |
| Daniela Branzan, MD |
11/21/2025 7:22 AM |
79 |
Presenter |
With The Extensive Single Center Clinical Experience With Intercostal Coil Embolization (MIS2ACE) To Prevent SCI With Endo TAAA Repair Do We Still Need An RCT: When And How To Do The Procedure |
| Clayton J. Brinster, MD |
11/21/2025 2:48 PM |
84 |
Presenter |
Update On Carotid Webs: Diagnosis, Symptoms/Morbidity And Optimal Current Treatment: Medical, Endo Or Open |
| Marianne Brodmann, MD |
11/19/2025 1:12 PM |
27 |
Presenter |
More Distal Angioplasty Can Salvage Some "No Option" Limbs: Below-The-Ankle Endo Interventions In 2025: Techniques, Devices And Should Balloons Be Drug Coated Or Not |
| Marianne Brodmann, MD |
11/19/2025 3:24 PM |
29 |
Presenter |
iThera: A New Laser Measurement Tool To Assess Microcirculation And Foot Perfusion After Revascularization In CLTI Patients |
| Marianne Brodmann, MD |
11/19/2025 9:05 AM |
25 |
Presenter |
2-Year Results Of The Magnitude Sirolimus Eluting Bioresorbable Stent (From R3 Vascular): For BTK Lesions: How Does It Compare With Other Treatments: Is Intravascular Lithotripsy (IVL-Shockwave) Feasible To Treat BTK Lesions |
| Marianne Brodmann, MD |
11/18/2025 |
20, |
Session
Moderator |
MORE HOT NEW TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE AND ITS TREATMENT – EVALUATING ARTERIAL ANATOMY AND TREATMENT OUTCOMES WITH CLTI
|
| Marianne Brodmann, MD |
11/19/2025 |
26, |
Session
Moderator |
NEW DEVELOPMENTS IN DRUG COATED BALLOONS (DCBs) AND DRUG ELUTING STENTS (DESs): UPDATES ON PACLITAXEL TOXICITY, RANDOMIZED CONTROLLED TRIALS
(RCTs) AND BTK LESION TREATMENTS WITH DCBs AND DESs
|
| Allan L. Brook, MD |
11/18/2025 5:30 PM |
22 |
Presenter |
Spinal Cord Stimulation: Another Method To Treat CLTI Patients: How Does It Work And When Might It Be Indicated: Can It Be Effective In Patients With Tissue Loss |
| Allan L. Brook, MD |
11/18/2025 |
11, |
Session
Moderator |
UPDATES ON TREATMENTS FOR INTRACRANIAL ARTERIAL DISEASE; INVASIVE ENDOVASCULAR TREATMENT FOR ACUTE STROKES; COMBINED CAROTID STENOSIS AND INTRACRANIAL CLOT OR DISEASE; CAROTID DISSECTIONS |
| Benjamin S. Brooke, MD |
11/19/2025 2:48 PM |
36 |
Presenter |
In What Circumstances Can Nonoperative Management Improve Patient-Reported Outcomes As Revascularization: Does This Apply To Intermittent Claudication, Asymptomatic Carotid Stenosis, Small AAAs, Etc. |
| Benjamin S. Brooke, MD |
11/19/2025 3:06 PM |
36 |
Presenter |
Artificial Intelligence Will Transform How Vascular Surgery Is Practiced: How Does It Work And How Will It Help: How Do Machine Learning, Algorithmic Learning And Enhanced Reality Fit In |
| Thomas G. Brott, MD |
11/21/2025 1:18 PM |
83 |
Presenter |
First Game Changing Results From CREST 2: Do They Resolve The Controversy Conclusively Or Are Further Studies Needed |
| Thomas G. Brott, MD |
11/18/2025 |
10, |
Session
Moderator |
NEW DEVELOPMENTS IN CAROTID DISEASE AND ITS TREATMENT: A NEW LOOK AT THE TREATMENT OF ASYMPTOMATIC CAROTID STENOSIS (ACS) AND OTHER CAROTID TOPICS |
| Thomas G. Brott, MD |
11/21/2025 |
81, |
Session
Moderator |
MORE CAROTID HOT TOPICS RELATED TO TCAR, CAS AND EFFECTS OF INTERVENTIONS ON COGNITIVE FUNCTION
|
| Deborah Brouwer-Maier, RN, CNN |
11/22/2025 10:34 AM |
111 |
Presenter |
Management Of Infiltration Inquiries |
| Deborah Brouwer-Maier, RN, CNN |
11/22/2025 8:14 AM |
110 |
Presenter |
Health Literacy In Patients With Chronic Kidney Disease |
| Kellie R. Brown, MD |
11/21/2025 3:12 PM |
93 |
Presenter |
Optimal Current Management Of Takayasu's Disease Involving The Supra-Aortic Branches: Technical Details For Open Surgical Management And What Is The Role For Endo Treatment With Bare Or Covered Stents In 2025 |
| Kellie R. Brown, MD |
11/21/2025 |
93, |
Session
Moderator |
MEDICAL AND ADJUNCTIVE (DRUG AND CELL) TREATMENTS IN VASCULAR PATIENTS; RARE VASCULAR DISEASES; VASCULAR PROCEDURES TO FACILITATE OTHER SURGERIES |
| O. William Brown, MD, JD |
11/19/2025 3:00 PM |
36 |
Presenter |
Legal Implications Of Performing PMEGs And Laser Fenestrations Without An IDE: When Is The Vascular Specialist Vulnerable And When Are They Not |
| O. William Brown, MD, JD |
11/19/2025 4:46 PM |
38 |
Presenter |
We Don't Hold Physicians Who Provide False Or Misleading Testimony Against Vascular Surgeons Accountable: Why Has The SVS Committee On This Topic Failed To Be Effective: A New Standard For Medical Malpractice |
| Elchanan Bruckheimer, MBBS |
11/18/2025 4:42 PM |
16 |
Presenter |
Long-Term Follow-Up Of Covered Stents To Treat Coarctation Of The Aorta: How To Deal With Complications |
| Elchanan Bruckheimer, MBBS |
11/20/2025 4:42 PM |
62 |
Presenter |
Update On The Novelrad Percutaneous Endovascular Suturing Device: How Does It Work: Advantages And Clinical Experience To Date |
| Richard Bulbulia, MA, MD, FRCS |
11/21/2025 1:24 PM |
83 |
Presenter |
Update On ACST-2: This RCT Found That CEA And CAS For ACS Had Comparable Stroke/Death Rates For 10 Years And Implied That Both Invasive Treatments Were Superior To Now Obsolete BMT: Why This Conclusion Is No Longer Applicable |
| Richard Bulbulia, MA, MD, FRCS |
11/21/2025 2:48 PM |
93 |
Presenter |
Lowering LDL-C And Controlling Elevated Blood Pressure And Lipoprotein Little A [Lp(a)] Can Lower Cardiovascular Risk 80%: What To Do If Patients Can't Tolerate A Statin Dose: Ezetimibe (Zetia), A PCSK9 Inhibitor, Inclisiran, Bempedoic Acid (Nexletol), Etc. |
| Richard Bulbulia, MA, MD, FRCS |
11/21/2025 3:06 PM |
93 |
Presenter |
Why A New Oral PCSK9 Inhibitor (AZD0780) Will Be A Game Changer In Lipid Management And Lowering The Morbidity Of Atherosclerosis: Implications Of Its Dikfferent Mode Of Action |
| Richard Bulbulia, MA, MD, FRCS |
11/19/2025 7:10 AM |
31 |
Presenter |
The Risk Of Arteriosclerosis And Its Complications Are Increased By LDL Cholesterol (LDL-C) Levels: What Are The Best Medical Strategies To Decrease These Complications: Statins, Adjunctive LDL-C Lowering Drugs - Inclisiran, Bempedoic Acid, Ezetimibe, PCSK-9 Inhibitors, Lepodisiran, Colchicine, Olezarsen: How They Should Be Administered |
| Jacques Busquet, MD |
11/21/2025 2:42 PM |
84 |
Presenter |
In Stent Stenosis After CAS: How Can It Be Predicted: When Is It Threatening And How Is It Best Managed |
| Keith D. Calligaro, MD |
11/21/2025 2:26 PM |
92 |
Presenter |
For Venous TOS An Anterior Infraclavicular Approach With Resection Of The Anterior Third Of The First Rib Provides Access To The Vein And Relieves Its Compression: Technique, Limitations And Results |
| Keith D. Calligaro, MD |
11/18/2025 2:36 PM |
14 |
Presenter |
Why The SVS Leaders Have Not Pushed Harder For An ABMS Approved Independent Board When Cardiology Is Aggressively Applying For Such An Independent Board In Cardiovascular Medicine |
| Keith D. Calligaro, MD |
11/22/2025 9:26 AM |
107 |
Presenter |
Duplex Ultrasound For Diagnosis Of Failing Stents Placed For Arterial Occlusive Disease: Why Is It Important And How Often Should It Be Done After Treatment In Claudicants; In CLTI Patients |
| Keith D. Calligaro, MD |
11/18/2025 |
14, |
Session
Moderator |
ISSUES IMPORTANT TO VASCULAR SURGERY’S INDEPENDENCE, IDENTITY, WELL BEING AND TRAINING
|
| Keith D. Calligaro, MD |
11/20/2025 |
52, |
Session
Moderator |
PROGRESS IN ENDO AND OPEN TREATMENT TECHNIQUES FOR RUPTURED INFRARENAL AAAs, COMPLEX AAAs AND TAAAs; NEW DEVELOPMENTS IN SURVEILLANCE AND SCREENING |
| Keith D. Calligaro, MD |
11/21/2025 |
84, |
Session
Moderator |
MORE HOT CAROTID TOPICS: TREATMENT IN 2025 OF EXTRACRANIAL CAROTID ANEURYSMS, RECURRENT STENOSIS, WEBS, ETC. |
| Keith D. Calligaro, MD |
11/21/2025 |
88, |
Session
Moderator |
NEW DEVELOPMENTS IN TREATING ARTERIAL (INCLUDING AORTIC) GRAFT AND ENDOGRAFT INFECTIONS |
| Ludovic Canaud, MD, PhD |
11/18/2025 8:14 AM |
2 |
Presenter |
Percutaneous Endovascular Repair Of Aortic Arch Lesions With A Double Fenestrated Endograft (Valiant Captiva From Medtronic) |
| Piergiorgio Cao, MD, FRCS |
11/19/2025 9:28 AM |
41 |
Presenter |
F/B/EVAR In Complex AAAs And TAAAs, Early And Long-Term Results Are Better In Fit And Young Patients In Whom F/B/EVAR Should Be The Treatment Of Choice |
| Laura Capoccia, MD, PhD |
11/18/2025 9:58 AM |
11 |
Presenter |
Are The Guidelines For Managing Acute Strokes In Patients With Carotid Bifurcation And Intracranial Clot Wrong: What Is The Best System For Current Management And Who Should Do The Procedures |
| Francis Caputo, MD |
11/19/2025 2:24 PM |
44 |
Presenter |
The Value Of TEVAR In Patients With CTDs: When Is It Acceptable Treatment And When Is It Contraindicated |
| Francis Caputo, MD |
11/20/2025 3:46 PM |
53 |
Presenter |
What Are The Effects Of Glucagon Like Peptide (GLP-1) Agonists: How Do They Work And How Do They Influence AAA Growth |
| Neal S. Cayne, MD |
11/19/2025 9:54 AM |
33 |
Presenter |
Glue Embolization Is Effective Treatment For Most Threatening Type 2 Endoleaks: When And How To Do It: How Can Fusion Help: Limitations |
| Neal S. Cayne, MD |
11/18/2025 |
21, |
Session
Moderator |
HOT NEW TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE AND ITS TREATMENTS |
| Rabih A. Chaer, MD |
11/21/2025 4:42 PM |
94 |
Presenter |
Long-Term Outcomes Following TEVAR For BTAI: Late Complications Are Extremely Rare |
| Rabih A. Chaer, MD |
11/18/2025 8:56 AM |
10 |
Presenter |
How Should The Presence Of Severe Renal Dysfunction Or ESRD Influence The Treatment Of Symptomatic Or Asymptomatic Carotid Stenosis |
| Elliot L. Chaikof, MD, PhD |
11/19/2025 6:52 AM |
31 |
Presenter |
Advances In The Use Of Anticoagulant, Antithrombotic And Antiplatelet Drugs In Vascular Patients: What Are The Next Generation Drugs And How Do They Help As Baseline Treatment And Peri-Procedurally |
| Venita R. Chandra, MD |
11/21/2025 10:10 AM |
89 |
Presenter |
Radiation Hazards To The Pregnant Surgeon/Specialist: What Practice Modifications And Techniques Are Needed To Minimize Them |
| Venita R. Chandra, MD |
11/22/2025 7:18 AM |
106 |
Presenter |
A Comparison Of Directional Atherectomy Followed By DCB vs PTA Followed By DCB To Treat Long Calcified FemPop Lesions: From The TOTAL REALITY Pooled Analysis |
| Venita R. Chandra, MD |
11/22/2025 8:50 AM |
107 |
Presenter |
Value Of Intravascular Lithotripsy (Shockwave-J&J) For Treatment Of Calcified BTK Lesions Causing CLTI: Results Of The BTK-PAD II Study |
| Venita R. Chandra, MD |
11/22/2025 |
106, |
Session
Moderator |
LOWER EXTREMITY TOPICS TOO IMPORTANT TO MISS |
| Heepeel Chang, MD |
11/19/2025 10:40 AM |
42 |
Presenter |
Surprisingly Occlusion Of One Or Both Hypogastric Arteries During EVAR Does Not Result In Colon Ischemia Or Other Serious Consequences: From A Large VQI Study |
| Heepeel Chang, MD |
11/21/2025 3:48 PM |
85 |
Presenter |
Surprisingly A Bovine Aortic Arch Does NOT Confer Increased Stroke Risk With TFCAS: From A Large VQI Study |
| Robert W. Chang, MD |
11/20/2025 3:00 PM |
52 |
Presenter |
How AI And 3D Imaging Software Can Improve Aortic Screening And Surveillance Of AAAs Before And After Invasive Treatment: Should Screening Groups Be Expanded |
| Robert W. Chang, MD |
11/18/2025 8:02 AM |
10 |
Presenter |
How AI Analysis Of Plaque Features On CT, Ultrasound And MRI Can Predict Stroke Risk More Accurately To Eliminate Unnecessary Invasive Procedures For ACS: While Medical Treatment Is Improving, A Few ACS Patients May Benefit From CAS Or CEA: When Will We Know |
| Zhong Chen, MD |
11/18/2025 |
12, |
Session
Moderator |
PROGRESS IN THE TREATMENT OF AORTIC AND AORTOILIAC OCCLUSIVE DISEASE (AIOD) |
| Jae S. Cho, MD |
11/20/2025 1:00 PM |
59 |
Presenter |
Perigraft Seromas After PTFE Lower Extremity And Aortic Arterial Grafts: Frequency, Etiology, When Do They Need To Be Treated And How |
| Jae S. Cho, MD |
11/18/2025 4:44 PM |
7 |
Presenter |
Ultrasonic Emulsification And Aspiration For Coral Reef Atherosclerosis As A Novel Alternative To Transaortic Endarterectomy And Thoracic Aorta-Based Bypass Grafting |
| Timothy A.M. Chuter, MD |
11/20/2025 3:24 PM |
61 |
Presenter |
Why A Curved Angioplasty Balloon Would Be Beneficial: Where Does It Stand In Development: How Does It Work And When Will It Be Available |
| Timothy A.M. Chuter, MD |
11/20/2025 |
48, |
Session
Moderator |
PROGRESS IN FENESTRATED AND BRANCHED EVAR (F/B/EVAR) AND PARALLEL GRAFTS FOR COMPLEX AAAs AND TAAAs; AND RELATED TOPICS
|
| Timothy A.M. Chuter, MD |
11/20/2025 |
61, |
Session
Moderator |
NEW OR IMPROVED ENDOVASCULAR DEVICE COMBINATIONS FOR LOWER EXTREMITY TREATMENTS: ANGIOPLASTY BALLOON IMPROVEMENTS
|
| Daniel G. Clair, MD |
11/18/2025 10:54 AM |
12 |
Presenter |
Intravascular Lithotripsy (IVL - Shockwave-J&J) Improves The Endovascular Treatment Of Aortoiliac Lesions: Indications, New Technology (L6 And E8 IVL Catheters) And Technical Tips For Use |
| Daniel G. Clair, MD |
11/18/2025 |
12, |
Session
Moderator |
PROGRESS IN THE TREATMENT OF AORTIC AND AORTOILIAC OCCLUSIVE DISEASE (AIOD) |
| Timothy W.I. Clark, MD |
11/18/2025 1:42 PM |
19 |
Presenter |
Treatment Of Pedal Arch Occlusive And Stenotic Lesions: Thrombectomy Tools And Techniques That Work |
| Timothy W.I. Clark, MD |
11/18/2025 5:48 PM |
22 |
Presenter |
Simple, Quick And Safe Conversion Of Retrograde Arterial Access To Antegrade Femoral Access And How To Get A Guidewire Going Into The Deep Femoral Artery Into The SFA |
| Rachel E. Clough, PhD, FRCS |
11/18/2025 1:06 PM |
13 |
Presenter |
Is Image Fusion Advanced Guidance For Complex And Simple Aortic Procedures: When Is It Certainly Worthwhile Because It Decreases Radiation Exposure And When Do We Need An RCT To Show Its Benefits |
| W. Darrin Clouse, MD |
11/21/2025 3:36 PM |
85 |
Presenter |
With Tandem Carotid Lesions In The Neck And Supra-Aortic Trunks, How Should Acutely Symptomatic Patients Be Managed: What About Asymptomatic Patients With Such Lesions: Controversies And Optimal Strategy |
| W. Darrin Clouse, MD |
11/18/2025 4:30 PM |
15 |
Presenter |
Current Role For Open SMA Reconstruction In The Endo-First Era: When Is Retrograde Open Mesenteric Stenting (ROMS) Indicated |
| Dawn M. Coleman, MD, FACS |
11/18/2025 2:48 PM |
14 |
Presenter |
Recent Developments In Vascular Surgery Training Programs: Changes In Numbers And Quality Of 0+5 And 5+2 Trainees; Why We Need More Qualified Vascular Surgeons And How Are We Going To Get Them |
| Dawn M. Coleman, MD, FACS |
11/21/2025 4:24 PM |
94 |
Presenter |
Evolving Techniques In Pediatric Vascular And Endovascular Trauma Surgery: What Special Precautions Are Needed: How To Deal With Arterial Spasm: When And How Can Endovascular Grafts Be Used |
| Anthony J. Comerota, MD, FACS, FACC |
11/19/2025 7:04 AM |
31 |
Presenter |
All Acute Adverse Events From Arteriosclerosis (Stroke, MI, ALI) Depend On Thrombosis: This Explains The Positive Outcomes From The Use Of Rivaroxaban In The VOYAGER And COMPASS Trials: Recent VOYAGER Data Show That Rivaroxaban Improves Claudication Symptoms |
| Michael S. Conte, MD |
11/18/2025 4:12 PM |
21 |
Presenter |
DEBATE: Not So: Some Patients Should Undergo A Bypass As The First Procedure: Which Ones |
| Michael S. Conte, MD |
11/19/2025 |
25, |
Session
Moderator |
LOWER EXTREMITY TOPICS RELATED TO BTK LESION STENTING – STANDARD AND NEW BIORESORBABLE
|
| George Coritsidis, MD |
11/22/2025 8:30 AM |
110 |
Presenter |
Point Of Care Ultrasound For Assessing AV Fistula Maturation And Facilitating Safe Cannulation In Outpatient Hemodialysis |
| Joseph S. Coselli, MD |
11/19/2025 5:36 PM |
46 |
Presenter |
An Innovative New Stapling Device To Facilitate Aortic Anastomoses: How Does It Work And What Makes It Different And Limitations |
| Joseph S. Coselli, MD |
11/18/2025 8:32 AM |
2 |
Presenter |
Open Repair Of The Aortic Arch And Frozen Elephant Trunk (FET) With The ThoacoFlex (Terumo) Device Is Often Necessary And Best; It Can Easily Be Combined With TEVAR: Indications And Results |
| Victor S. Costache, MD, PhD |
11/18/2025 10:36 AM |
4 |
Presenter |
Value Of Multilayer Uncovered Stents To Treat Aortic Dissections (Type A And B): Indications And Limitations, Long Term Results And When Are They The Easiest And Best Treatment |
| Victor S. Costache, MD, PhD |
11/19/2025 11:34 AM |
42 |
Presenter |
Treatment With 9 Years Of Follow Up Of Aortic Dissections With Multilayer Bare Stents: When Are They Effective And When Aren't They |
| Frank J. Criado, MD |
11/19/2025 2:00 PM |
36 |
Presenter |
The Sudden Death And Revealing Autopsy Of King George II In 1760: A 265-Year Perspective On Aortic Dissection And How It Influenced History |
| Frank J. Criado, MD |
11/19/2025 7:57 AM |
40 |
Presenter |
Origins Of Intramural Hematomas (IMHs): Why So Many Prove Benign And Do Well With Medical Treatment: When And How To Treat Them With TEVAR |
| Frank J. Criado, MD |
11/18/2025 9:26 AM |
3 |
Presenter |
A Critical Look At Asymmetrical Saccular Aneurysms Of The Thoracic Aorta: How To Best Measure And Define Diameter: Do They Rupture When Small: Should They All Be Considered Ticking Time Bombs Regardless Of Size |
| Jack L. Cronenwett, MD |
11/19/2025 |
36, |
Session
Moderator |
MORE ISSUES IMPORTANT IN VASCULAR SURGERY: HISTORY, PRACTICE PATTERNS, VALUE OF GUIDELINES AND RCTs, MALPRACTICE, SCIENCE, TRAINING AND HUMAN BEHAVIOR |
| Jacob Cynamon, MD, FACR, FSIR |
11/19/2025 10:24 AM |
33 |
Presentation
Moderator |
Limb Salvage From Dotter To Stents And Beyond: Regulatory Hurdles Then And Now |
| Jacob Cynamon, MD, FACR, FSIR |
11/19/2025 10:36 AM |
33 |
Presenter |
The History And Future Of Clot Management: Fogarty, Thrombolysis, Thrombectomy, Etc. |
| Jacob Cynamon, MD, FACR, FSIR |
11/20/2025 |
54, |
Session
Moderator |
PROGRESS IN RADIATION SAFETY, DEVICES AND TECHNIQUES |
| Jacob Cynamon, MD, FACR, FSIR |
11/21/2025 |
89, |
Session
Moderator |
PROGRESS IN VASCULAR IMAGING AND GUIDANCE FOR ENDOVASCULAR TREATMENTS; DECREASING RADIATION EXPOSURE OR CONTRAST TOXICITY
|
| Michael D. Dake, MD |
11/18/2025 9:56 AM |
3 |
Presenter |
Update On Total And Partial Aortic Arch Lesion Repairs With The Gore TAG Thoracic Branch Endograft (TBE) Branch Endograft: An Off-The-Shelf (OTS) Device For Revascularizing Arch Branches: Experience To Date Across Zones 0 And 1: Advantages And Limitations |
| Michael D. Dake, MD |
11/18/2025 |
3, |
Session
Moderator |
PROGRESS IN THE ENDOVASCULAR TREATMENT OF THE ASCENDING AORTA, AORTIC ARCH, AORTIC DISSECTIONS, STABILISE, THORACIC AORTA AND MORE
|
| Ronald L. Dalman, MD |
11/19/2025 1:12 PM |
43 |
Presenter |
How Does Patient Age At Endograft Implantation Influence The Durability Of EVAR Success: How Should This Guide The Choice Of Endo vs Open Repair |
| Ronald L. Dalman, MD |
11/18/2025 1:24 PM |
5 |
Presenter |
Update On Medical Treatment Trials To Slow AAA Growth: What Treatments Or Drugs Show Promise And Why: What About Metformin And The MAAAGI And MAT Trials |
| Ronald L. Dalman, MD |
11/19/2025 5:10 PM |
38 |
Presenter |
Leveraging The Vascular Quality Initiative To Reduce Length Of Stay Following EVAR And CEA |
| Ronald L. Dalman, MD |
11/18/2025 |
5, |
Session
Moderator |
NEW DEVELOPMENTS IN ABDOMINAL AORTIC ANEURYSM (AAA) ETIOLOGY, DETECTION, TREATMENT AND EVAR |
| R. Clement Darling III, MD |
11/20/2025 2:24 PM |
52 |
Presenter |
Open Retroperitoneal Aortic Approach For Ruptured AAAs: Technical Tips, Advantages And Limitations: When Is It Better Than EVAR And F/EVAR |
| R. Clement Darling III, MD |
11/18/2025 |
16, |
Session
Moderator |
PROGRESS IN THE TREATMENT OF AORTIC COARCTATIONS AND EXPERT TECHNICAL SKILLS FOR OPEN VASCULAR OPERATIONS |
| Alun H. Davies, MA, DM, DSc, FRCS, FLSW, FMedSci, FEBVS |
11/18/2025 11:37 AM |
18 |
Panelist |
Challenging The Experts: Interactive Q&A |
| Alun H. Davies, MA, DM, DSc, FRCS, FLSW, FMedSci, FEBVS |
11/18/2025 1:00 PM |
5 |
Presenter |
Are We Over Treating Patients With AAA: Which Patients Should NOT Be Treated Invasively Based On Frailty, Comorbidities, Anatomy And Aneurysm Size |
| Alun H. Davies, MA, DM, DSc, FRCS, FLSW, FMedSci, FEBVS |
11/18/2025 4:36 PM |
22 |
Presenter |
Why Ankle Brachial Indices (ABIs), Toe Pressures, Handheld Doppler Signals And Doppler Wave Forms May Be Misleading In Diabetics With CLTI: Pulse Volume Recordings Are Always Reliable |
| Mark G. Davies, MD |
11/18/2025 10:55 AM |
18 |
Presenter |
Pulmonary Denervation: A New Frontier In The Treatment Of Pulmonary Hypertension |
| Mark G. Davies, MD |
11/22/2025 3:22 PM |
115 |
Presenter |
Management Strategies For Cephalic Arch Stenosis |
| Brian G. DeRubertis, MD |
11/19/2025 10:48 AM |
26 |
Presenter |
DESs vs Bare Stents: Data From The TRUETA Trial: What New Information Influencing Practice Comes From This Large Data Analysis |
| Brian G. DeRubertis, MD |
11/19/2025 2:06 PM |
27 |
Presenter |
Alternate Catheter Based System For DVA: The Boomerang Device And Trial (Cardiva Medical) Creates An Endovascular A-V Fistula Without the Need For A Stent-Graft: How Does It Work: Advantages And Results |
| Brian G. DeRubertis, MD |
11/19/2025 9:24 AM |
25 |
Presenter |
With The Good Results Of The DERSs: After Their Approval What Unmet Needs In The Treatment Of BTK Disease Remain To Be Met |
| Brian G. DeRubertis, MD |
11/18/2025 |
22, |
Session
Moderator |
MORE HOT NEW TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE, CLTI AND ITS TREATMENTS
|
| David H. Deaton, MD FACS |
11/19/2025 2:54 PM |
44 |
Presenter |
DEBATE: Large Amount Of AAA Sac Thrombus Promotes Morbidity Without Rupture And With Rupture: By What Mechanisms Is Thrombus Harmful And How Can Thrombus Load Be Quantitated |
| David H. Deaton, MD FACS |
11/20/2025 7:24 AM |
55 |
Presenter |
A New 11 Fr EVAR Device (From Major Medical) capable Of Delivery From The Upper Extremity: How Does It Work And Why Won't It Be Flimsy Like Other Low Profile Devices |
| David H. Deaton, MD FACS |
11/20/2025 |
62, |
Session
Moderator |
NEW OR IMPROVED DEVICES AND TECHNIQUES TO PREVENT OR TREAT ENDOLEAKS OR DEVICE MIGRATION: ENDOANCHORS, ETC.
|
| Sebastian E. Debus, MD, PhD |
11/20/2025 9:26 AM |
57 |
Presenter |
Updated Clinical Experience And Advantages Of The Thoracoflo Graft (Terumo) For The Hybrid Repair Of TAAAs (Proximal TEVAR; Distal Open) How And Why To Preserve IMA Flow And Other Technical Tips |
| Colin P. Derdeyn, MD |
11/18/2025 8:08 AM |
10 |
Presenter |
A Neuroradiologist's View Of Current Interventions For Extracranial Carotid Disease: Do They Represent Exuberant Enthusiasm, Financial Opportunity For Industry, Doctors And Institutions, Or A Path To Excessive Risk: Impact Of The Recent Expanded Medicare Reimbursement For CAS |
| Colin P. Derdeyn, MD |
11/18/2025 9:28 AM |
11 |
Presenter |
Current Status Of Intracranial Angioplasty And Stenting And EC - IC Bypasses: Indications And Results |
| David J. Dexter, MD |
11/20/2025 1:18 PM |
59 |
Presenter |
Heparin Coated PTFE Grafts (Propaten - Gore) vs Autologous Vein Grafts For Bypasses To Targets Above And Below The Knee: The Heparin Coated Grafts Are Better And Worth The Cost: Based On A Propensity Matched Analysis |
| David J. Dexter, MD |
11/20/2025 5:19 PM |
63 |
Presenter |
Novel Thrombus Aspiration System (Prodigy From TRUVIC Medical) For Removing Arterial And Venous Clots: How Does It Work, Advantages And Results |
| Nuno V. Dias, MD, PhD |
11/20/2025 2:54 PM |
52 |
Presenter |
For Ruptured Complex AAAs A Short Custom Made Single Fenestrated Graft Can Be Used To Revascularize The SMA Followed By A Bifurcated Graft And Laser Fenestration For The Renal Arteries: Technique And Experience |
| Nuno V. Dias, MD, PhD |
11/19/2025 8:45 AM |
40 |
Presenter |
With Chronic TBADs Laser Assisted Resection Of The Dissection Septum Or Membrane Septotomy Creates A Single Lumen For A TEVAR Landing Zone: How Is This Technique Performed And Updated Results |
| Nuno V. Dias, MD, PhD |
11/18/2025 9:20 AM |
3 |
Presenter |
Results From Multicenter Experience Of Endovascular Arch Repair With Exclusively Retrograde Branches (Femoral Access) Placed Through Orifices In The Aortic Graft: Which Devices, Value Of The Steerable Sheath And Technical Tips |
| Alan M. Dietzek, MD, RPVI, DFSVS |
11/18/2025 2:42 PM |
14 |
Presenter |
Why The ABVS, An Organization Committed To Establish An Independent ABMS Approved Board of Vascular Surgery, Has Been Unable To Make Significant Progress For The Past 6 Years |
| Hasan H. Dosluoglu, MD |
11/19/2025 1:24 PM |
27 |
Presenter |
Long-Term Multicenter Outcomes Show That Prosthetic (PTFE) Bypasses To Tibial And Peroneal Arteries Are Worthwhile |
| Hasan H. Dosluoglu, MD |
11/18/2025 1:36 PM |
19 |
Presenter |
Tissue Necrosis Persisting Despite A Patent Endovascular Intervention Can Be Healed By An Additional Bypass: What Is The Mechanism And The Experience |
| Hasan H. Dosluoglu, MD |
11/19/2025 |
27, |
Session
Moderator |
PROGRESS IN EXOTIC AND EXTREME NEW TREATMENTS FOR VERY DISTAL LOWER EXTREMITY DISEASE CAUSING ADVANCED CLTI: OPTIONS TO SAVE THE “NO OPTION FOR TREATMENT” LIMB AND THE “DESERT FOOT”
|
| Matthew J. Dougherty, MD |
11/22/2025 3:14 PM |
115 |
Presenter |
Strategies For Hemodialysis Access In Patients With Implanted Cardiac Devices |
| Maciej L. Dryjski, MD, PhD |
11/19/2025 8:06 AM |
32 |
Presenter |
Congestive Heart Failure And A Low Ejection Fraction Negatively Influence The Duration Of Patency Following Lower Extremity Bypasses: What To Do About It |
| Maciej L. Dryjski, MD, PhD |
11/20/2025 |
60, |
Session
Moderator |
NEW OR IMPROVED ENDOVASCULAR DEVICES FOR LOWER EXTREMITY TREATMENTS: ATHERECTOMY, STENTS, ACCESSORIES, ETC. (SEE ALSO SESSIONS 23-27)
|
| Joseph J. DuBose, MD |
11/20/2025 11:31 AM |
50 |
Presenter |
Update On The Management Of Arterial And Venous Injuries – Civilian And Military: When Should The Treatment Be "Endovascular First" And When Should It Be Open Surgery: Equipment And Training Are Important Determinants |
| Joseph J. DuBose, MD |
11/21/2025 3:48 PM |
94 |
Presenter |
Update On Resuscitative Endovascular Balloon Occlusion Of The Aorta (REBOA): When Is It A Valuable Procedure And When Is It Not: Limitations And Precautions |
| Anahita Dua, MD, MS, MBA |
11/19/2025 1:54 PM |
27 |
Presenter |
Results With LimFlow Deep Vein Arterialization (DVA) Are So Good That There Are Few CLTI Patients That Are Truly "No Option" For Invasive Treatment: What Are The Adjuncts To The Procedure That Contribute To Its Success – Anticoagulation, Etc. |
| Anahita Dua, MD, MS, MBA |
11/19/2025 4:06 PM |
45 |
Presenter |
Ultra Low Profile, Fully Retractable And Repositionable Transaxillary Endovascular Graft Device For Infrarenal AAA Repair: How Does It Work And Advantages |
| Anahita Dua, MD, MS, MBA |
11/19/2025 |
28, |
Session
Moderator |
NEW DEVELOPMENTS IN PROSTHETIC GRAFTS; STENT GRAFTS; PERCUTANEOUS ENDOVASCULAR BYPASSES; STENT OCCLUSIONS AND TREATMENT OF IN STENT RESTENOSIS (ISR) |
| David M. Dudzinski, MD |
11/18/2025 7:25 AM |
17 |
Presenter |
Echocardiography Is All You Need To Manage Acute Submassive PE |
| Audra A. Duncan, MD |
11/18/2025 5:00 PM |
16 |
Presenter |
Technical Pearls To Facilitate Open Repairs Of Complex AAAs |
| Audra A. Duncan, MD |
11/21/2025 8:14 AM |
88 |
Presenter |
Current Concepts In The Management Of Endograft Infections After EVAR: When And How Can The Endograft Be Preserved |
| Matthew J. Eagleton, MD |
11/18/2025 7:38 AM |
9 |
Presenter |
Status Of The 3D Radiation Free Electromagnetic Intraoperative Positioning System (IOPS From Centerline) For Endovascular Guidance: How Does It Work, Advantages And Limitations: How Widespread Is Its Usage |
| Matthew J. Eagleton, MD |
11/20/2025 8:00 AM |
55 |
Presenter |
5-Year Results And Advantages Of The TREO (Terumo) Endograft For Standard Infrarenal EVARs: Status In The US |
| Matthew J. Eagleton, MD |
11/18/2025 |
9, |
Session
Moderator |
PROGRESS IN VASCULAR ROBOTICS AND IMAGING AND GUIDANCE SYSTEMS WITH LESS RADIATION AND CONTRAST
|
| John F. Eidt, MD |
11/18/2025 3:06 PM |
14 |
Presenter |
How To Handle Bad Clinical Outcomes And Other Professional And Personal Adversity: It Really Matters For A Vascular Surgeon/Specialist/Trainee |
| John F. Eidt, MD |
11/20/2025 3:58 PM |
53 |
Presenter |
Implantable Carotid Stent-Like Device To Stimulate The Carotid Sinus Nerve (Of Hering) And Treat Intractable Heart Failure And Hypertension (The Barostim System): How Does It Work And Current Clinical Status |
| John F. Eidt, MD |
11/21/2025 8:38 AM |
88 |
Presenter |
Improvements In The NAIS Procedure (Graft Removal And In-Line Deep Vein Reconstruction) For Infected Aortic Grafts: How To Make The Operation Easier And Faster: When Is It Indicated And When Not |
| Hosam F. El Sayed, MD |
11/21/2025 5:06 PM |
86 |
Presenter |
Optimal Treatment For Deep Groin Infection After Prosthetic Bypasses From The Common Femoral Artery: How To Save The Graft, The Patient And The Extremity |
| Jens Eldrup-Jorgensen, MD |
11/19/2025 2:42 PM |
36 |
Presenter |
Vascular Surgeons/Specialists Need To Develop High Quality Evidence To Improve Care: Why And How To Do It: How Registry-Based RCTs Can Help: What Are They, Why Are They Different From And Better Than Standard RCTs |
| Guillermo A. Escobar, MD |
11/20/2025 4:40 PM |
53 |
Presenter |
Technical Tips For Removing Lost Or Malpositioned Intravascular Stents, Wires, Etc.: It Can Be Difficult And Special Techniques May Be Required |
| Guillermo A. Escobar, MD |
11/21/2025 8:26 AM |
88 |
Presenter |
Update On Rifampin Soaked Endografts To Treat Mycotic AAAs: How To Prepare Them: When To Use Them And When Not: When Are They A Stand-Alone Treatment And When Are They A Life Saving Measure Requiring Further Definitive Treatment |
| Ignacio Escotto, MD |
11/20/2025 1:54 PM |
60 |
Presenter |
Atherectomy In Patients With CLTI And Diabetes For In Stent Restenosis (ISR): When Is It Helpful; How Durable Is It: Which Devices Are The Best |
| Anthony L. Estrera, MD |
11/18/2025 7:50 AM |
1 |
Presenter |
DEBATE: Not So: Combined Ascending Aorta And Valve Disease Is Still And Will Be Best Treated By Open Surgery |
| Yana Etkin, MD |
11/22/2025 10:50 AM |
111 |
Presenter |
Is Regional Anesthesia The Best Option For Hemodialysis Access |
| Yana Etkin, MD |
11/22/2025 8:00 AM |
106 |
Presenter |
Open Treatment First For CLTI In The Era Of BEST-CLI: When Is It Best: It's Not Just For Patients With Good Ipsilateral Great Saphenous Veins |
| Yana Etkin, MD |
11/22/2025 |
112, |
Session
Moderator |
MINISYMPOSIUM: MANAGEMENT OF THE COMPLEX HEMODIALYSIS PATIENT |
| Christian D. Etz, MD, PhD |
11/21/2025 7:16 AM |
79 |
Presenter |
Current Strategies To Minimize SCI With TAAA Repairs (Endo And Open) By Improving The Intraspinal Collateral Arterial Network: Status Of Intercostal Embolization As Preconditioning To Prevent Ischemia (MIS2ACE): Update On Progress Of The PAPA-ARTIS RCT |
| Christian D. Etz, MD, PhD |
11/21/2025 |
79, |
Session
Moderator |
PROGRESS IN THE PREVENTION AND TREATMENT OF SPINAL CORD ISCHEMIA (SCI) ASSOCIATED WITH THE TREATMENT OF THORACIC, THORACOABDOMINAL AND COMPLEX ABDOMINAL ANEURYSMS |
| Gianluca Faggioli, MD |
11/21/2025 10:17 AM |
81 |
Presenter |
DEBATE: Not So: A Systematic Review Shows NO Benefit In Cognitive Function From Invasive Treatment Of Carotid Stenosis |
| Alex Fairman, MD |
11/18/2025 3:36 PM |
15 |
Presenter |
Diagnosis and Management of Renal Artery Stenosis With Or Without Mid-Aortic Syndrome In Pediatric Patients: Open Aortic Surgery Is Alive And Well: When Is Stenting Justified |
| Alex Fairman, MD |
11/20/2025 4:16 PM |
53 |
Presenter |
Median Arcuate Ligament Syndrome (MALS) In The Pediatric Population: Diagnosis And Optimal Treatment |
| Fabrizio Fanelli, MD, EBIR |
11/19/2025 10:24 AM |
26 |
Presenter |
Comparative Long-Term Outcomes With DESs And DCBs To Treat Fem-Pop Lesions: Unique Observations After 2-12 Years In 1000 Patients: What Is The Best Technique For Vessel Preparation |
| Fabrizio Fanelli, MD, EBIR |
11/18/2025 3:54 PM |
21 |
Presenter |
DEBATE: IVUS-Guided Revascularization Of Fem-Pop Lesions: Advantages, Limitations And Why It's Better Than Duplex Guided Treatment |
| Fabrizio Fanelli, MD, EBIR |
11/19/2025 |
35, |
Session
Moderator |
RECORDED LIVE CHALLENGING CASES AND INNOVATIVE TECHNIQUES FROM THE PLINIO ROSSI AND LINC COMPONENTS
|
| Alik Farber, MD, MBA |
11/19/2025 3:54 PM |
29 |
Presenter |
What New Conclusions Can Be Reached By Combining The Data From BEST-CLI And BASIL Trials: When Are They Applicable And When Are They Not |
| Alik Farber, MD, MBA |
11/22/2025 9:08 AM |
107 |
Presenter |
Outcomes Of Greater Saphenous Vein (GSV) Bypasses In The Setting Of Traumatic Injuries: Do They Differ From Those Of GSV Bypasses For Occlusive Disease And If So Why |
| Alik Farber, MD, MBA |
11/19/2025 |
30, |
Session
Moderator |
NEW DEVELOPMENTS IN THE TREATMENT OF INTERMITTENT CLAUDICATION (IC) AND ACUTE LIMB ISCHEMIA (ALI)
|
| Mark A. Farber, MD |
11/20/2025 10:58 AM |
58 |
Presenter |
Endovascular Arch Repair With Cook 2 Or 3 Branched Devices For Lesions Involving The Whole Aortic Arch: When Are They Indicated; When Contradicted And Tips For Making Them Work |
| Mark A. Farber, MD |
11/18/2025 5:20 PM |
8 |
Presenter |
DEBATE ROUND 3: With Acute Uncomplicated TBADs, The Case For Waiting 2-6 Weeks From Onset For TEVAR And Then Limiting Aortic Coverage: Then Facts Support It |
| Mark A. Farber, MD |
11/20/2025 9:03 AM |
48 |
Presenter |
Why Balloon Expandable Bridging Stent-Grafts Are Best For F/B/EVAR: Which One Is Best And Why: A US Perspective: Advantages Of The Gore VBX Stent-Graft |
| Mark A. Farber, MD |
11/18/2025 |
2, |
Session
Moderator |
PROGRESS IN THE TREATMENT OF AORTIC ARCH LESIONS AND AORTIC DISSECTIONS |
| Mark A. Farber, MD |
11/18/2025 |
7, |
Session
Moderator |
MORE NEW DEVELOPMENTS IN THE TREATMENT OF THORACIC AORTIC PATHOLOGY INCLUDING CORAL REEF AORTA
|
| Peter L. Faries, MD, FACS |
11/21/2025 1:48 PM |
83 |
Presenter |
Optimal Current Management Of Carotid Stenosis After Radiation Therapy For Cancer - Symptomatic And Asymptomatic: What Is The Pathology: How Is It Best Treated And How Results Differ From Standard Carotid Stenosis |
| Peter L. Faries, MD, FACS |
11/20/2025 2:24 PM |
60 |
Presenter |
Xact Carotid Stent (Abbott) With A Short-Transcarotid Access Delivery System For TCAR Procedures: Advantages And Results |
| Peter L. Faries, MD, FACS |
11/21/2025 2:30 PM |
84 |
Presenter |
Current Optimal Treatment Of Extracranial Carotid Aneurysms: When Endo, When Open: Technical Tips |
| Peter L. Faries, MD, FACS |
11/21/2025 8:42 AM |
80 |
Presenter |
IVL (Shockwave) For Treating Symptomatic Patients With Heavily Calcified Carotid Stenoses By TCAR And TFCAS: Technical Tips And Results |
| Javairiah Fatima, MD |
11/20/2025 5:22 PM |
54 |
Presenter |
How Does The EggNest System Of Radiation Protection Help Us Prevent Eye Damage, Cancer, Osteoporosis, Etc. During Endovascular Procedures: How And How Well Does The System Work |
| Marcelo Ferreira, MD |
11/20/2025 9:44 AM |
57 |
Presenter |
T-Branch Off-The-Shelf (OTS) Endograft (Cook) For Treatment Of TAAAs: Technical Tips, Indications, Limitations And Long-Term Results |
| Ciro Ferrer, MD, PhD |
11/20/2025 9:38 AM |
57 |
Presenter |
How To Reduce Reinterventions After F/B/EVAR By Improving Branch Stability: Technical Tips |
| Timothy Fitzpatrick, MD |
11/22/2025 1:08 PM |
113 |
Presenter |
A Futuristic View Of Dialysis Access Innovations |
| Thomas L. Forbes, MD |
11/18/2025 3:18 PM |
21 |
Presenter |
DEBATE: Why Endarterectomy Is Still The Best Approach For All CFA Lesions |
| Thomas L. Forbes, MD |
11/18/2025 4:20 PM |
7 |
Presenter |
Transposition vs Bypass vs Endo: What Is The Best Option For Revascularization Of The Left Subclavian Artery (LSA) During TEVAR |
| Thomas L. Forbes, MD |
11/18/2025 |
7, |
Session
Moderator |
MORE NEW DEVELOPMENTS IN THE TREATMENT OF THORACIC AORTIC PATHOLOGY INCLUDING CORAL REEF AORTA
|
| Thomas L. Forbes, MD |
11/19/2025 |
34, |
Session
Moderator |
ISSUES IMPORTANT TO VASCULAR SURGEONS/SPECIALISTS |
| Thomas L. Forbes, MD |
11/20/2025 |
51, |
Session
Moderator |
PROGRESS IN THE TREATMENT OF RUPTURED INFRARENAL AAAs |
| Mazin Foteh, MD |
11/19/2025 10:16 AM |
41 |
Presenter |
Open TAAA Repair With The Thoracoflo (Terumo) Hybrid Graft System For Failed Open And Endovascular Aortic Repairs: Technical Tips, Advantages, Limitations And Results |
| Mazin Foteh, MD |
11/19/2025 11:46 AM |
42 |
Presenter |
Thoraflex Hybrid Graft Rescue When Treatment Of Aortic Dissection In The Arch With Bare Stents (AMDS From Artivion And Allay From Intressa) Fails: What Is The Mechanism Of Failure And What Is The Bailout Procedure |
| Mazin Foteh, MD |
11/20/2025 7:18 AM |
55 |
Presenter |
Rescue Techniques For Late Type 1A Endoleaks After Alto Stent Graft Treatment Of AAA; How To Deal With The Large Barbed Suprarenal Stent |
| Charles J. Fox, MD, FACS |
11/21/2025 7:40 AM |
87 |
Presenter |
Optimal Surgical Approach And Graft For Popliteal Artery Injuries: Can Tissue Engineered Human Biological Grafts (Humacyte) Be Used Effectively: How Best To Treat Associated Popliteal Venous Injuries: Best Venous Graft |
| Weiguo Fu, MD |
11/20/2025 |
49, |
Session
Moderator |
MORE PROGRESS IN F/B/EVAR AND PARALLEL GRAFTS FOR COMPLEX AAAs AND TAAAs; AND RELATED TOPICS |
| Weiguo Fu, MD |
11/20/2025 |
58, |
Session
Moderator |
NEW OR IMPROVED DEVICES FOR THE AORTIC ARCH OR NEAR THE ARCH, TAAAs AND TEVAR |
| Naoki Fujimura, MD, PhD |
11/19/2025 5:24 PM |
46 |
Presenter |
DEBATE: Preemptive IMA And Lumbar Coil Embolization Before EVAR Does NOT Improve EVAR Outcomes: From The CLARIFY IMA Trial: Is It Ever Beneficial |
| Naoki Fujimura, MD, PhD |
11/22/2025 7:30 AM |
106 |
Presenter |
In Patients Requiring Endovascular Intervention For FemPop Disease What Lesion Characteristics Should Determine Whether DCB or DES Treatment Is Best |
| Naoki Fujimura, MD, PhD |
11/20/2025 7:54 AM |
55 |
Presenter |
AFX (Endologix) And Excluder (Gore) Endografts For AAA Treatment Had Comparable 5-Year Outcomes: However The AFX Graft Was Best With Conical Necks: From A Japanese Multicenter Study (Activseal) |
| Naoki Fujimura, MD, PhD |
11/19/2025 9:42 AM |
33 |
Presenter |
When Do Persistent Type 2 Endoleaks After EVAR Lead To AAA Rupture: How Can Such Ruptures Be Predicted And How Should They Be Treated With Different Endografts |
| Vijay Gadhvi, MBBS, MSc |
11/22/2025 10:18 AM |
108 |
Presenter |
The Alto Endograft (Endologix) Is As Good Or Better Than F/EVAR For Some Short Necked Juxtarenal AAAs: From 5-Year Results Of The UK-COMPASS Trial |
| Ripal T. Gandhi, MD, FSVM, FSIR |
11/21/2025 10:04 AM |
89 |
Presenter |
Simple And Not So Simple Radiation Protection Techniques And Devices: What's Here And What's On The Horizon |
| Lawrence A. Garcia, MD |
11/19/2025 11:12 AM |
26 |
Presenter |
What's New And What's Next For The Treatment Of BTK Lesions: When Is POBA Still Acceptable And What About Drug Eluting And Non-Drug Eluting Devices, Resorbable Or Not |
| Lawrence A. Garcia, MD |
11/19/2025 9:36 AM |
25 |
Presenter |
How Does The LIFE BTK Study With Esprit Bioresorbable DERS (From Abbott) Change The BEST-CLI Conclusions For BTK Lesions |
| Karan Garg, MD |
11/18/2025 2:06 PM |
5 |
Presenter |
Unexpected Small Bowel Necrosis When Performing EVAR In Patients With Visceral Artery (SMA) Occlusive Disease: How To Predict It And How To Avoid It |
| Mauro Gargiulo, MD |
11/21/2025 3:30 PM |
85 |
Presenter |
Cervical Carotid Artery Open Approaches For TAVR And TCAR: Technical Tips, Complications And How To Avoid Them |
| Mauro Gargiulo, MD |
11/20/2025 9:50 AM |
57 |
Presenter |
T-Branch OTS Endografts (Cook) For The Treatment Of Failed EVAR: Indications, Advantages, Limitations And Clinical Experience |
| Hugh A. Gelabert, MD |
11/21/2025 1:56 PM |
92 |
Presenter |
What's New In The Management Of Vascular And Neurogenic TOSs In Athletes |
| Elizabeth L. George, MD |
11/21/2025 3:18 PM |
93 |
Presenter |
Twenty Years Of Large Blood Vessel Management In The Treatment Of Retroperitoneal Sarcomas: Lessons Learned And Why A Vascular Surgeon Is Critical To Successful Treatment |
| Patrick J. Geraghty, MD |
11/19/2025 11:30 AM |
26 |
Presenter |
Update On The SELUTION4BTK RCT Comparing A Sirolimus-Coated DCB (From Cordis/Medalliance) With POBA For BTK Lesions |
| Patrick J. Geraghty, MD |
11/20/2025 3:30 PM |
61 |
Presenter |
Update On The Tack Device (From Philips): Value And Limitations Resulting In An FDA Class I Recall: Can They Be Overcome |
| Patrick J. Geraghty, MD |
11/21/2025 8:06 AM |
80 |
Presenter |
How To Optimize Carotid Stenting Using A Double Mesh Covered Stent (CGuard From InspireMD) And TCAR With Flow Reversal: Device Details And Results |
| Patrick J. Geraghty, MD |
11/22/2025 9:20 AM |
107 |
Presenter |
Novel Uses Of Selective Superficial Venous Arterialization To Achieve Lower Limb Salvage: Techniques, Indications, Precautions And Results |
| Patrick J. Geraghty, MD |
11/19/2025 |
27, |
Session
Moderator |
PROGRESS IN EXOTIC AND EXTREME NEW TREATMENTS FOR VERY DISTAL LOWER EXTREMITY DISEASE CAUSING ADVANCED CLTI: OPTIONS TO SAVE THE “NO OPTION FOR TREATMENT” LIMB AND THE “DESERT FOOT”
|
| George Geroulakos, MD, PhD |
11/19/2025 9:22 AM |
41 |
Presenter |
With Complex AAAs Mortality For Endo Repair Is Lower Than That Of Open Repair: What Other Factors Should Be Considered In Making An Endo vs Open Choice For Each Patient: How Does The UK-COMPASS (Endo vs Open) Study Help |
| Brian B. Ghoshhajra, MD, MBA |
11/18/2025 7:35 AM |
17 |
Presenter |
CTA Is All You Need To Manage Acute Submassive PE |
| Richard G.J. Gibbs, FRCS |
11/22/2025 10:38 AM |
109 |
Presenter |
RCT Comparing CO2 vs Saline Flushing For Stroke Prevention With TEVAR: Do We Really Need CO2: From The INTERCEPT Multicenter study |
| Richard G.J. Gibbs, FRCS |
11/18/2025 3:28 PM |
6 |
Presenter |
Aortic Dissection In Pregnancy: Why Is The Mortality So High: Why Is Its Diagnosis Delayed: How Should Its Treatment Differ From Non-Pregnant Patients |
| Jay Giri, MD, MPH |
11/18/2025 8:25 AM |
17 |
Presenter |
Intravenous Thrombolytic Therapy For PE: Why, When, And At What Dose |
| Rocco Giudice, MD |
11/20/2025 8:08 AM |
48 |
Presenter |
With Complex AAAs (Juxta, Para, TAAAs) What Is The Best Endovascular Treatment And When: Standard F/B/EVAR, Inner Branched B/EVAR (Artivion E-nside) Or Parallel Graft EVAR (Chimney Or Sandwich) |
| Peter Gloviczki, MD |
11/18/2025 |
16, |
Session
Moderator |
PROGRESS IN THE TREATMENT OF AORTIC COARCTATIONS AND EXPERT TECHNICAL SKILLS FOR OPEN VASCULAR OPERATIONS |
| Peter Gloviczki, MD |
11/19/2025 |
45, |
Session
Moderator |
MORE HOT AORTIC TOPICS, PMEGs AND IDEs, GRAFT CHOICES FOR COMPLEX AAAs AND TAAAs
|
| Jerry Goldstone, MD, FACS, FRCSEd |
11/19/2025 2:06 PM |
36 |
Presenter |
From The SVS History Collection: The Importance Of Battlefield Failures In World War II And How They Led To The Formation Of The SVS |
| Jerry Goldstone, MD, FACS, FRCSEd |
11/19/2025 |
36, |
Session
Moderator |
MORE ISSUES IMPORTANT IN VASCULAR SURGERY: HISTORY, PRACTICE PATTERNS, VALUE OF GUIDELINES AND RCTs, MALPRACTICE, SCIENCE, TRAINING AND HUMAN BEHAVIOR |
| Philip P. Goodney, MD, MS |
11/18/2025 3:40 PM |
6 |
Presenter |
What Is The LEAF Initiative For Assessing Long-Term Outcomes For EVAR Devices From Various Manufactures: What Are Some Of The Interesting Findings To Date And How Might They Influence Clinical Practice |
| Philip P. Goodney, MD, MS |
11/22/2025 9:02 AM |
107 |
Presenter |
Endovascular vs Open Repair Of Popliteal Aneurysms: Indications And Contraindications For Each: Comparable Long-Term (5 Years) Durability Can Be Achieved: From The VISION Database |
| Yann Gouëffic, MD, PhD |
11/19/2025 10:42 AM |
26 |
Presenter |
Long-Term Results Of The EMINENT RCT Show The Superiority Of DESs (Eluvia — Boston Scientific) Over Bare Metal Stents For Long Complex FemPop Lesions |
| Yann Gouëffic, MD, PhD |
11/20/2025 1:24 PM |
59 |
Presenter |
Does Heparin Bonding To PTFE Grafts Really Make A Difference And Improve Results: Is The Heparin Bonding To Propaten Grafts (Gore) Different Enough To Improve Results |
| Yann Gouëffic, MD, PhD |
11/19/2025 2:31 PM |
28 |
Presenter |
Heparin-Bonded Expanded PTFE Grafts For BTK Bypasses: What Is The Evidence That They Are Better And Are Propaten (Gore) Grafts The Best For Extensive FemPop Disease: Based On An RCT And A Systemic Review And Meta-Analysis |
| Yann Gouëffic, MD, PhD |
11/18/2025 3:12 PM |
21 |
Presenter |
DEBATE: Endovascular Treatment Of Common Femoral Artery (CFA) Bifurcation Lesions Should Be The Intervention Of Choice: What Is The Eiffel Tower Technique And What Are Its Results |
| Yann Gouëffic, MD, PhD |
11/19/2025 9:48 AM |
25 |
Presenter |
The Value Of Everolimus Eluting Coronary Stents (Xience — Abbott) Bailout Stenting Of BTK Lesions After Angioplasty Causing CLTI: From A Real-World Multicenter Study |
| William A. Gray, MD |
11/21/2025 3:06 PM |
84 |
Presenter |
Neuroguard 3-In-1 Carotid Stent System (Contego Medical) With Integrated Balloon, Stent And Distal Filter: Updated 2-Year Results From The PERFORMANCE II Trial And Advantages Including Preventing Particulate Emboli Released During Presumed Flow Reversal Protected CAS From Reaching The Brain (Or Distal Filter) |
| William A. Gray, MD |
11/22/2025 8:12 AM |
106 |
Presenter |
Adventitial Drug Delivery With The BullFrog Device (From Mercator MedSystems) And The Spur Device (From ReFlow): How Do They Work And How Will We Know They Improve Results |
| William A. Gray, MD |
11/22/2025 |
107, |
Session
Moderator |
MORE LOWER EXTREMITY TOPICS TOO IMPORTANT TO MISS |
| Marcelo Guimaraes, MD, MBA, FSIR |
11/20/2025 4:46 PM |
53 |
Presenter |
Radial Access For Visceral And Lower Extremity Lesions: Equipment, Technical Tip, Limitations And Precautions |
| Wei Guo, MD |
11/19/2025 11:42 AM |
26 |
Presenter |
Late (5-Year) Results From The AcoArt II BTK DCB RCT Show Safety With No Increased Mortality And Improved Patency vs POBA To Treat BTK Lesions |
| Wei Guo, MD |
11/19/2025 6:56 AM |
39 |
Presenter |
Updated Clinical Experience With The Endopatch: A Promising Solution For Endovascular Repairs For Aortic Dissections: What Is It And How Does It Work |
| Wei Guo, MD |
11/20/2025 8:48 AM |
56 |
Presenter |
Current Status Of The WeFlow Endografts For Treatment Of Complex AAAs And TAAAs: A Combined Inner Branch And Outer Branch Device: How Does It Work And Promising Results |
| Sukgu M. Han, MD, MS |
11/20/2025 11:34 AM |
58 |
Presenter |
Status Of And When And How To Use The Gore Conformable CTAG Endograft With Variable Angulation Control Optimally: Advantages And Limitations |
| Sukgu M. Han, MD, MS |
11/19/2025 5:42 PM |
46 |
Presenter |
Mid-Term Outcomes Of Total Endovascular Repair Of The Entire Aorta From Zone 0 To 9: How To Minimize Complications: When Is It Necessary |
| Sukgu M. Han, MD, MS |
11/21/2025 7:04 AM |
79 |
Presenter |
Extra Anatomic Bypasses To Preserve Segmental Spinal Artery Flow And Protect Against SCI With Endo TAAA Repairs: When And How To Do Them |
| Leo Harduin, MD |
11/22/2025 2:31 PM |
114 |
Presenter |
First Results Of The DEScover Randomized Trial Of Drug Eluting Stents vs. PTA In Hemodialysis Access |
| Linda M. Harris, MD |
11/19/2025 3:28 PM |
37 |
Presenter |
Aortic And Lower Extremity Artery Gender Differences Exist In The Treatment And Outcomes Of Vascular Disease: Why Is This So And What Can Be Done To Remedy The Deficiencies That Exist |
| Kenichi Hashizume, MD, PhD |
11/22/2025 10:44 AM |
109 |
Presenter |
Successful Factors For Improving Aortic Remodeling After TBAD Treatment With TEVAR And Bare Stent Extension (Petticoat Technique) |
| Ziv J. Haskal, MD, FACR, FAHA, FSIR |
11/19/2025 10:30 AM |
33 |
Presenter |
Embolization: The Most Transformative And Diverse Innovations Of IR |
| Stephan Haulon, MD |
11/19/2025 5:18 PM |
46 |
Presenter |
DEBATE: An RCT Shows The Advantages Of IMA And Lumbar Embolization: When Should This Be Done And When Is It Unnecessary Before EVAR Dominique Fabre, MD, PhD |
| Stephan Haulon, MD |
11/18/2025 7:44 AM |
1 |
Presenter |
DEBATE: Update On Endo-Bentall Procedures For Combined Ascending Aorta And Valve Disease: Devices And Results To Date: Open Surgery Is Destined To Be Replaced |
| Stephan Haulon, MD |
11/18/2025 9:14 AM |
3 |
Presenter |
Retrograde Branches For Arch Endovascular Repairs: How To Do Them Safely Totally Via Transfemoral Access Using Specialized Reinforced Variable Sheaths: Indications And Results |
| Stephan Haulon, MD |
11/21/2025 9:58 AM |
89 |
Presenter |
Experience With A New Better Setup For A Hybrid OR/Suite: Features, Advantage And Cost: Who Supplies It And What Components Make A Difference For Standard And Advanced Procedures |
| Stephan Haulon, MD |
11/19/2025 |
43, |
Session
Moderator |
NEW DEVELOPMENTS IN AAA BEHAVIOR, TREATMENT AND STANDARD INFRARENAL EVAR: THE INFLUENCE OF DIABETES, BLOOD PRESSURE, AGE, ECT. ON AAA GROWTH;
IMPROVED ULTRASOUND SURVEILLANCE, LOCAL ANESTHESIA FOR EVAR, 3D CTA ANALYSIS, CONSEQUENCES OF AAAs LOST TO FOLLOW-UP AND ALL AAAs ARE NOT TIME BOMBS WAITING TO EXPLODE
|
| Peter Henke, MD |
11/21/2025 2:54 PM |
93 |
Presenter |
Current Optimal Antiplatelet And Anticoagulation Treatment For Various Vascular Procedures In Various Vascular Beds: What Newer Drugs And DOACs Are Useful And What Is The Optimal Timing Of Treatment |
| Peter Henke, MD |
11/18/2025 3:54 PM |
15 |
Presenter |
Is Median Arcuate Ligament Syndrome (MALS) Overdiagnosed And Overtreated: Is It Real Or Just Rare: What Is The Pathogenesis And How Is It Best Treated |
| Peter Henke, MD |
11/19/2025 6:58 AM |
31 |
Presenter |
Best Preoperative Preparation To Prevent Postoperative Myocardial Infarctions (MIs) With Vascular Surgery Or Endo Interventions: What Tests, What Drugs, What Invasive Coronary Procedures Before Or After The Vascular Procedure |
| Peter Henke, MD |
11/19/2025 7:16 AM |
23 |
Presenter |
What Are The Best Medical Adjuncts To Improve Patency Of Bypass Grafts And Endovascular Procedures |
| Jan M.M. Heyligers, MD, PhD, FEBVS |
11/21/2025 10:28 AM |
89 |
Presenter |
Update On The ARCUS System Of Augmented Reality (Derived From A Contrast CT) And Its Value In Vascular And Endovascular Procedures: How Does It Work And Experience To Date |
| Jan M.M. Heyligers, MD, PhD, FEBVS |
11/20/2025 5:28 PM |
54 |
Presenter |
The Rampart IC Radiation Protection System: What Is It And How Effective Is It |
| Jan M.M. Heyligers, MD, PhD, FEBVS |
11/21/2025 |
89, |
Session
Moderator |
PROGRESS IN VASCULAR IMAGING AND GUIDANCE FOR ENDOVASCULAR TREATMENTS; DECREASING RADIATION EXPOSURE OR CONTRAST TOXICITY
|
| Caitlin W. Hicks, MD, MS |
11/21/2025 10:36 AM |
82 |
Presenter |
Trends In Use Of CEA, CAS, And TCAR Before And After Medicare's Expansion Of Reimbursement For Carotid Stenting: Why Medicare's Recent Expansion Of Reimbursement For Carotid Stenting Was Factually Unjustified |
| Caitlin W. Hicks, MD, MS |
11/19/2025 3:24 PM |
45 |
Presenter |
Hospitals Without Investigational Device Exemptions (IDEs) Have Worse Outcomes After PMEGs: These Are Often Unreported And Not In The VQI |
| Caitlin W. Hicks, MD, MS |
11/18/2025 4:42 PM |
22 |
Presenter |
Why Pre-Intervention Physiologic Testing Is Important In Determining Treatment Of Patients With Intermittent Claudication: When Is Invasive Treatment Justified |
| Caitlin W. Hicks, MD, MS |
11/19/2025 4:50 PM |
30 |
Presenter |
Weight Loss Semaglutide Drugs (Ozempic, Wegovy) Increase Walking Ability And ABIs In Diabetics With IC: The STRIDE RCT |
| Caitlin W. Hicks, MD, MS |
11/19/2025 5:02 PM |
30 |
Presenter |
Infrapopliteal Peripheral Vascular Interventions For IC Are Performed Frequently In The US And Are Associated With Poor Long-Term Outcomes: What Specialty And Sites Of Treatment Are Most Involved And What Should Be Done About It |
| Caitlin W. Hicks, MD, MS |
11/18/2025 |
22, |
Session
Moderator |
MORE HOT NEW TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE, CLTI AND ITS TREATMENTS
|
| Caitlin W. Hicks, MD, MS |
11/19/2025 |
30, |
Session
Moderator |
NEW DEVELOPMENTS IN THE TREATMENT OF INTERMITTENT CLAUDICATION (IC) AND ACUTE LIMB ISCHEMIA (ALI)
|
| Anil P. Hingorani, MD |
11/18/2025 3:12 PM |
14 |
Presenter |
What Proportion Of General Surgery Chairs Are Filled By Vascular Surgeons: Is It Helpful To Vascular Surgery Or Not: Why They Often Do Not Support Vascular Surgery |
| Anil P. Hingorani, MD |
11/19/2025 4:04 PM |
37 |
Presenter |
Geriatric Vascular Surgery In The OBL: What Is Different, What Is Unknown |
| Anil P. Hingorani, MD |
11/21/2025 5:00 PM |
86 |
Presenter |
A New Technology (From AOTI) Combining Local Oxygen Therapy With Cycled Compression And Humidification Enhances Healing Of Diabetic Wounds And Ischemic Ulcers After Revascularization |
| Jade S. Hiramoto, MD |
11/20/2025 9:44 AM |
49 |
Presenter |
Aortic Mural Thrombus: How To Detect And Quantitate It: What Is Its Effect On SCI Risk With Complex AAA And TAAA Repairs: How Should It Change Management |
| Kim J. Hodgson, MD |
11/19/2025 |
34, |
Session
Moderator |
ISSUES IMPORTANT TO VASCULAR SURGEONS/SPECIALISTS |
| Tal M. Hoerer, MD, PhD |
11/20/2025 11:43 AM |
50 |
Presenter |
Advances In Endovascular Resuscitation And Bleeding Control: Update On The Value Of Standard And Partial REBOA |
| Tal M. Hoerer, MD, PhD |
11/19/2025 4:12 PM |
45 |
Presenter |
Use Of Endografts To Manage Access Complications During Routine And Complex Endovascular Procedures: Technical Tips And What Devices Need To Be Stocked In The OR And Angio Suite |
| Tal M. Hoerer, MD, PhD |
11/21/2025 4:48 PM |
86 |
Presenter |
When And How To Use Fascial Suture Technique To Control Percutaneous Large Vessel Access: Technical Tips |
| Tal M. Hoerer, MD, PhD |
11/21/2025 8:50 AM |
88 |
Presenter |
The Role Of Percutaneous CT-Guided Drainage And Antibiotics Irrigation For Endograft Infections: How To Do It And Real-World Results |
| Andrew Holden, MBChB |
11/19/2025 10:06 AM |
33 |
Presenter |
Active AAA Sac Management With Shape Memory Polymers: They Can Be Placed Prophylactically Or To Treat Endoleaks And Improve Outcomes After EVAR: Technique And Updated Results (From The shAAApe Trial) |
| Andrew Holden, MBChB |
11/18/2025 2:00 PM |
5 |
Presenter |
New Endovascular Technology (Nectero — Intra-Sac Drug After AAA Balloon Isolation) To Slow AAA Growth: Updated Clinical Results Of The First-In-Human (FIH) Trial And The stAAAble RCT |
| Andrew Holden, MBChB |
11/18/2025 2:12 PM |
5 |
Presenter |
Comparison Of Long-Term Survival After Open And Endo AAA Repairs: Does It Help To Build A Case For Raising The Size Threshold For AAA Repair |
| Andrew Holden, MBChB |
11/20/2025 2:12 PM |
60 |
Presenter |
Long-Term Comparative Data For The Gore VBX Balloon Expandable Covered Stents (vs Bare Metal Stents) To Treat Iliac Occlusive Disease: Advantages And Limitations Of VBX: From The FORWARD RCT |
| Andrew Holden, MBChB |
11/20/2025 3:18 PM |
61 |
Presenter |
Intravascular Lithotripsy (IVL) In Tibial Arteries: Updates From The Shockwave BTK II And Javelin Trials: New Technology Is Available |
| Andrew Holden, MBChB |
11/20/2025 3:48 PM |
61 |
Presenter |
A New Sirolimus DCB (Scionix From BD) To treat Lower Extremity Occlusive Lesions: Early Results |
| Andrew Holden, MBChB |
11/20/2025 5:37 PM |
63 |
Presenter |
FluidX: A New Conformable Liquid Occlusive Agent (From Obsidio): What Makes It Different, Indications, Advantages And Precautions |
| Andrew Holden, MBChB |
11/19/2025 |
35, |
Session
Moderator |
RECORDED LIVE CHALLENGING CASES AND INNOVATIVE TECHNIQUES FROM THE PLINIO ROSSI AND LINC COMPONENTS
|
| Misty D. Humphries, MD, MAS |
11/21/2025 11:18 AM |
82 |
Presenter |
Expanding The Use Of TCAR For Patients With Anatomic Or Plaque Related Limitations |
| Mohamad A. Hussain, MD, PhD |
11/22/2025 2:50 PM |
115 |
Presenter |
Should Intravenous Heparin Be Used During AV Access Creation |
| Osamu Iida, MD, PhD |
11/19/2025 2:37 PM |
28 |
Presenter |
Viabahn Stent-Graft For Complex Fem-Pop Lesions: When Are They The Best Treatment: Technical Tips For Making Them Work And Avoiding Intimal Hyperplasia At Their Ends: Long-Term Results And What Treatment Is Best If They Thrombose – Endo Or Open |
| Osamu Iida, MD, PhD |
11/22/2025 8:06 AM |
106 |
Presenter |
The Importance Of Establishing In Line Flow To A Wound To Achieve Healing In Patients With CLTI |
| Sriram S. Iyer, MD, FACC |
11/20/2025 4:28 PM |
53 |
Presenter |
Update On External Sirolimus Patch Wrap-Arounds For PTFE Graft Anastomoses: Do They Decrease Intimal Hyperplasia And Improve Prosthetic Graft Patency |
| Michael J. Jacobs, MD |
11/18/2025 11:18 AM |
4 |
Presenter |
Open Repair Of TAAAs Following TEVAR Treatment Of TBADs: How Common Are They And Technical Tips: Will This Procedure Survive In The Endovascular Era |
| Michael J. Jacobs, MD |
11/19/2025 2:30 PM |
44 |
Presenter |
Value Of F/B/EVAR In The Management Of Failed Open Repairs Of Complex AAAs In Patients With Heritable Aortic Disease: Technical Tips |
| Michael J. Jacobs, MD |
11/18/2025 |
4, |
Session
Moderator |
MORE NEW DEVELOPMENTS IN THE TREATMENT OF AORTIC DISSECTIONS, THORACIC AORTIC DISEASE AND THORACOABDOMINAL ANEURYSMS (TAAAs)
|
| Michael R. Jaff, DO |
11/18/2025 11:37 AM |
18 |
Panelist |
Challenging The Experts: Interactive Q&A |
| Michael R. Jaff, DO |
11/18/2025 3:48 PM |
15 |
Presenter |
Current Role Of Renal Artery Angioplasty And Stenting: In View Of The RCT Data When Is It Justifiably Indicated |
| Michael R. Jaff, DO |
11/18/2025 |
15, |
Session
Moderator |
PROGRESS IN THE TREATMENT OF RENAL AND VISCERAL ARTERY DISEASE |
| Michael R. Jaff, DO |
11/19/2025 |
31, |
Session
Moderator |
ADVANCES IN MEDICAL DIAGNOSIS AND TREATMENTS IN VASCULAR PATIENTS; NEW ANTI-ATHEROGENIC DRUGS AND LIPID MANAGEMENT
|
| Krishna Jain, MD |
11/19/2025 3:52 PM |
37 |
Presenter |
How Can Viable OBLs Be Maintained In The Current Environment: For What Procedures: When Is An ASC A Better Solution: What Are The Obstacles |
| Krishna Jain, MD |
11/19/2025 |
37, |
Session
Moderator |
MORE ISSUE-RELATED TOPICS IMPORTANT TO VASCULAR SURGEONS AND VASCULAR SPECIALISTS; ISSUES RELATED TO OUTPATIENT CENTERS OR OFFICE BASED LABS (OBLs) AND AMBULATORY SURGERY CENTERS (ASCs) |
| Michael P. Jenkins, MBBS, BSc, MS, FRCS, FEBVS |
11/19/2025 7:14 AM |
39 |
Presenter |
Relay Custom Made Endografts (Terumo) For TEVAR, Scalloped, Etc: When And Why Are They Advantageous Compared To Single Branch LSA TEVAR Devices |
| William Jennings, MD |
11/22/2025 11:41 AM |
112 |
Presenter |
Choosing The Optimal Access In Obese Patients |
| Douglas W. Jones, MD |
11/19/2025 5:04 PM |
38 |
Presenter |
Measuring Aortic Surgery Quality Of Care Has Been All Wrong: The Future Of Surgical Quality Reporting Must Incorporate Baseball Statistical Approaches And How This And AI Will Help |
| William D. Jordan Jr., MD |
11/19/2025 4:18 PM |
45 |
Presenter |
Use Of The Aptus Endoanchor Variable Curve Sheath As A Rescue Tool To Fix Maldeployed EVAR Endografts: When And How To Do It: Technical Tips |
| William D. Jordan Jr., MD |
11/18/2025 5:14 PM |
8 |
Presenter |
DEBATE ROUND 3: With Acute Uncomplicated TBADs, The Case For Early TEVAR With Extensive Aortic Coverage In Most Patients: New Data Supports It |
| William D. Jordan Jr., MD |
11/18/2025 |
8, |
Session
Moderator |
MORE NEW DEVELOPMENTS REGARDING TBADs AND TEVAR: NEED FOR AND TIMING OF TEVAR FOR ACUTE UNCOMPLICATED TYPE B AORTIC DISSECTION (uTBADs)
|
| William D. Jordan Jr., MD |
11/20/2025 |
62, |
Session
Moderator |
NEW OR IMPROVED DEVICES AND TECHNIQUES TO PREVENT OR TREAT ENDOLEAKS OR DEVICE MIGRATION: ENDOANCHORS, ETC.
|
| Loay S. Kabbani, MD, MHSA |
11/20/2025 5:01 PM |
63 |
Presenter |
Endovascular Arterial Thrombo-Embolectomy Devices: What's The Difference Between Them: Jeti, Penumbra, AngioJet, Pounce, Etc.: What's Coming Down The Road |
| Andrea Kahlberg, MD |
11/21/2025 11:30 AM |
82 |
Presenter |
Transradial CAS Using Novel Low-Profile Double-Mesh Stents (Roadsaver - Terumo): Results And Technical Tips |
| Andrea Kahlberg, MD |
11/19/2025 8:21 AM |
40 |
Presenter |
Full-Endo Repair Of Aortic Arch Disease: How Do Industry Made Customized Endografts Compare To PMEGs And In Situ Fenestrated Endografts |
| Andrea Kahlberg, MD |
11/18/2025 9:38 AM |
3 |
Presenter |
New Developments With The STABILISE Technique For Acute And Subacute TBADs: How Is The STABILISE Registry Helping: Technical Tips And Precautions |
| Stavros K. Kakkos, MD, PhD |
11/19/2025 2:00 PM |
43 |
Presenter |
Endovascular Solutions To Effectively Deal With Hostile Neck Anatomy Of AAAs Other Than F/B/EVAR: Why They Should Be Favored |
| Stavros K. Kakkos, MD, PhD |
11/18/2025 8:44 AM |
9 |
Presenter |
Screening For ACS: Its Main Value Is In Guiding Lipid Treatment: How Low Should LDL-Cholesterol (LDL-C) Be Pushed And What Will It Do To Carotid Plaques |
| Manju Kalra, MBBS |
11/19/2025 10:04 AM |
41 |
Presenter |
Patch Aneurysms After Open TAAA Repairs: How To Treat Them When They Occur And How To Prevent Them |
| Manju Kalra, MBBS |
11/21/2025 8:20 AM |
88 |
Presenter |
Rifampin-Soaked Dacron Or Cryopreserved Aorto-Iliac Conduits: When Is Each The Best Treatment For Infected Aortic Grafts Or EVARs: Technical Tips |
| Manju Kalra, MBBS |
11/18/2025 |
15, |
Session
Moderator |
PROGRESS IN THE TREATMENT OF RENAL AND VISCERAL ARTERY DISEASE |
| Manju Kalra, MBBS |
11/18/2025 |
7, |
Session
Moderator |
MORE NEW DEVELOPMENTS IN THE TREATMENT OF THORACIC AORTIC PATHOLOGY INCLUDING CORAL REEF AORTA
|
| Manju Kalra, MBBS |
11/21/2025 |
88, |
Session
Moderator |
NEW DEVELOPMENTS IN TREATING ARTERIAL (INCLUDING AORTIC) GRAFT AND ENDOGRAFT INFECTIONS |
| Vikram S. Kashyap, MD |
11/19/2025 11:00 AM |
34 |
Presenter |
Why Heart And Vascular Centers Benefit All Stakeholders Including Vascular Surgeons: How To Assure That Vascular Surgery Has A Fair Role In Leadership And Allocation Of Resources |
| Vikram S. Kashyap, MD |
11/18/2025 2:22 PM |
20 |
Presenter |
What Is Optimal Medical Therapy For Patients With CLTI: Why Does It Paradoxically Improve MALE But Not MACE In The Data From The BEST-CLI Trial |
| Vikram S. Kashyap, MD |
11/22/2025 |
106, |
Session
Moderator |
LOWER EXTREMITY TOPICS TOO IMPORTANT TO MISS |
| Piotr M. Kasprzak, MD |
11/18/2025 9:02 AM |
3 |
Presenter |
How And Why The Aortic Arch Is An Unhospitable Location For Endovascular Graft Treatments |
| Piotr M. Kasprzak, MD |
11/19/2025 9:12 AM |
33 |
Presenter |
How A Five Branched Endograft System (Cook) Can Be More Effective For Treating Challenging Type IA Endoleak After EVAR: How It Works, Advantage And Limitations |
| Konstantinos Katsanos, MSc, MD, PhD, EBIR |
11/19/2025 10:12 AM |
26 |
Presenter |
Although Paclitaxel Coated Devices Confer No Increase In Mortality Rates, They May Still Be Associated With Increased Amputation Rates When Used To Treat CLTI Patients: What Mechanism May Be Responsible |
| Konstantinos Katsanos, MSc, MD, PhD, EBIR |
11/20/2025 4:22 PM |
53 |
Presenter |
Artificial Intelligence Angiographic Flow Analysis During Peripheral Angioplasty Procedures To Aid Intra-Procedural Decision Making And Prediction Of Clinical Outcomes |
| Athanasios Katsargyris, MD |
11/19/2025 5:26 PM |
30 |
Presenter |
Different Options For Thrombosuction In ALI: Which Device For Which Case And When Is Open Surgery Necessary |
| Athanasios Katsargyris, MD |
11/19/2025 9:46 AM |
41 |
Presenter |
Late Complications Of F/B/EVAR: What Are The Causes And How Are They Best Treated |
| Barry T. Katzen, MD |
11/19/2025 10:24 AM |
33 |
Presenter |
Limb Salvage From Dotter To Stents And Beyond: Regulatory Hurdles Then And Now |
| Barry T. Katzen, MD |
11/18/2025 2:00 PM |
13 |
Presenter |
Can Microchips, Wireless Technology And AI Come Together To Alter Workflow For Peripheral Interventions And Improve Treatment Outcomes |
| Barry T. Katzen, MD |
11/18/2025 7:08 AM |
9 |
Presenter |
What Is The Future For Vascular Robotics: What Clinical Benefits Are Needed To Make It Successful And What Improved Techniques Are On The Horizon: How Can They Help In Training |
| Barry T. Katzen, MD |
11/18/2025 |
13, |
Session
Moderator |
NEW CONCEPTS; MACHINE LEARNING AND ARTIFICIAL INTELLIGENCE (AI); TO DECREASE RADIATION (SEE ALSO SESSIONS 9 AND 90)
|
| Ali B. Khoynezhad, MD, PhD |
11/18/2025 7:08 AM |
1 |
Presenter |
Update On Improvements In Transcatheter Aortic Valve Replacement (TAVR) Including Alternate Access And When Is Open Surgical Valve Replacement Currently Indicated |
| Ali B. Khoynezhad, MD, PhD |
11/18/2025 7:38 AM |
1 |
Presenter |
Advances In Endograft Repair Of The Ascending Aorta Without And With Involvement Of The Aortic Valve (Endo-Bentall): What Lesions Are Or Will Be Suitable: World Clinical Experience With Endo-Bentall To Date |
| Ali B. Khoynezhad, MD, PhD |
11/18/2025 |
2, |
Session
Moderator |
PROGRESS IN THE TREATMENT OF AORTIC ARCH LESIONS AND AORTIC DISSECTIONS |
| Nicholas Kipshidze, MD, PhD, DSc |
11/19/2025 7:28 AM |
31 |
Presenter |
Update On The New Anti-Atherosclerosis Vaccine (AtheroVax): A Drug To Produce Lifelong LDL-C Lowering With A Single Gene Modifying Treatment: The Heart-1 Gene-Editing Trial: How Does AtheroVax Work And Results To Date |
| Melissa L. Kirkwood, MD |
11/21/2025 10:16 AM |
89 |
Presenter |
Myths And New Facts About Decreasing Radiation Exposure: Leaded Caps, Glasses And Most Light Weight Gowns Don't Help; The Egg Nest System (Egg Medical) Of Shields And Other Techniques Do |
| Tilo Koelbel, MD, PhD |
11/20/2025 11:16 AM |
58 |
Presenter |
New TEVAR Options for Lesions Close To Or Involving The LSA: Advantages And Results With Cook's Custom Single Branch TEVAR Endograft |
| Tilo Koelbel, MD, PhD |
11/19/2025 4:54 PM |
46 |
Presenter |
Single vs Double Antiplatelet Therapy After F/B/EVAR Based On Key Findings From A Large Multicenter Clinical Trial: What Drugs Are Best And For How Long |
| Tilo Koelbel, MD, PhD |
11/19/2025 7:32 AM |
39 |
Presenter |
DEBATE: Not So Fast: A Multimodular Approach To Treating Acute, Subacute And Chronic TBADs With TAAAs: Who Needs A F/B/EVAR; Who Needs A Candy-Plug Or Other Techniques: What Is The Role For STABILISE |
| Tilo Koelbel, MD, PhD |
11/18/2025 8:50 AM |
2 |
Presenter |
Status Of Fenestrated Aortic Arch Repair: What Devices Are Best And How To Avoid Strokes Beside CO2 Device Flushing |
| Tilo Koelbel, MD, PhD |
11/19/2025 |
40, |
Session
Moderator |
MORE ADVANCES RELATED TO TREATING PATHOLOGY INVOLVING THE ASCENDING AORTA AND THE AORTIC ARCH: INTRAMURAL HEMATOMAS (IMHs), AORTIC DISSECTIONS AND THEIR TREATMENT |
| Ralf R. Kolvenbach, MD |
11/19/2025 8:27 AM |
40 |
Presenter |
In Situ Fenestration For Endovascular Repair Of Aortic Arch Lesions: Does It Reduce Perioperative Strokes And How To Avoid Cerebral Ischemia During The Procedure |
| Ralf R. Kolvenbach, MD |
11/21/2025 9:59 AM |
81 |
Presenter |
TCAR With Flow Reversal Combined With The New Mesh Covered Stent (CGuard From InspireMD) Is The Best Invasive Treatment For Carotid Stenosis: What Are The Results And Are There Downsides Or Limitations |
| Kimihiro Komori, MD, PhD |
11/18/2025 1:00 PM |
19 |
Presenter |
In Octogenarians And Nonagenarians With CLTI When Is Revascularization Indicated: When Should It Be Endo And When Open And What Results Should Be Achievable |
| Kimihiro Komori, MD, PhD |
11/18/2025 3:36 PM |
21 |
Presenter |
Comparison Of Limb Outcomes Between Bypass Surgery And Endovascular Therapy In CLTI Patients With Decreased Renal Function And ESRD |
| Stavros Konstantinides, MD |
11/18/2025 8:10 AM |
17 |
Presenter |
An Overview Of Clinical Trials For PE: Will Any Of Them Move The Needle |
| Peter Kotanko, MD |
11/22/2025 9:21 AM |
110 |
Presenter |
Predicting Mortality Risk In Dialysis: Assessment Of Risk Factors Using Traditional And Advanced Modeling Techniques Within The Monitoring Dialysis Outcomes Initiative |
| Panos Kougias, MD, MSc |
11/20/2025 1:00 PM |
51 |
Presenter |
Why EVAR Is Currently The Best Treatment For All Or Most Ruptured Infrarenal AAAs: Why The RCTs Comparing Open And Endo Repair Are Misleading: When In 2025 Might Open Repair Be The Best Treatment |
| Panos Kougias, MD, MSc |
11/19/2025 6:52 AM |
23 |
Presenter |
Despite Aggressive Efforts By All Vascular Specialists To Save Lower Limbs, The Incidence Of Major Amputations (BKA And AKA) Is Increasing In The US: What Is The Cause And What Can Be Done To Reverse This Trend |
| Panos Kougias, MD, MSc |
11/19/2025 8:30 AM |
32 |
Presenter |
Managing Postoperative Anemia After Major Vascular Surgery: When Can It Be Tolerated And When Should It Be Corrected By Transfusion |
| Zvonimir Krajcer, MD, FACC |
11/21/2025 4:30 PM |
86 |
Presenter |
New Devices (Including PerQseal) For Large Bore Arterial And Venous Closure Devices: Advantages And Limitations Of Each And How To Avoid Complications |
| Zvonimir Krajcer, MD, FACC |
11/21/2025 |
86, |
Session
Moderator |
NEW CONCEPTS AND NEW DEVELOPMENTS IN PERCUTANEOUS ACCESS CLOSURE AND WOUND CARE |
| Dainis K. Krievins, MD |
11/20/2025 4:24 PM |
62 |
Presenter |
Progress With The VESTECK Catheter Based Endosuturing Technology For EVAR And TEVAR Fixation: How Does It Work: How Is It Different From Endoanchors: Advantages And Successful Clinical Results |
| Dainis K. Krievins, MD |
11/19/2025 7:22 AM |
23 |
Presenter |
With CLTI Patients Silent Coronary Ischemia Is Deadly: Coronary CT Angiography And FFRct (By Heartflow) Facilitates Detection And Treatment Of High Risk Coronary Plaques Which Decreases Mortality As Shown By An RCT: The Coronary Intervention Can Precede Or Follow The Lower Extremity Procedure |
| Dainis K. Krievins, MD |
11/18/2025 8:38 AM |
10 |
Presenter |
All Patients With Carotid Stenosis (Whether Invasively Treated Or Not) Have A High Incidence Of Coronary Artery Disease Which May Be Lethal: A 5-Year RCT Shows That Coronary CT Angiography With Fractional Flow Reserve (FFRCT) Can Lead To Treatment Which Lowers Mortality |
| Boonprasit Kritpracha, MD |
11/18/2025 1:42 PM |
5 |
Presenter |
When Is EVAR An Effective Treatment For Infected AAAs: Incidence, Pattern, And Prevention Of Recurrent Infection After EVAR For Infected AAAs: From A 20-Year Experience With >180 Cases |
| Boonprasit Kritpracha, MD |
11/20/2025 9:38 AM |
49 |
Presenter |
A Real-World Experience Of Using An Off-The-Shelf (OTS) Preloaded Inner Branched Endogrtaft (E-nside - Artivion) For The Treatment Of Complex AAAs And TAAAs: When Is It Helpful And When Is It Not |
| Waclaw B. Kuczmik, MD, PhD |
11/21/2025 7:10 AM |
79 |
Presenter |
Prevention Of SCI During Endo Repair Of TAAAs By Adding An Additional Branch To Revascularize The "Adamkiewicz Artery": How To Identify The Artery And Do The Procedure |
| Steven Kum, MD |
11/19/2025 1:48 PM |
27 |
Presenter |
Long-Term 5-Year Experience With LimFlow DVA For CLTI: Optimal Case Selection, Technical And Post Procedure Pearls To Improve Results: Role And Methods Of Vein Embolization |
| Steven Kum, MD |
11/20/2025 2:48 PM |
60 |
Presenter |
A Novel Device For Percutaneous FemPop Bypass With End To Side Sutureless Clampless Anastomosis In 3 Minutes: How Does It Work And Early Results |
| Steven Kum, MD |
11/20/2025 3:36 PM |
61 |
Presenter |
The Serranator® Balloon Catheter (From Cagent Vascular) For Vessel Prep In Lower Extremity Arteries (From The PRELUDE And PRELUDE BTK Trials): Clinical Experience And Current Status |
| Steven Kum, MD |
11/20/2025 3:54 PM |
61 |
Presenter |
High-Pressure PTA Balloons: How Can They Help With Standard PTA And Deep Vein Arterialization (DVA): What Is The Evidence |
| Steven Kum, MD |
11/19/2025 9:30 AM |
25 |
Presenter |
Promising Results To Date With Bioresorbable DESs To Treat BTK Lesions: How Will They Change The Open/Endo Balance For Treating CLTI: The Need For Open Bypasses Will Be Diminished But Will Never Fade Away |
| Toru Kuratani, MD, PhD |
11/18/2025 8:02 AM |
2 |
Presenter |
Issues And Experience With Three Types Of Branch Devices To Treat Aortic Arch Diseases (Terumo Relay, Endospan Nexus, Gore Single Branched Thoracic Endograft (TBE) Compared To Debranching TEVAR |
| Christopher J. Kwolek, MD, MBA |
11/18/2025 10:10 AM |
18 |
Presenter |
The Angiovac Strategy For The Treatment Of PE |
| Christopher J. Kwolek, MD, MBA |
11/18/2025 11:37 AM |
18 |
Panelist |
Challenging The Experts: Interactive Q&A |
| Christopher J. Kwolek, MD, MBA |
11/19/2025 3:46 PM |
37 |
Presenter |
How To Make Outpatient Vascular Treatment Facilities (OBLs, ASCs) Safe, Effective And Profitable Without Doing Unjustified Procedures: How Can They Make Uniquely Important Vascular Research Contributions |
| Christopher J. Kwolek, MD, MBA |
11/19/2025 |
41, |
Session
Moderator |
OPEN AND ENDO TREATMENT OF COMPLEX AAAs (JUXTA, PARA- AND SUPRA-RENAL) AND TAAAs; INTERESTING NEW DEVICES FOR THEIR TREATMENT |
| Christopher J. Kwolek, MD, MBA |
11/20/2025 |
56, |
Session
Moderator |
NEW OR UPDATED EVAR DEVICES FOR AAAs, COMPLEX AAAs OR TAAAs |
| Glenn M. LaMuraglia, MD |
11/21/2025 |
83, |
Session
Moderator |
MORE HOT CAROTID TOPICS: UPDATES ON KEY CAROTID RCTs AND TREATMENT OF ASYMPTOMATIC CAROTID STENOSIS (ACS) AND POST RADIATION STENOSIS |
| Nicos Labropoulos, BSc (Med), PhD, DIC, RVT |
11/18/2025 4:24 PM |
22 |
Presenter |
Compensatory Arterial Enlargement In Patients With Diabetes: What Is The Mechanism And How Should It Influence Treatment |
| Mario L. Lachat, MD |
11/18/2025 10:48 AM |
12 |
Presenter |
The VORTEC Technique To Eliminate The Need For Aortic Circumferential Dissection, Clamping And Suturing In An Aortofemoral Bypass: What Is It And How To Do It: Why It Is Especially Valuable For Heavily Calcified And Scarred Aortas |
| Mario L. Lachat, MD |
11/20/2025 |
52, |
Session
Moderator |
PROGRESS IN ENDO AND OPEN TREATMENT TECHNIQUES FOR RUPTURED INFRARENAL AAAs, COMPLEX AAAs AND TAAAs; NEW DEVELOPMENTS IN SURVEILLANCE AND SCREENING |
| John R. Laird, MD |
11/20/2025 4:04 PM |
53 |
Presenter |
Fiber And Lint Contamination During Endovascular And Surgical Procedures Promotes Thrombosis: How To Reduce And Prevent It |
| John R. Laird, MD |
11/20/2025 |
61, |
Session
Moderator |
NEW OR IMPROVED ENDOVASCULAR DEVICE COMBINATIONS FOR LOWER EXTREMITY TREATMENTS: ANGIOPLASTY BALLOON IMPROVEMENTS
|
| Brajesh K. Lal, MD |
11/21/2025 1:12 PM |
83 |
Presenter |
First Game Changing Results From CREST 2: CEA vs Best Medical Treatment (BMT) And CAS vs BMT For ACS: Some 5-Year RESULTS TO DATE Show... |
| Brajesh K. Lal, MD |
11/21/2025 |
83, |
Session
Moderator |
MORE HOT CAROTID TOPICS: UPDATES ON KEY CAROTID RCTs AND TREATMENT OF ASYMPTOMATIC CAROTID STENOSIS (ACS) AND POST RADIATION STENOSIS |
| Gregg S. Landis, MD |
11/22/2025 11:26 AM |
109 |
Presenter |
The Importance Of Transcarotid Access For TAVRs: The Role Of Vascular Surgeons: Technical Tips And Advantages |
| Werner Lang, MD |
11/19/2025 4:32 PM |
30 |
Presenter |
Perfusion Measurements To Detect Muscle Perfusion In Claudicants Are More Diagnostically Conclusive Than Walking Tests: What Techniques Should Be Used And Do They Help In Selecting Patients For Invasive Treatment |
| Kamphol Laohapensang, MD |
11/18/2025 3:06 PM |
21 |
Presenter |
Update On New And Innovative Techniques To Treat Buerger's Disease: What Are They And How Do They Improve Results |
| Igor A. Laskowski, MD, PhD |
11/19/2025 7:26 AM |
39 |
Presenter |
DEBATE: The STABILISE Technique To Eliminate The False Lumen And Relaminate The Aorta Will Change The Treatment Of Acute And Subacute TBADs And Will Replace Most False Lumen Occlusion Devices And F/B/EVAR Treatments: How To Do It And Precautions |
| Peter F. Lawrence, MD |
11/20/2025 3:28 PM |
53 |
Presenter |
Aberrant Subclavian Artery And Dysphasia Lusoria: An Anomaly That We Should All Understand And Be Able To Treat: Treatment Of Associated Kommeral's Diverticulum |
| Peter F. Lawrence, MD |
11/19/2025 |
46, |
Session
Moderator |
MORE HOT NEW TOPICS RELATED TO AORTC DISEASE AND ITS TREATMENT |
| Jeffrey H. Lawson, MD, PhD |
11/22/2025 10:42 AM |
111 |
Presenter |
Diagnosis And Management Of Hypercoagulable States In Patients With Recurrent Access Thrombosis |
| Jason T. Lee, MD |
11/19/2025 10:22 AM |
41 |
Presenter |
The Gore TAMBE Device For Complex AAAs And TAAAs: Advantages, Limitations, Technical Tips And Lessons Learned |
| Jason T. Lee, MD |
11/21/2025 1:50 PM |
92 |
Presenter |
Neurogenic TOS: When And How To Use Botox Treatment: When Is Surgical Treatment Necessary And How Best To Do Them |
| Jason T. Lee, MD |
11/19/2025 7:08 AM |
39 |
Presenter |
When A Single Branched TEVAR Is Used But Requires A Longer Proximal Seal In The Aortic Arch, How Can This Be Achieved |
| Jason T. Lee, MD |
11/21/2025 7:34 AM |
87 |
Presenter |
Functional Popliteal Entrapment In Athletes: How Best To Diagnose And Treat: How To Know What Structure Needs To Be Addressed To Achieve Arterial Decompression: Is Recurrence Ever A Problem |
| Jason T. Lee, MD |
11/21/2025 |
87, |
Session
Moderator |
POPLITEAL DISEASE TOPICS RELATED TO ANEURYSM TREATMENT, ENTRAPMENTS, ADVENTITIAL CYSTIC DISEASE AND TRAUMA |
| Robert E. Lee, MD |
11/22/2025 1:16 PM |
113 |
Presenter |
How To Improve Oversight Of New Technologies And Next Generation Devices |
| W. Anthony Lee, MD |
11/19/2025 10:58 AM |
42 |
Presenter |
Long-Term Outcomes With The Cook PRESERVE II Study Of The Cook IBD (ZBIS) From The US And European Studies: Why Is It Better And Different From Other IBD Devices: When Is It Contraindicated |
| W. Anthony Lee, MD |
11/20/2025 2:36 PM |
52 |
Presenter |
In Situ Laser Fenestration To Facilitate Urgent F/EVARs For Ruptured Complex AAAs: Technical Considerations And Equipment Needed |
| W. Anthony Lee, MD |
11/21/2025 4:42 PM |
86 |
Presenter |
Closure Techniques And Devices For Percutaneous Brachial And Axillary Access: What's Different, What Works, Results And Complications |
| Christos D. Liapis, MD |
11/21/2025 1:54 PM |
83 |
Presenter |
Management Options With A Carotid String Sign Or Near Occlusion: Why Are They Controversial: Current Optimal Treatment In Symptomatic And Asymptomatic Patients |
| Michael K.W. Lichtenberg, MD |
11/18/2025 2:34 PM |
20 |
Presenter |
Remote Wireless Monitoring Of Stent Blood Flow Is Possible With The Vesselsens Flow System: How Does It Work And Results |
| Michael K.W. Lichtenberg, MD |
11/18/2025 3:48 PM |
21 |
Presenter |
Intravascular Ultrasound Guided Interventions For Fem-Pop Occlusive Disease: When And How To Make Them Work And Be Cost Effective |
| Michael K.W. Lichtenberg, MD |
11/18/2025 4:54 PM |
22 |
Presenter |
Laser And Optics Based Intravascular Lithotripsy (IVL-Bolt Medical) System For The Treatment Of Below-The-Knee (BTK) Calcified Lesions: How Does It Work And Results Of The RESTORE BTK Trial |
| Francesco Liistro, MD |
11/19/2025 11:18 AM |
26 |
Presenter |
Updated 2-Year Results Of The DEBATE-BTK SHOCK RCT Evaluating The Value Of Lithotripsy (Shockwave-J&J) Prior To DCB Treatment In Diabetic Patients Undergoing BTK Revascularization |
| Francesco Liistro, MD |
11/19/2025 11:36 AM |
26 |
Presenter |
Why Some BTK DCB Trials Have Not Shown Uniformly Better Results: Technical And Balloon Factors Matter |
| Jes S. Lindholt, MD |
11/18/2025 1:54 PM |
5 |
Presenter |
High Dose Statin Therapy Has A Profound Influence On The Clinical Course Of AAA Disease: From Two Prospective Screening Trials |
| Jes S. Lindholt, MD |
11/19/2025 4:56 PM |
30 |
Presenter |
Why Supervised Exercise Therapy For IC Has Higher Late Mortality Than Early Revascularization (From A Systematic Review): How Can This Be And Should It Be An Indication For Wider Treatment Of IC |
| Thomas F. Lindsay, MDCM, FRCS |
11/18/2025 5:44 PM |
8 |
Presenter |
With Aortic Dissections: How Should Visceral Malperfusion Be Diagnosed And What Strategies Are Available To Treat It Before Or After TEVAR |
| Thomas F. Lindsay, MDCM, FRCS |
11/19/2025 9:34 AM |
41 |
Presenter |
Outcomes Of F/EVAR And B/EVAR After Five Or More Years: What Risk Factors Are Associated With Early Death And The Chances Of Long-Term Survival |
| Evan C. Lipsitz, MD, MBA |
11/22/2025 1:32 PM |
110 |
Presenter |
Update On CMS Quality Metrics In Hemodialysis Access |
| Evan C. Lipsitz, MD, MBA |
11/19/2025 4:34 PM |
38 |
Presenter |
What Is The Merit Based Incentive Payment System (MIPS) For Value Based Reimbursement: How Does It And Other Value Based Reimbursement Systems (MVPs) Work For Vascular Surgeons: Are They Good Or Bad |
| Evan C. Lipsitz, MD, MBA |
11/19/2025 |
44, |
Session
Moderator |
MORE NEW DEVELOPMENTS IN AAAs: ENDOVASCULAR TREATMENTS WITH HERITABLE AORTIC DISEASE (CONNECTIVE TISSUE GENETIC DISORDERS - CTDs): HOW DOES INTRASAC THROMBUS LOAD AFFECT AAA BEHAVIOR AND PROGNOSIS AFTER EVAR |
| Evan C. Lipsitz, MD, MBA |
11/22/2025 |
111, |
Session
Moderator |
MORE IMPORTANT ISSUES IN HEMODIALYSIS ACCESS |
| Terry Litchfield, MPA |
11/22/2025 1:00 PM |
113 |
Presenter |
Potential Impact Of Federal 'Efficiency' VCuts On Chronic Kidney Disease Patients |
| Terry Litchfield, MPA |
11/19/2025 4:40 PM |
38 |
Presenter |
Precautions To Take With Operative And Other Records: Tips To Avoid Noxious Legal Or Governmental Audit Problems |
| Armando C. Lobato, MD, PhD |
11/20/2025 10:02 AM |
49 |
Presenter |
Three Parallel Graft Techniques For Repair Of Aortic And Iliac Degenerative And Post Dissection Aneurysms: What Are The Differences Between The Sandwich, Lobato And Chimney Methods And What Are Their Advantages, Limitations And Results |
| Armando C. Lobato, MD, PhD |
11/19/2025 11:10 AM |
42 |
Presenter |
Long-Term Results Of The Lobato Parallel Graft Technique For Treating Iliac Artery Aneurysms: What Makes It Different: Technical Tips, Advantages And Limitations |
| Ian Loftus, MD |
11/18/2025 3:04 PM |
6 |
Presenter |
Update On How Best To Manage The Celiac Artery During Endo Repairs Of Complex AAAs: Let It Be Covered And Occluded Or Not; Fenestrate It With Or Without A Stent: How Does A Pre-Op CTA Help |
| Ian Loftus, MD |
11/20/2025 3:06 PM |
52 |
Presenter |
Lessons Learned From 15 Years Of National Aneurysm Screening In The UK: Is It Still A Viable Service And Does It Really Save Lives: What Changes Are Needed |
| Ian Loftus, MD |
11/19/2025 7:51 AM |
40 |
Presenter |
DEBATE: Early TEVAR For Type B IMHs Is Safe And The Guidelines Should Be Changed |
| Shang Loh, MD |
11/18/2025 4:02 PM |
7 |
Presenter |
The Importance Of Aortic Dissection Entry Tear Size And Morphology: How Should They Influence Treatment And Predict Remodeling Behavior After TEVAR |
| Joann M. Lohr, MD |
11/21/2025 4:54 PM |
86 |
Presenter |
The Value Of Local Oxygen Therapy Combined With Compression And Humidification (AOTI) And Low Frequency Ultrasound Stimulation To Enhance Non-Specific And Venous Wound Healing |
| Charmaine Lok, MD |
11/22/2025 8:22 AM |
110 |
Presenter |
Have KDOQI Guideline Revisions Changed Clinical Practice |
| Joseph V. Lombardi, MD, MBA |
11/18/2025 11:48 AM |
4 |
Presenter |
The SVS-STS Aortic Dissection Reporting Standards And Classification System: What Is It; What Are Its Advantages And Limitations; How Is It Helping To Understand The Disease Process And Improve Treatment |
| Joseph V. Lombardi, MD, MBA |
11/18/2025 |
3, |
Session
Moderator |
PROGRESS IN THE ENDOVASCULAR TREATMENT OF THE ASCENDING AORTA, AORTIC ARCH, AORTIC DISSECTIONS, STABILISE, THORACIC AORTA AND MORE
|
| Lars B. Lonn, MD, PhD |
11/18/2025 1:18 PM |
13 |
Presenter |
Simulation-Based Training Can Improve Radiation Protection As Well As Procedural Performance As Shown By An RCT |
| Lars B. Lonn, MD, PhD |
11/20/2025 3:52 PM |
53 |
Presenter |
Geniculate Artery Embolization Can Improve Symptoms Of Knee Osteoarthritis: It Reduces Inflammation And Pain: Indications, How To Do It And Results |
| Lars B. Lonn, MD, PhD |
11/20/2025 7:20 AM |
47 |
Presenter |
Provider Skill Is Not Appropriately Recognized And Rewarded In Health Care Systems: Even Within A Specialty All Doctors Are Not Equal And Should Be Rewarded Differentially According To Their Expertise And Results: How To Do It |
| Robert A. Lookstein, MD, MHCDL, FSIR, FAHA |
11/18/2025 11:37 AM |
18 |
Panelist |
Challenging The Experts: Interactive Q&A |
| Robert A. Lookstein, MD, MHCDL, FSIR, FAHA |
11/19/2025 8:53 AM |
25 |
Presenter |
Experience To Date With Everolimus And Other Nonabsorbable Coronary DESs To Treat Infrapopliteal BTK Lesions – Long And Short – Causing CLTI: What Are The Stents And When Do They Help: Might The Drug Eluting Resorbable Stents (DERSs) Be Better |
| Robert A. Lookstein, MD, MHCDL, FSIR, FAHA |
11/18/2025 9:05 AM |
17 |
Presenter |
Percutaneous Mechanical Thrombectomy Without Lytics: The Indigo System |
| Robert A. Lookstein, MD, MHCDL, FSIR, FAHA |
11/18/2025 |
9, |
Session
Moderator |
PROGRESS IN VASCULAR ROBOTICS AND IMAGING AND GUIDANCE SYSTEMS WITH LESS RADIATION AND CONTRAST
|
| Qingsheng Lu, MD |
11/18/2025 8:44 AM |
2 |
Presenter |
Triple-Branch Graft For Endovascular Repair Of Aortic Arch Aneurysms And Dissections: How Does It Work, What Makes It Different: Advantages And Challenges |
| John F. Lucas III, MD |
11/22/2025 3:30 PM |
115 |
Presenter |
Tips And Tricks To Achieve Long-Term Dialysis Access Patency |
| Alan B. Lumsden, MD, FACS |
11/18/2025 6:56 AM |
9 |
Presenter |
How Can Current Robotic Techniques With The Da Vinci System (Intuitive) Facilitate Open Aortic Procedures: Benefits And Drawbacks |
| Alan B. Lumsden, MD, FACS |
11/18/2025 |
2, |
Session
Moderator |
PROGRESS IN THE TREATMENT OF AORTIC ARCH LESIONS AND AORTIC DISSECTIONS |
| Alan B. Lumsden, MD, FACS |
11/21/2025 |
90, |
Session
Moderator |
AUGMENTED REALITY (AR), MIXED REALITY AND ARTIFICIAL INTELLIGENCE (AI): HOW WILL THEY IMPROVE VASCULAR IMAGING AND ENDOVASCULAR DEVICE GUIDANCE WHILE MINIMIZING RADIATION |
| Sean P. Lyden, MD |
11/19/2025 2:43 PM |
28 |
Presenter |
4-6-Year Results With Percutaneous (PQ) Transvenous Fem-Pop PTFE Bypasses (From Endologix): How Is It Done And Updated Results From The DETOUR Trials Compare Favorably To Open Fem-Pop Bypasses: What Are The Limitations |
| Sean P. Lyden, MD |
11/18/2025 7:56 AM |
10 |
Presenter |
Transfemoral CAS (TFCAS) For ACS Is Being Overused Since CMS Expanded Its Reimbursement Without Limits |
| Sean P. Lyden, MD |
11/19/2025 |
26, |
Session
Moderator |
NEW DEVELOPMENTS IN DRUG COATED BALLOONS (DCBs) AND DRUG ELUTING STENTS (DESs): UPDATES ON PACLITAXEL TOXICITY, RANDOMIZED CONTROLLED TRIALS
(RCTs) AND BTK LESION TREATMENTS WITH DCBs AND DESs
|
| Thanila A. Macedo, MD |
11/19/2025 8:54 AM |
33 |
Presenter |
Improving Endoleak Detection And Accurately Defining Their Source With Contrast Enhanced Sonography: Equipment Needed And How To Do It |
| Lindsay Machan, MD |
11/20/2025 4:58 PM |
54 |
Presenter |
New Developments In Radiation Protection: How Can AI Help: A New More Ergonomic System: It Can Overcome Imperfections In Older Protection Devices |
| Lindsay Machan, MD |
11/19/2025 7:48 AM |
32 |
Presenter |
Renal Artery Denervation Is Back: New Evidence; New Devices, New Applications And Adjuncts (IVUS And Pressure Wires) To Facilitate The Treatment: Why Does It Work And When Should It Be Used |
| Lindsay Machan, MD |
11/19/2025 |
32, |
Session
Moderator |
CATHETER BASED TREATMENTS FOR RESISTANT HYPERTENSION; MANAGEMENT OF CARDIAC PROBLEMS, CORONARY DESs, SMOKING AND TRANSFUSION IN VASCULAR SURGERY PATIENTS; PREVENTING VASCULAR AND CARDIAC COMPLICATIONS
|
| Lindsay Machan, MD |
11/20/2025 |
54, |
Session
Moderator |
PROGRESS IN RADIATION SAFETY, DEVICES AND TECHNIQUES |
| Michel Makaroun, MD |
11/18/2025 |
6, |
Session
Moderator |
MORE ABOUT AAAs AND EVAR, STANDARD AND COMPLEX: UPDATES ON PHYSICIAN MODIFIED ENDOGRAFTS (PMEGs) AND GUIDELINES
|
| Michel Makaroun, MD |
11/19/2025 |
45, |
Session
Moderator |
MORE HOT AORTIC TOPICS, PMEGs AND IDEs, GRAFT CHOICES FOR COMPLEX AAAs AND TAAAs
|
| Michel Makaroun, MD |
11/20/2025 |
51, |
Session
Moderator |
PROGRESS IN THE TREATMENT OF RUPTURED INFRARENAL AAAs |
| Michel Makaroun, MD |
11/20/2025 |
55, |
Session
Moderator |
NEW OR IMPROVED DEVICES FOR INFRARENAL AAA AND COMPLEX AAA REPAIR |
| Mahmoud B. Malas, MD, MHS |
11/19/2025 11:48 AM |
26 |
Presenter |
Open vs Endo RevascularizationFor Patients With Infrapopliteal Disease Causing CLTI: A Large Population Based Study Confirms The Superiority Of Saphenous Vein Bypass: Newer Technologies May Alter This Conclusion |
| Mahmoud B. Malas, MD, MHS |
11/21/2025 4:00 PM |
85 |
Presenter |
TCAR Is Safe In Recently Symptomatic Patients And Those With Contralateral Carotid Occlusions: Why TCAR Should Be The Procedure Of Choice In These Conditions |
| Mahmoud B. Malas, MD, MHS |
11/21/2025 8:18 AM |
80 |
Presenter |
Comparative Safety And Efficacy Of TCAR vs TFCAS vs CEA: What Is The Effect Of Anemia, Uncontrolled Hypertension, Recent MI, Weekend Effect And Arch Type: Which Procedure Is Best And When: How Will An Individual Treatment Plan Help |
| Mahmoud B. Malas, MD, MHS |
11/21/2025 |
81, |
Session
Moderator |
MORE CAROTID HOT TOPICS RELATED TO TCAR, CAS AND EFFECTS OF INTERVENTIONS ON COGNITIVE FUNCTION
|
| Mahmoud B. Malas, MD, MHS |
11/21/2025 |
85, |
Session
Moderator |
MORE HOT AND CONTROVERSIAL CAROTID TOPICS |
| Thomas S. Maldonado, MD |
11/22/2025 11:38 AM |
109 |
Presenter |
The Importance Of Plavix Resistance With TFCAS And TCAR: How To Detect It, How Common Is It; Does It Matter And What To Do About It |
| Thomas S. Maldonado, MD |
11/21/2025 2:54 PM |
84 |
Presenter |
Coronary Calcium Scores May Stratify Distinct Phenotypes Of Carotid Artery Stenosis: How Should This Influence Management |
| Thomas S. Maldonado, MD |
11/19/2025 5:06 PM |
46 |
Presenter |
AAA Sac Embolization With Shape Memory Polymer Plugs During The EVAR Procedure Can Prevent Type 2 Endoleaks If The Plugs Are Placed Near To Branch Orifices: Technique And Imaging Matters: Results |
| Thomas S. Maldonado, MD |
11/19/2025 5:20 PM |
30 |
Presenter |
New Findings From The STRIDE Multicenter Trial: Mechanical Computer Assisted Suction Thrombectomy With The Indigo Aspiration System (Penumbra): Subgroups Showed Similar Outcomes For Patients With Stent Or Graft vs Native-Vessel Thrombosis: When Was Angioplasty, Stenting Or Bypass Necessary |
| Thomas S. Maldonado, MD |
11/19/2025 |
30, |
Session
Moderator |
NEW DEVELOPMENTS IN THE TREATMENT OF INTERMITTENT CLAUDICATION (IC) AND ACUTE LIMB ISCHEMIA (ALI)
|
| Thomas S. Maldonado, MD |
11/19/2025 |
42, |
Session
Moderator |
PROGRESS IN TREATING ILIAC ANEURYSMS; ILIAC BRANCHED DEVICES (IBDs); UPDATE ON FLOW MODULATING AND BARE STENTS FOR TREATING ANEURYSMS AND DISSECTIONS |
| Martin Malina, MD, PhD |
11/21/2025 8:44 AM |
88 |
Presenter |
For Many Infected Prosthetic Arterial/Aortic Grafts, Endografts And Mycotic Aneurysms Less Than The Current Standard Radical Graft Excisional Treatment Is Best: Details And Examples Of This Less Radical Treatment |
| Martin Malina, MD, PhD |
11/21/2025 9:34 AM |
89 |
Presenter |
Skills That Vascular Surgeons/Specialists Must Have To Improve Imaging And Decrease Radiation Exposure Include Control Of Gantry Angle Projections, All Image Settings, Columniation, Contrast Dilution, Mechanical Injection Pressure And Flow Rates, Frame Rates, Cone Beam CT, Fusion Setup And More |
| Nicola Mangialardi, MD |
11/18/2025 8:08 AM |
2 |
Presenter |
Total Endovascular Treatment Of Aortic Arch Lesions Is Possible: What Are The Best Devices And Techniques: Open Surgery Is No Longer Needed: Is There Any Role For Chimney Grafts |
| Armando Mansilha, MD, PhD, FEBVS |
11/18/2025 4:24 PM |
15 |
Presenter |
Technical Tips To Recanalize Long Complex SMA Occlusions: When Is Open Treatment Required |
| Ashraf Mansour, MD |
11/21/2025 2:36 PM |
84 |
Presenter |
Most Recurrent Carotid Stenosis (After CEA And CAS) Is Benign: When Is Intervention Justified And What Intervention Should Be Used |
| Ashraf Mansour, MD |
11/18/2025 5:12 PM |
16 |
Presenter |
The Right Retroperitoneal Approach For Open AAA Repair: When To Do It, Advantages And Technical Tips |
| Ashraf Mansour, MD |
11/21/2025 9:41 AM |
81 |
Presenter |
DEBATE: The Role For TFCAS In The Era Of TCAR Is Minimal: What Is It |
| Marco G. Manzi, MD |
11/19/2025 1:18 PM |
27 |
Presenter |
Extreme New Endovascular Treatments For Otherwise Untreatable "No Option" CLTI: Plantar Loop And Other Techniques: How To Do Them, Specialized Equipment And Results |
| Marco G. Manzi, MD |
11/19/2025 |
27, |
Session
Moderator |
PROGRESS IN EXOTIC AND EXTREME NEW TREATMENTS FOR VERY DISTAL LOWER EXTREMITY DISEASE CAUSING ADVANCED CLTI: OPTIONS TO SAVE THE “NO OPTION FOR TREATMENT” LIMB AND THE “DESERT FOOT”
|
| Marco G. Manzi, MD |
11/19/2025 |
29, |
Session
Moderator |
FOOT PERFUSION EVALUATION METHODS; LOWER EXTREMITY RCTs: NEW CONCLUSIONS PRO AND CON |
| Michael L. Marin, MD |
11/18/2025 |
5, |
Session
Moderator |
NEW DEVELOPMENTS IN ABDOMINAL AORTIC ANEURYSM (AAA) ETIOLOGY, DETECTION, TREATMENT AND EVAR |
| Michael L. Marin, MD |
11/19/2025 |
43, |
Session
Moderator |
NEW DEVELOPMENTS IN AAA BEHAVIOR, TREATMENT AND STANDARD INFRARENAL EVAR: THE INFLUENCE OF DIABETES, BLOOD PRESSURE, AGE, ECT. ON AAA GROWTH;
IMPROVED ULTRASOUND SURVEILLANCE, LOCAL ANESTHESIA FOR EVAR, 3D CTA ANALYSIS, CONSEQUENCES OF AAAs LOST TO FOLLOW-UP AND ALL AAAs ARE NOT TIME BOMBS WAITING TO EXPLODE
|
| Gabriele Maritati, MD |
11/18/2025 3:34 PM |
6 |
Presenter |
Why The Open Retroperitoneal Approach Should Be Used More Often To Treat Complex AAAs And Failed EVARs: Training, Techniques, Indications, Advantages And Limitations: Have We Gone Too Far In The Endo vs Open Transformation |
| Klaus D. Mathias, MD |
11/18/2025 10:04 AM |
11 |
Presenter |
Current Optimal Treatment Of Carotid Artery Dissections: When Anticoagulation And When Antiplatelet Drugs; When CAS And When Open Surgery: Technical Tips |
| Klaus D. Mathias, MD |
11/21/2025 8:30 AM |
80 |
Presenter |
DEBATE: Not So: Contemporary Data Show That TFCAS Can Be Performed At Very Low Stroke Rates And Is The Best Treatment For Most Patients Requiring Treatment For Carotid Stenosis: The Operator's Experience And Skill Are Critical |
| Klaus D. Mathias, MD |
11/18/2025 9:46 AM |
11 |
Presenter |
Current Optimal Treatment When Carotid Stenosis In The Neck Coexists With Intracranial Disease Or Clot |
| Klaus D. Mathias, MD |
11/18/2025 |
11, |
Session
Moderator |
UPDATES ON TREATMENTS FOR INTRACRANIAL ARTERIAL DISEASE; INVASIVE ENDOVASCULAR TREATMENT FOR ACUTE STROKES; COMBINED CAROTID STENOSIS AND INTRACRANIAL CLOT OR DISEASE; CAROTID DISSECTIONS |
| Klaus D. Mathias, MD |
11/21/2025 |
80, |
Session
Moderator |
NEW DEVELOPMENTS IN THE TREATMENT OF CAROTID STENOSIS: UPDATE ON MESH COVERED STENTS AND TCAR (TRANSCERVICAL CAROTID ARTERY REVASCULARIZATION)
|
| Klaus D. Mathias, MD |
11/21/2025 |
84, |
Session
Moderator |
MORE HOT CAROTID TOPICS: TREATMENT IN 2025 OF EXTRACRANIAL CAROTID ANEURYSMS, RECURRENT STENOSIS, WEBS, ETC. |
| Jon S. Matsumura, MD |
11/21/2025 1:06 PM |
83 |
Presenter |
When Invasively Treating Asymptomatic Carotid Stenosis (ACS) Patients >70, Should CEA Be Preferred Over TFCAS: Has Anything Changed Or Are The Data From ACT1 And CREST RCTs Showing Comparable Outcomes For The Two Treatments Still Applicable |
| Jon S. Matsumura, MD |
11/18/2025 2:18 PM |
5 |
Presenter |
AAA Treatment And Outcomes For Women: There Are Dramatic Differences Compared To Men |
| Jon S. Matsumura, MD |
11/20/2025 9:56 AM |
57 |
Presenter |
Duplex Findings From The TAMBE Trial: Why Are They Important And How Will They Improve Results |
| Jon S. Matsumura, MD |
11/18/2025 |
8, |
Session
Moderator |
MORE NEW DEVELOPMENTS REGARDING TBADs AND TEVAR: NEED FOR AND TIMING OF TEVAR FOR ACUTE UNCOMPLICATED TYPE B AORTIC DISSECTION (uTBADs)
|
| Mark A. Mattos, MD |
11/19/2025 3:40 PM |
37 |
Presenter |
How Can OBLs Provide Good Vascular Care With Excellent Results, Be Profitable, Do Research, And Still Allow Vascular Surgeons To Work From 8 AM To 5 PM: Why Is A Hospital Affiliation Still Mandatory |
| Neghae Mawla, MD, FASDIN |
11/22/2025 10:58 AM |
111 |
Presenter |
Management Of Life And Limb-Threatening Complications In The Outpatient Dialysi8s Center |
| Steven Maximus, MD |
11/18/2025 11:42 AM |
4 |
Presenter |
Off-The-Shelf Endovascular Aortic Devices For TAAA Repair And Their Impact On The Need For Physician Modified Endografts (PMEGs): Which Devices And When |
| David T. McGreevy, MD, PhD |
11/20/2025 1:12 PM |
51 |
Presenter |
A 15-Year Experience With Universal (100%) Endovascular Management Of Ruptured AAAs: Technical Tips; Insights And Updates: When May Open Surgery Be Necessary |
| James F. McKinsey, MD |
11/19/2025 10:00 AM |
33 |
Presenter |
Transgraft Treatment Of Type 2 Endoleaks After EVAR: When And How To Do It: Advantages: How To Make And Seal The Graft Puncture Site |
| James F. McKinsey, MD |
11/20/2025 10:20 AM |
57 |
Presenter |
Real-World Experience With The TAMBE Device (Gore) For The Treatment Of TAAAs: Advantages, Limitations And Results |
| James F. McKinsey, MD |
11/19/2025 1:24 PM |
43 |
Presenter |
Late Rescue For Renal Artery Occlusion After EVAR: How To Do It And Why There Are No Time Limits |
| James F. McKinsey, MD |
11/20/2025 |
48, |
Session
Moderator |
PROGRESS IN FENESTRATED AND BRANCHED EVAR (F/B/EVAR) AND PARALLEL GRAFTS FOR COMPLEX AAAs AND TAAAs; AND RELATED TOPICS
|
| Robert B. McLafferty, MD, MBA |
11/20/2025 4:34 PM |
53 |
Presenter |
Hyperbaric Oxygen Therapy And Its Applications In Vascular Surgery For Diabetic And Non-Diabetic Patients: What Is The Level 1 Evidence That It Works: When Is It Indicated, When Is It Not |
| Robert B. McLafferty, MD, MBA |
11/21/2025 5:12 PM |
86 |
Presenter |
Advantages Of Having A Wound Care Center In A Vascular Surgery Practice: How To Finance It |
| Barend M.E. Mees, MD, PhD, FEBVS |
11/18/2025 11:30 AM |
12 |
Presenter |
Radiation Free CERAB Procedures Are Possible Using FORS Technology (Philips) With Its 3-D Hub: How Is It Done And Technical Tips: Clinical Experience To Date |
| Barend M.E. Mees, MD, PhD, FEBVS |
11/20/2025 8:32 AM |
48 |
Presenter |
Late Results Of F/EVAR For Failed EVAR: Although Technically Successful, Late Mortality Is Disappointingly High: Why Is This So |
| Roxana Mehran, MD |
11/18/2025 7:14 AM |
1 |
Presenter |
Update On The Status Of Transcatheter Mitral And Tricuspid Valve Replacement/Repair |
| Roxana Mehran, MD |
11/19/2025 8:12 AM |
32 |
Presenter |
New Developments In Methods To Prevent Kidney Damage From Iodinated Contrast Agents: Are Any Drugs Truly Protective |
| Roxana Mehran, MD |
11/18/2025 |
1, |
Session
Moderator |
PROGRESS IN TRANSCATHETER VALVE REPLACEMENT AND TREATMENT OF ASCENDING AORTIC DISEASE |
| Manish Mehta, MD, MPH |
11/20/2025 2:18 PM |
52 |
Presenter |
With Ruptured Complex AAAs And TAAAs, Parallel Grafts Are The Best Treatment: They Are Simpler, More Effective And Less Costly Than Other Treatments |
| Manish Mehta, MD, MPH |
11/20/2025 8:14 AM |
48 |
Presenter |
Complete Aortic Endovascular Repairs For Complex AAAs And TAAAs Using Parallel Endografts With A Docking Station: How And Why To Make Them Work Effectively Despite Doubts About Parallel Grafts: What Are The Limitations |
| Manish Mehta, MD, MPH |
11/20/2025 |
48, |
Session
Moderator |
PROGRESS IN FENESTRATED AND BRANCHED EVAR (F/B/EVAR) AND PARALLEL GRAFTS FOR COMPLEX AAAs AND TAAAs; AND RELATED TOPICS
|
| Manish Mehta, MD, MPH |
11/20/2025 |
52, |
Session
Moderator |
PROGRESS IN ENDO AND OPEN TREATMENT TECHNIQUES FOR RUPTURED INFRARENAL AAAs, COMPLEX AAAs AND TAAAs; NEW DEVELOPMENTS IN SURVEILLANCE AND SCREENING |
| Germano C.G. Melissano, MD |
11/20/2025 10:14 AM |
49 |
Presenter |
Open TAAA Repairs: How Do The Results Of Primary Repairs Compare With Those Done For Failed TEVAR, B/EVAR And F/EVAR: What Are The Technical Challenges Of The Secondary Repairs |
| Germano C.G. Melissano, MD |
11/20/2025 3:34 PM |
53 |
Presenter |
Technical Tips For Performing Safe And Effective Open Repair Of Degenerative And Post Dissection TAAAs |
| Germano C.G. Melissano, MD |
11/21/2025 7:34 AM |
79 |
Presenter |
Changes In Protocols To Prevent SCI During Open And Endo TAAA Repairs Including The Role Of CSF Drainage: What Is Known, What Is Unknown And What Remains Controversial |
| Germano C.G. Melissano, MD |
11/21/2025 8:56 AM |
88 |
Presenter |
New Developments In The Surgical Treatment For Infected Thoracic Aortic Graft And Endografts, With Or Without Aorto-Esophageal Fistulas: Technical Tips And Current Results In A Committed Center |
| Germano C.G. Melissano, MD |
11/21/2025 |
79, |
Session
Moderator |
PROGRESS IN THE PREVENTION AND TREATMENT OF SPINAL CORD ISCHEMIA (SCI) ASSOCIATED WITH THE TREATMENT OF THORACIC, THORACOABDOMINAL AND COMPLEX ABDOMINAL ANEURYSMS |
| Matthew W. Mell, MD, MS |
11/19/2025 1:00 PM |
43 |
Presenter |
Why Is It Important To Avoid "Lost To Follow Up" For Patients With AAA (Pre - Or Post Treatment |
| Matthew W. Mell, MD, MS |
11/20/2025 1:48 PM |
51 |
Presenter |
How Can The Turndown Rate For Invasive Treatment Of Ruptured AAAs Be Decreased: It Is Worthwhile |
| Matthew T. Menard, MD |
11/19/2025 3:42 PM |
29 |
Presenter |
Findings And Interpretations From New Sub Analysis Of The BEST-CLI RCT: When Are They Applicable And When They Are Not |
| Matthew T. Menard, MD |
11/19/2025 |
29, |
Session
Moderator |
FOOT PERFUSION EVALUATION METHODS; LOWER EXTREMITY RCTs: NEW CONCLUSIONS PRO AND CON |
| Bernardo C. Mendes, MD |
11/18/2025 4:48 PM |
16 |
Presenter |
Experience With The Gore TBE (Thoracic Single Branched Endograft) For Treatment Of Recurrent Aortic Coarctation Or Aneurysm Formation: Technical Tips |
| Bernardo C. Mendes, MD |
11/19/2025 9:40 AM |
41 |
Presenter |
With All The New Devices What Is The Role For PMEGs In The Treatment Of Complex AAAs Or TAAAs |
| Geno J. Merli, MD, MACP, FHM, FSVM |
11/18/2025 7:55 AM |
17 |
Presenter |
Medical Treatment Of PE: When, Why, For How Long, And How Can I Remember |
| D. Christopher Metzger, MD |
11/21/2025 10:42 AM |
82 |
Presenter |
Current Optimal Strategies To Maximize Embolic Protection During TFCAS |
| D. Christopher Metzger, MD |
11/21/2025 9:47 AM |
81 |
Presenter |
DEBATE: Not So: There Is Still A Major Role For TFCAS: What Is It: How Much Does Operator Experience And Skill Matter With TFCAS |
| Mark W. Mewissen, MD, FSIR, RVT |
11/19/2025 10:24 AM |
33 |
Presentation
Moderator |
Limb Salvage From Dotter To Stents And Beyond: Regulatory Hurdles Then And Now |
| Mark W. Mewissen, MD, FSIR, RVT |
11/19/2025 |
33, |
Session
Moderator |
PROGRESS IN MANAGING ENDOLEAKS: UNDERSTANDING THEIR CONSEQUENCES AND PREDICTING, PREVENTING AND TREATING THEM
|
| Claude Mialhe, MD |
11/21/2025 10:22 AM |
89 |
Presenter |
Holographic Guidance Of Endovascular Procedures (With Augmented Reality Goggles And No Screen): How Does It Work And Clinical Experience: What Is Possible And What Is Not |
| Ross Milner, MD |
11/20/2025 1:30 PM |
51 |
Presenter |
A Novel Technique To Facilitate Quick Contralateral Gate Cannulation During Ruptured EVAR Even With Proximal Balloon Control |
| Ross Milner, MD |
11/20/2025 4:36 PM |
62 |
Presenter |
A New Device (Aortoseal From Endoron) To Improve Aortic Endograft Seal And Fixation: How Does It Work, When Is It Indicated And What Are Its Advantages: Experience To Date |
| Ross Milner, MD |
11/18/2025 5:02 PM |
8 |
Presenter |
Aortic Geometry Can Be Predictive Of TBAD Behavior And Treatment Failure After TEVAR: How To Assess It And How Should It Change Treatment |
| Ross Milner, MD |
11/19/2025 8:39 AM |
40 |
Presenter |
Updated Results From The US TRIOMPHE Trial Of The Endospan Nexus Endograft (OTS) For Treating Complex Aortic Arch Lesions Including Chronic Dissections: Advantages, Limitations And Will It Have A Major Role |
| Ross Milner, MD |
11/20/2025 |
57, |
Session
Moderator |
NEW OR IMPROVED DEVICES FOR THORACOABDOMINAL ANEURYSM (TAAA) REPAIRS AND THORACIC AORTIC LESION REPAIRS (TEVAR)
|
| David J. Minion, MD |
11/18/2025 10:42 AM |
12 |
Presenter |
Chronic Flush Juxtarenal Aortic Occlusions Endovascularly With Safety: How To Do It And What Is The Role Of Lysis; Is There Ever A Need For Open Surgery |
| David J. Minion, MD |
11/22/2025 10:56 AM |
109 |
Presenter |
Balloon Optimized Molding For Better Deployment And Sealing Of Alto (From Endologix) Low Profile Endografts For EVAR: How To Do It And How It Helps Prevent Endoleaks And Migration |
| David J. Minion, MD |
11/20/2025 8:51 AM |
48 |
Presenter |
Value Of Parallel Endografts In The Management Of TAAAs And Complex AAAs: Why Do They Fail And Have A Bad Reputation: How To Make Them Work Effectively And Consistently |
| David J. Minion, MD |
11/19/2025 9:00 AM |
33 |
Presenter |
How To Minimize Gutter Type 1 Endoleaks With Chimney EVAR: How Does A Standard Protocol Help; How To Treat Them When They Occur |
| David J. Minion, MD |
11/22/2025 9:54 AM |
108 |
Presenter |
How To Minimize Gutter Type 1A Endoleaks With Chimney EVAR (Ch/EVAR): How Does The "Eye Of The Tiger" Technique And A Standard Protocol Help; How To Treat Them When They Occur |
| David J. Minion, MD |
11/22/2025 |
108, |
Session
Moderator |
AORTIC TOPICS TOO IMPORTANT TO MISS AND SPINE EXPOSURE |
| Erica L. Mitchell, MD, MEd |
11/21/2025 4:12 PM |
94 |
Presenter |
New Developments In The Diagnosis And Treatment Of Penetrating And Blunt Carotid Artery Injuries: The Evolving Role Of Endovascular Treatments |
| Erica L. Mitchell, MD, MEd |
11/21/2025 4:48 PM |
94 |
Presenter |
Thoracic Aortic Pseudo-Coarctation After BTAI: What Is It: How Does It Produce Distal Organ Ischemia: How Should It Be Diagnosed And Treated Emergently By TEVAR: Technical Tips |
| Erica L. Mitchell, MD, MEd |
11/20/2025 7:08 AM |
47 |
Presenter |
New Developments In The Endo And Open Management Of Pediatric Iatrogenic And Traumatic Vascular Injuries: When An Arterial Graft Is Needed Which Ones Are Best |
| Bijan Modarai, PhD, FRCS |
11/19/2025 4:38 PM |
30 |
Presenter |
How Can AI Predict Rapid Disease Progression In Patients With Intermittent Claudication And How Should It Influence Treatment |
| Bijan Modarai, PhD, FRCS |
11/20/2025 5:04 PM |
54 |
Presenter |
New Strategies To Reduce Radiation Exposure During Complex Endovascular Aortic Procedures |
| Bijan Modarai, PhD, FRCS |
11/21/2025 6:46 AM |
79 |
Presenter |
How To Measure Blood Flow To The Spinal Cord: How Can It Help In The Prediction And Prevention Of SCI After TAAA Repair |
| Irwin V. Mohan, MBBS, MD, FRCS, FEBVS, FRACS |
11/21/2025 6:58 AM |
87 |
Presenter |
Advances In The Treatment Of Popliteal Artery Aneurysm And Adventitial Cystic Disease (Endo vs Open): What Treatments Are Currently Best And Long-Term Results |
| Frans L. Moll, MD, PhD |
11/20/2025 7:02 AM |
47 |
Presenter |
Polymer Biodegradable Grafts To Create Autogenous Living Conduits: A New Paradigm: Where Do They Stand And What Are The Potential Benefits |
| Samuel R. Money, MD, MBA |
11/19/2025 11:24 AM |
34 |
Presenter |
DEBATE: Why Unionization Of Doctors Including Vascular Surgeons/Specialists Will Not Benefit Doctors Or Patients And May Be Harmful |
| Samuel R. Money, MD, MBA |
11/20/2025 |
59, |
Session
Moderator |
UPDATED INFORMATION ON LOWER EXTREMITY PROSTHETIC GRAFTS (SEE ALSO SESSION 28) AND RE-ENTRY DEVICES |
| Peter Monteleone, MD |
11/18/2025 7:05 AM |
17 |
Presenter |
Welcome And Introduction |
| Peter Monteleone, MD |
11/18/2025 8:35 AM |
17 |
Presenter |
Ultrasound-Assisted Pharmacomechanical Thrombolysis: Emerging Data To Define Use In PE |
| Peter Monteleone, MD |
11/18/2025 |
17, |
Session
Moderator |
MANAGEMENT OF PULMONARY EMBOLISM: THE ULTIMATE APPROACH – PART 1 |
| Peter Monteleone, MD |
11/18/2025 |
18, |
Session
Moderator |
MANAGEMENT OF PULMONARY EMBOLISM: THE ULTIMATE APPROACH – PART 2 |
| Miguel F. Montero-Baker, MD |
11/19/2025 3:58 PM |
37 |
Presenter |
How To Build An Outpatient Center Of Excellence Committed To The Treatment Of CLTI: When Is An OBL Better And When Is An ASC Better – For Patients, For Surgeons |
| Miguel F. Montero-Baker, MD |
11/19/2025 |
28, |
Session
Moderator |
NEW DEVELOPMENTS IN PROSTHETIC GRAFTS; STENT GRAFTS; PERCUTANEOUS ENDOVASCULAR BYPASSES; STENT OCCLUSIONS AND TREATMENT OF IN STENT RESTENOSIS (ISR) |
| Miguel F. Montero-Baker, MD |
11/22/2025 |
107, |
Session
Moderator |
MORE LOWER EXTREMITY TOPICS TOO IMPORTANT TO MISS |
| Robert A. Montgomery, MD, DPhil |
11/20/2025 7:44 AM |
47 |
Presenter |
Current Status And Future Potential Of Pig To Human Organ Xenografting |
| Erin Moore, MD |
11/22/2025 2:07 PM |
114 |
Presenter |
Access Tracker For Management And Care Of Hemodialysis Grafts And Fistulas |
| Randy D. Moore, MD |
11/20/2025 9:32 AM |
57 |
Presenter |
Clinical Experience With The Thoracoflo Graft For The Hybrid Repair Of TAAAs |
| Wesley S. Moore, MD |
11/21/2025 11:00 AM |
82 |
Presenter |
Percutaneous TCAR Is Possible: Technical Aspects Of How This Can Be Accomplished Safely |
| Wesley S. Moore, MD |
11/21/2025 3:00 PM |
84 |
Presenter |
Because Drug Eluting Balloons Are Associated With Microembolization, They Can Only Be Used For Treating Carotid Stent Recurrent Stenosis With Reversal Of Flow Cerebral Protection |
| Wesley S. Moore, MD |
11/21/2025 |
83, |
Session
Moderator |
MORE HOT CAROTID TOPICS: UPDATES ON KEY CAROTID RCTs AND TREATMENT OF ASYMPTOMATIC CAROTID STENOSIS (ACS) AND POST RADIATION STENOSIS |
| Robert A. Morgan, MD |
11/21/2025 1:38 PM |
92 |
Presenter |
How MRI Provides Improved Imaging For Vascular TOS And Influences Treatment |
| Robert A. Morgan, MD |
11/18/2025 3:42 PM |
15 |
Presenter |
Endovascular Treatment Of Renal Artery Aneurysms: Indications, Embolic Techniques, Bare And Covered Stents: Technical Tips And Outcomes |
| Robert A. Morgan, MD |
11/19/2025 9:18 AM |
33 |
Presenter |
Update On Embolization Treatment For Type 1 Endoleaks After EVAR: Indications, Techniques, Embolic Agents And Contraindications |
| John Moriarty, MD, FSIR |
11/18/2025 11:25 AM |
18 |
Presenter |
The Team Approach To PE Management: The National PERT Consortium |
| John Moriarty, MD, FSIR |
11/18/2025 11:37 AM |
18 |
Panelist |
Challenging The Experts: Interactive Q&A |
| Patrick E. Muck, MD, FACS |
11/19/2025 3:36 PM |
45 |
Presenter |
Technical Tips For In Situ Fenestration For F/B/EVAR Using A Radiofrequency Powerwire (From Baylis) And Biplane Angiography: Advantages And Limitations |
| Patrick E. Muck, MD, FACS |
11/20/2025 5:07 PM |
63 |
Presenter |
New Percutaneous Options For Acute Limb Ischemia: Which Is Best And Why |
| Patrick E. Muck, MD, FACS |
11/19/2025 5:32 PM |
30 |
Presenter |
New Developments And Devices To Treat ALI: How Do The Newer Devices Work: What Is The Current Need For Thrombolytics: When Is Open Treatment Necessary And When Is A Bypass Necessary |
| Stefan Mueller-Huelsbeck, MD |
11/21/2025 8:12 AM |
80 |
Presenter |
Latest Real-World Results Of More Than 2,000 Patients Treated With The Roadsaver (Terumo) Dual-Layer Micromesh Covered Carotid Stent |
| Dipankar Mukherjee, MD |
11/20/2025 7:12 AM |
55 |
Presenter |
A Conformable Neck Sealing Ring Endograft (Alto From Endologix) Combined With Sac Embolization Using Shape Memory Polymer Devices Yields Good 1-Year Results |
| Dipankar Mukherjee, MD |
11/22/2025 7:54 AM |
106 |
Presenter |
Aggressive Interventions Including Atherectomy In Claudicants Leads To More Harm Than Good |
| Piotr Musialek, MD, DPhil |
11/21/2025 10:05 AM |
81 |
Presenter |
CGuard Micronet-Covered Stents (From InspireMD) Trap Plaque Particles Between The Stent And Vessel Wall (Plaque Sequestration): When Is It Valuable With High-Risk Lesions Other Than The Carotids |
| Piotr Musialek, MD, DPhil |
11/21/2025 8:00 AM |
80 |
Presenter |
Progress And Updated Clinical Trials With The CGuard And CGuard Prime MicroMesh Covered Stents (From InspireMD): Are They Making A Positive Difference And Are There Thrombotic Or ISR Downsides: Should They Become First Line Therapy For All CAS And TCAR Procedures |
| Firas F. Mussa, MD |
11/18/2025 5:32 PM |
8 |
Presenter |
Progress With The IMPROVE-AD And SUNDAY RCTs Comparing TEVAR vs Best Medical Treatment Of Acute And Subacute uTBADs: Recruitment To Date And Estimated Time To Completion |
| Pramook Mutirangura, FRCS (Edinburgh) |
11/19/2025 2:12 PM |
27 |
Presenter |
Open Surgical Vein Arterialization: Indications, Technical Tips, Long-Term Results And Advantages Of Open vs Endo |
| Piotr Myrcha, MD |
11/18/2025 10:36 AM |
12 |
Presenter |
Can Mesh Covered Stents Replace Stent-Grafts For The Treatment Of Complex Iliac Occlusive Lesions: Which Device; Advantages And Disadvantages; Results |
| Yuliia Nahaliuk, MD |
11/20/2025 11:19 AM |
50 |
Presenter |
Progress In Dealing With Major Civilian Vascular Injuries And Their Complications During The Ukraine War: Are The Resources Adequate And How Are The Medical And Surgical Personnel Coping |
| Richard F. Neville, MD |
11/18/2025 1:30 PM |
19 |
Presenter |
Open Versus Endovascular Deep Venous Arterialization (DVA): Advantages And Limitations Of Each: How To Choose One Or The Other |
| Richard F. Neville, MD |
11/19/2025 3:36 PM |
29 |
Presenter |
Near Infrared Spectral Imaging (NIRS) Is The Best Way To Assess Foot Perfusion Before And After Revascularization Treatments: Equipment Needed And How Does It Work |
| Richard F. Neville, MD |
11/20/2025 6:56 AM |
47 |
Presenter |
Progress In Remote Monitoring Of Vascular Graft Flow Rates And Other Parameters Including Hematocrit, Serum Potassium Levels, O₂ Saturation, Etc. (The Alio System): Where Is It At Present And Where Is It Going |
| Richard F. Neville, MD |
11/19/2025 |
28, |
Session
Moderator |
NEW DEVELOPMENTS IN PROSTHETIC GRAFTS; STENT GRAFTS; PERCUTANEOUS ENDOVASCULAR BYPASSES; STENT OCCLUSIONS AND TREATMENT OF IN STENT RESTENOSIS (ISR) |
| Richard F. Neville, MD |
11/20/2025 |
47, |
Session
Moderator |
EXCITING NEW OR REDISCOVERED TECHNIQUES, DEVICES, CONCEPTS |
| Richard F. Neville, MD |
11/22/2025 |
107, |
Session
Moderator |
MORE LOWER EXTREMITY TOPICS TOO IMPORTANT TO MISS |
| Christoph A. Nienaber, MD, PhD |
11/18/2025 11:30 AM |
4 |
Presenter |
When And How Best To Treat Persistent Patent False Lumens After TEVAR Treatment Of Aortic Dissections: Update On The FLIRT Procedure: What Is It And How To Do It |
| Christoph A. Nienaber, MD, PhD |
11/18/2025 |
3, |
Session
Moderator |
PROGRESS IN THE ENDOVASCULAR TREATMENT OF THE ASCENDING AORTA, AORTIC ARCH, AORTIC DISSECTIONS, STABILISE, THORACIC AORTA AND MORE
|
| Sigrid Nikol, MD |
11/21/2025 9:40 AM |
89 |
Presenter |
The Value Of CO2 Contrast Angiography: Indications, Contraindications, Precautions, Value: Vascular Beds Where It Can Be Used And Where It Cannot Be: How To Do It Simply And Effectively |
| Samy S. Nitecki, MD |
11/20/2025 11:25 AM |
50 |
Presenter |
Progress In Dealing With Vascular Trauma – Military And Civilian – During The Gaza/Israeli War |
| Katariina M. Noronen, MD |
11/19/2025 5:14 PM |
30 |
Presenter |
The PROMOTE-ALI Study Shows That Open Surgery Is Still The Best Treatment For ALI Because Emboli And Thrombosis Are Usually Superimposed On Underlying Arteriosclerosis |
| Furuzan Numan, MD |
11/19/2025 10:12 AM |
33 |
Presenter |
Are We Taking Invasive Treatment Of Type 2A (1 Vessel) And 2B (>1 Vessel) Endoleak Too Far: Where Should We Stop |
| Andriy O. Nykonenko, MD |
11/20/2025 11:07 AM |
50 |
Presenter |
What Has Been The Effect Of The Russia/Ukraine War On Ukrainian Vascular Surgery Care – Civilian And Military |
| Gustavo S. Oderich, MD, FACS |
11/20/2025 10:32 AM |
57 |
Presenter |
Value Of Endo TAAA Repair In Patients With Connective Tissue Disorders: Which Device Or Devices Are Best And Why |
| Gustavo S. Oderich, MD, FACS |
11/21/2025 7:28 AM |
79 |
Presenter |
Why Cerebrospinal Fluid (CSF) Drainage To Decrease SCI With TAAA Repair Is Not A Benign Procedure: When To Use It And When Not |
| Gustavo S. Oderich, MD, FACS |
11/19/2025 |
40, |
Session
Moderator |
MORE ADVANCES RELATED TO TREATING PATHOLOGY INVOLVING THE ASCENDING AORTA AND THE AORTIC ARCH: INTRAMURAL HEMATOMAS (IMHs), AORTIC DISSECTIONS AND THEIR TREATMENT |
| Gustavo S. Oderich, MD, FACS |
11/20/2025 |
49, |
Session
Moderator |
MORE PROGRESS IN F/B/EVAR AND PARALLEL GRAFTS FOR COMPLEX AAAs AND TAAAs; AND RELATED TOPICS |
| Gustavo S. Oderich, MD, FACS |
11/21/2025 |
90, |
Session
Moderator |
AUGMENTED REALITY (AR), MIXED REALITY AND ARTIFICIAL INTELLIGENCE (AI): HOW WILL THEY IMPROVE VASCULAR IMAGING AND ENDOVASCULAR DEVICE GUIDANCE WHILE MINIMIZING RADIATION |
| Matteo Orrico, MD |
11/20/2025 10:14 AM |
57 |
Presenter |
Comparison Of The Cook t-Branch OTS Endograft Device With The E-nside (Artivion) Multibranched Device For Juxta- And Pararenal AAAs And TAAAs: Advantages And Limitations Of Each |
| Matteo Orrico, MD |
11/19/2025 4:30 PM |
45 |
Presenter |
Fate Of Renal Arteries After Complex AAA Endo Repairs: What Are The Potential Obstacles Or Threats: How To Overcome Them And Maintain Renal Function |
| Kenneth Ouriel, MD, MBA |
11/19/2025 |
25, |
Session
Moderator |
LOWER EXTREMITY TOPICS RELATED TO BTK LESION STENTING – STANDARD AND NEW BIORESORBABLE
|
| Kenneth Ouriel, MD, MBA |
11/21/2025 |
86, |
Session
Moderator |
NEW CONCEPTS AND NEW DEVELOPMENTS IN PERCUTANEOUS ACCESS CLOSURE AND WOUND CARE |
| Kenneth Ouriel, MD, MBA |
11/22/2025 |
108, |
Session
Moderator |
AORTIC TOPICS TOO IMPORTANT TO MISS AND SPINE EXPOSURE |
| Frank Padberg, MD |
11/22/2025 3:06 PM |
115 |
Presenter |
Desperate Options For Hemodialysis Access: What To Do When All Else Fails |
| Jean M. Panneton, MD |
11/18/2025 5:08 PM |
8 |
Presenter |
Re-Entry Specific Endovascular Therapy (RESET) For TBAD Features Treatment Of Reentry Tears And Improves Remodeling And Outcomes With TBADs: When And How To Do It |
| Jean M. Panneton, MD |
11/19/2025 7:45 AM |
40 |
Presenter |
DEBATE: When And How To Treat Type B Aortic Intramural Hematomas (IMHs) By TEVAR: Technical Tips, Precautions And Results: Why Very Early Treatment Yields Worse Results |
| Jean M. Panneton, MD |
11/18/2025 8:26 AM |
2 |
Presenter |
Endovascular Arch Repair With Retrograde In Situ Fenestration For Branches: How To Do It, What About Maintaining Cerebral Blood Flow And Durable Results |
| Jean M. Panneton, MD |
11/20/2025 9:56 AM |
49 |
Presenter |
Antegrade (From Upper Extremity Access) In Situ Laser Fenestration Of Visceral Branches For TAAA And Pararenal AAA Repairs: Technical Tips, How To Avoid Pitfalls And Mid-Term Results |
| Jean M. Panneton, MD |
11/18/2025 |
4, |
Session
Moderator |
MORE NEW DEVELOPMENTS IN THE TREATMENT OF AORTIC DISSECTIONS, THORACIC AORTIC DISEASE AND THORACOABDOMINAL ANEURYSMS (TAAAs)
|
| Jean M. Panneton, MD |
11/18/2025 |
8, |
Session
Moderator |
MORE NEW DEVELOPMENTS REGARDING TBADs AND TEVAR: NEED FOR AND TIMING OF TEVAR FOR ACUTE UNCOMPLICATED TYPE B AORTIC DISSECTION (uTBADs)
|
| Rajiv Parakh, MBBS, MS, FRCS |
11/19/2025 8:17 AM |
24 |
Presenter |
Long-Term Results With The Vasculomimetic, Interwoven Supera Stent (Abbott) To Treat Occlusive Disease In The Aorta, Iliac And Other Arteries: Advantages And Limitations: When Should It Be The Preferred Treatment |
| Kosmas I. Paraskevas, MD |
11/19/2025 4:00 PM |
29 |
Presenter |
How To Use The BEST-CLI And BASIL 2 Findings Optimally In A Real World CLTI Practice In 2025 And Beyond |
| Sahil A. Parikh, MD |
11/19/2025 9:42 AM |
25 |
Presenter |
Other BTK Resorbable Stent Platforms Including A Sirolimus Coated One From R3 Vascular: What Will Be The Impact Of BTK DERSs And How Will Vessel Prep Differ With BTK Bioresorbable Stent Platforms |
| Sahil A. Parikh, MD |
11/19/2025 |
25, |
Session
Moderator |
LOWER EXTREMITY TOPICS RELATED TO BTK LESION STENTING – STANDARD AND NEW BIORESORBABLE
|
| Juan C. Parodi, MD |
11/21/2025 4:12 PM |
85 |
Presenter |
Floating Clot At The Carotid Bifurcation Is A Prime Indication For Flow Reversal Technology During Treatment Of Carotid Stenosis: How Can Flow Reversal Best Be Achieved In This Setting |
| Juan C. Parodi, MD |
11/18/2025 7:20 AM |
1 |
Presenter |
Prevention Of Cerebral Embolization During Aortic Valve And Arch Instrumentation By Promoting Aortic Flow Caudally From An Aortic Sheath Into A Femoral Venous Sheath: Experimental And Clinical Experience |
| Juan C. Parodi, MD |
11/20/2025 7:50 AM |
47 |
Presenter |
How And Why Do Thoracic Endografts For TEVAR Negatively Affect The Blood Pressure And The Heart: Where Do We Stand With A Compliant Endograft To Solve The Problem |
| Danny Patel, MD |
11/22/2025 9:45 AM |
110 |
Presenter |
AV Access Revision Using The Viabahn® Endoprosthesis: Post Market Registry Results |
| Virendra I. Patel, MD, MPH |
11/20/2025 5:49 PM |
63 |
Presenter |
How Can Shape Memory Polymer Plug Embolization Devices Be Used To Improve Results After TEVAR For Degenerative Aneurysms And TBADs By False Lumen Obliteration |
| Lorenzo Patrone, MD |
11/18/2025 2:04 PM |
20 |
Presenter |
What Is The Woundosome Concept, How Is It Different And More Important Than The Angiosome Concept To Achieve Wound Healing |
| Lorenzo Patrone, MD |
11/18/2025 4:48 PM |
22 |
Presenter |
Technical Tips For Simple And Complex BTK And Pedal Punctures And Access: When Are They Useful And How To Do Them |
| Felice Pecoraro, MD |
11/22/2025 10:50 AM |
109 |
Presenter |
AAA Ruptures Are Not Always A Catastrophic Event: What Is The Best Treatment For Ruptured Aneurysms, Catastrophic And Non Catastrophic In 2025 |
| Felice Pecoraro, MD |
11/18/2025 5:18 PM |
22 |
Presenter |
Efficacy Of Chocolate Balloon (Medtronic) Stabilization In The Management Of Dissections After Fem-Pop Balloon Angioplasty: The CHOCO-STAB Study |
| Felice Pecoraro, MD |
11/22/2025 9:48 AM |
108 |
Presenter |
Chimney EVAR Is A Dependable And Durable (Over 2 Years) Way To Treat Pararenal AAAs: Endografts To Use And Technical Tips To Minimize Type 1A Endoleaks |
| Bruce A. Perler, MD, MBA |
11/19/2025 11:30 AM |
34 |
Presenter |
Despite What Many Organizations And Institutions Say, Most Partnerships And Close Relations Between Industry And Physicians Are Ethical, Benefit Society, Save Lives, And Improve The Healthcare System: It's Common Sense |
| Bruce A. Perler, MD, MBA |
11/19/2025 8:00 AM |
32 |
Presenter |
The Outcomes Of Major Vascular Procedures Are Better In Fat Than Thin Patients: What Is The Basis For This Obesity Paradox And Should It Influence Treatment: Thin May Be In, But Fat Is Where It’s At |
| Bruce A. Perler, MD, MBA |
11/21/2025 9:06 AM |
80 |
Presenter |
DEBATE: Not So: TCAR Results To Date May Not Be As Good As They Seem: Why We Still Need An RCT Comparing TCAR With CEA To Treat Carotid Stenosis |
| Bruce A. Perler, MD, MBA |
11/18/2025 |
10, |
Session
Moderator |
NEW DEVELOPMENTS IN CAROTID DISEASE AND ITS TREATMENT: A NEW LOOK AT THE TREATMENT OF ASYMPTOMATIC CAROTID STENOSIS (ACS) AND OTHER CAROTID TOPICS |
| Bruce A. Perler, MD, MBA |
11/21/2025 |
80, |
Session
Moderator |
NEW DEVELOPMENTS IN THE TREATMENT OF CAROTID STENOSIS: UPDATE ON MESH COVERED STENTS AND TCAR (TRANSCERVICAL CAROTID ARTERY REVASCULARIZATION)
|
| Jennifer L. Perri, MD, MBA |
11/18/2025 2:54 PM |
14 |
Presenter |
Obtaining Cardiac Surgery Training After Vascular Surgery Training: I Did It, So It's Possible: Is It Worthwhile: Advantages And Disadvantages |
| Ivo Petrov, MD, PhD |
11/19/2025 7:20 AM |
39 |
Presenter |
Chimneys For Endovascular Repairs Of Dissections In The Aortic Arch: When And How To Make Them Work |
| Michele Piazza, MD |
11/19/2025 3:48 PM |
45 |
Presenter |
Standardized 4-Vessel Fenestrated PMEGs Using The Medtronic Captiva Endograft: Technical Tips And Advantages: From The SPHERE Registry |
| Richard J. Powell, MD |
11/19/2025 11:06 AM |
34 |
Presenter |
In Heart And Vascular Centers, The Heart Dominates And Vascular Surgeons Are Often Undervalued And Subordinated |
| Richard J. Powell, MD |
11/21/2025 11:36 AM |
82 |
Presenter |
Maneuvers And Technical Tips To Make Open Treatment Of High Carotid Lesions Relatively Simple And Safe |
| Richard J. Powell, MD |
11/18/2025 1:18 PM |
19 |
Presenter |
Updates On The Value Of Stem Cell And Gene Therapies In CLTI: Are There New Developments Suggesting That They May Be Helpful For "No Option" Patients: How Many Such Patients Still Exist: What About The BioGenCell System |
| Richard J. Powell, MD |
11/18/2025 2:16 PM |
20 |
Presenter |
The Impact Of Prior Endovascular Failure On Subsequent Open And Endo Treatment Outcomes In The BEST-CLI RCT: It's Not Good |
| Richard J. Powell, MD |
11/20/2025 4:00 PM |
61 |
Presenter |
Is LimFlow DVA A Durable Treatment: What Happens When The Arteriovenous Connection Thromboses: Are New Arterial Connections Recruited: After What Interval |
| Richard J. Powell, MD |
11/21/2025 9:35 AM |
81 |
Presenter |
Carotid Dissections With TCAR: Causes; How Often; How Morbid; How To Avoid; How To Fix |
| Richard J. Powell, MD |
11/18/2025 |
19, |
Session
Moderator |
HOT NEW TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE AND ITS TREATMENTS: “NO OPTION” FOR LIMB SALVAGE ISSUES IN CLTI
|
| Ourania Preventza, MD |
11/19/2025 8:09 AM |
40 |
Presenter |
Updated Concepts In The Treatment Of Type A Aortic Dissections (TAADs): How Should The Distal Aorta Be Treated By TEVAR Before Repair Of The Ascending Aorta: Antegrade Insertion Of An Endograft With Open Arch Repair: Lessons Learned, Complications And Their Resolution |
| Robert M. Proczka, MD, PhD |
11/18/2025 5:18 PM |
16 |
Presenter |
Minimal Incisions For Open Vascular Operations Upon The Aorta And Femoral Arteries: How To Do Them: Advantages And Limitations |
| Elina Quiroga, MD, MPH |
11/21/2025 3:42 PM |
94 |
Presenter |
Patients With Head Injury, Solid Organ Injury And Vascular Trauma: When, How And Sequence Of Repair: When And How To Use Heparin For Endo And Open Vascular Procedures |
| Elina Quiroga, MD, MPH |
11/21/2025 4:30 PM |
94 |
Presenter |
Blunt Thoracic Aortic Injury (BTAI) In Pediatric Patients: When And How Should We Intervene: Lessons From The Aortic Trauma Foundation Registry |
| Ravi R. Rajani, MD |
11/21/2025 4:06 PM |
94 |
Presenter |
New Developments In The Endovascular Management Of Vascular Injuries: How Can A Hybrid Suite Be Helpful |
| Venkatesh G. Ramaiah, MD |
11/20/2025 1:06 PM |
59 |
Presenter |
Percutaneous (PQ) Transvenous Fem-Pop PTFE Bypasses (From Endologix): Tips To Simplify The Procedure And Avoid Tibial Venous Access: Will It Eliminate Open PTFE FemPop Bypasses |
| Venkatesh G. Ramaiah, MD |
11/20/2025 4:30 PM |
62 |
Presenter |
VESTECK: An EVAR Proximal Neck Fixation Device: Advantages And Clinical Experience To Date |
| Venkatesh G. Ramaiah, MD |
11/20/2025 5:13 PM |
63 |
Presenter |
New Endovascular Thrombectomy Devices: Prodigy, Symphony And Vesalio: How Do They Work And What Are Their Advantages Over Other Endo Clot Removing Technologies |
| Zoran Rancic, MD, PhD, EMBA HSG |
11/18/2025 11:36 AM |
12 |
Presenter |
How Can The VORTEC Technique Be Used To Simplify Hypogastric Revascularization With Open Repair Of Difficult Iliac Aneurysms: How To Do It |
| Zoran Rancic, MD, PhD, EMBA HSG |
11/20/2025 2:00 PM |
52 |
Presenter |
Aortic Endograft And Branch Diameter Sizing For Ruptured AAAs: How To Compensate For Size Changes Due To Hypotension: Does Patient Age Matter |
| Zoran Rancic, MD, PhD, EMBA HSG |
11/21/2025 8:08 AM |
88 |
Presenter |
Support For The Graft Preservation Concept For Treating Prosthetic Aortic Graft Infections From A European Multicenter Study (VASGRA): All Or Part Of The Infected Graft May Be Preserved: Under What Circumstances |
| Todd E. Rasmussen, MD, FACS |
11/20/2025 11:13 AM |
50 |
Presenter |
New Developments In REBOA (Resuscitative Endovascular Balloon Occlusion Of The Aorta): What Is Partial REBOA; How Does It Work And When Is It Indicated: A New Catheter (P-REBOA PRO) To Facilitate It; What Makes It Different |
| Todd E. Rasmussen, MD, FACS |
11/20/2025 1:12 PM |
59 |
Presenter |
Update On The Tissue Engineered Human Biological Arterial Grafts (Humacyte): 3-Year Clinical Results In Civilian And Military Settings: Indications, Advantages And Unanswered Questions |
| Todd E. Rasmussen, MD, FACS |
11/20/2025 |
50, |
Session
Moderator |
A TRIBUTE TO OUR MILITARY AND MILITARY PHYSICIANS: SOME MILITARY HISTORY; TREATMENT OF MILITARY AND CIVILIAN VASCULAR INJURIES AND CONTROL OF HEMORRHAGE; UPDATE ON REBOA |
| Todd E. Rasmussen, MD, FACS |
11/21/2025 |
94, |
Session
Moderator |
ADVANCES IN THE ENDO AND OPEN TREATMENT OF VASCULAR TRAUMA |
| Animesh Rathore, MD |
11/18/2025 10:20 AM |
18 |
Presenter |
ECMO-Assisted Pulmonary Embolectomy In Massive PE: Can It Replace Open Surgical Thromboembolectomy |
| Animesh Rathore, MD |
11/18/2025 11:37 AM |
18 |
Panelist |
Challenging The Experts: Interactive Q&A |
| Michel Reijnen, MD, PhD |
11/19/2025 10:52 AM |
42 |
Presenter |
6-Year Outcomes Of The ICEBERG Study Of The Gore IBD (IBE Device) For Revascularizing The Hypogastric Artery With Aorto-Iliac Aneurysms: Advantages And Limitations |
| Michel Reijnen, MD, PhD |
11/18/2025 11:18 AM |
12 |
Presenter |
New Developments In CERAB (Covered Endovascular Reconstruction Of The Aortic Bifurcation): Long-Term Results, Advantages And Limitations: When Is It Optimal Treatment And When Is It Not: When Is Open Surgery Best |
| Michel Reijnen, MD, PhD |
11/20/2025 2:06 PM |
60 |
Presenter |
With Viabahn Endografts (Gore) To Treat Fem-Pop Occlusive Disease Does Heparin Bonding Make A difference: Is The Evidence Solid |
| Michel Reijnen, MD, PhD |
11/20/2025 7:42 AM |
55 |
Presenter |
The E-Tegra Device (Artivion) For Infrarenal AAA Treatment: Advantages, Limitations And Results |
| Michel Reijnen, MD, PhD |
11/19/2025 9:48 AM |
33 |
Presenter |
The Influence Of Endograft Covering Material On The Occurrence And Behavior Of Type 2 Endoleaks And Sac Remodeling After EVAR: There Are Device Differences And They Affect Outcomes |
| Timothy A. Resch, MD, PhD |
11/18/2025 1:18 PM |
5 |
Presenter |
Are We Overtreating AAAs: The Current Diameter Thresholds For AAA Repair (5.5 cm For Men; 5.0 cm For Women) Are No Longer Relevant: Based On New Scrutiny Of Old Trials And A Meta-Analysis Of AAA Rupture Risk |
| Timothy A. Resch, MD, PhD |
11/19/2025 7:02 AM |
39 |
Presenter |
Options For Left Subclavian Revascularization During TEVAR: Laser Fenestration, Open Bypass, Single Branch Device (Gore), Etc.: Advantages And Limitations Of Each |
| Timothy A. Resch, MD, PhD |
11/18/2025 9:08 AM |
3 |
Presenter |
Percutaneous Femoral Access To All Supra Aortic Branches During Total Endo Arch Repair: Totally Femoral Insertion Of Branched Stent-Grafts Can Be Done Safely: Technical Tips And Results |
| Timothy A. Resch, MD, PhD |
11/20/2025 9:09 AM |
48 |
Presenter |
New Bridging Stents For F/EVAR: What Are Their Characteristics And Why They Make A Difference |
| Timothy A. Resch, MD, PhD |
11/19/2025 |
39, |
Session
Moderator |
MORE TOPICS RELATED TO THE THORACIC AORTA, AORTIC DISSECTIONS, INFLAMMATORY ANEURYSMS AND THEIR TREATMENT |
| Jorge Rey, MD |
11/22/2025 11:14 AM |
109 |
Presenter |
Open Surgical Rescue For Carotid Stent Complications And Failures: When Is It Necessary And Techniques For Performing It Safely |
| Robert Y. Rhee, MD |
11/20/2025 7:36 AM |
55 |
Presenter |
5-Year Results Of The Gore Conformable Excluder For EVAR: How Does It Work And Durability In Complex Anatomy (Angulated And Short Necks) |
| Vicente Riambau, MD, PhD |
11/22/2025 10:06 AM |
108 |
Presenter |
The Aortyx Aortic Patch: A More Compliant Way Than TEVAR To Seal Aortic Entry Tears With TBADs: A New Endovascular Approach: How Does It Work: Improved Delivery System And Progress To Date |
| Vicente Riambau, MD, PhD |
11/18/2025 5:38 PM |
8 |
Presenter |
How Important Is The Conformability Of Thoracic Endografts: Comparative Conformability Of The Various TEVAR Devices |
| Vicente Riambau, MD, PhD |
11/20/2025 8:36 AM |
56 |
Presenter |
The Advantages Of The TREO And Fenestrated TREO Endografts (Terumo) For Infrarenal And Complex EVAR Repairs |
| Jean-Baptiste Ricco, MD, PhD |
11/21/2025 2:00 PM |
83 |
Presenter |
Optimal Management Of Asymptomatic Carotid Stenosis With Coexistent Unruptured Intracerebral Aneurysm: Based On A Multicenter Study |
| Jean-Baptiste Ricco, MD, PhD |
11/18/2025 4:26 PM |
7 |
Presenter |
Open Surgery Should Still Be The Treatment Of Choice For Coral Reef Aorta With Visceral Involvement: Why Is Endovascular Treatment Inappropriate |
| Götz M. Richter, MD, PhD |
11/20/2025 10:20 AM |
49 |
Presenter |
F/EVAR And B/EVAR In Chronic Dissections Are Not Successful In All Patients; Further Interventions Are Often Needed: What Are They |
| Götz M. Richter, MD, PhD |
11/19/2025 8:51 AM |
40 |
Presenter |
Complications And Challenges After Arch Repair And FET: Many Secondary Procedures Needed: What Are They |
| Joseph J. Ricotta II, MD, MS, DFSVS, FACS |
11/21/2025 4:18 PM |
85 |
Presenter |
Techniques For Dealing With Challenging Carotid Lesions: How Does TCAR Facilitate Treatment When Nothing Else Could Work |
| Celia Riga, MD, FRCS |
11/18/2025 7:02 AM |
9 |
Presenter |
A Decade's Retrospective Look At Vascular Robotics: Lessons Learned, Challenges And Future Possibilities |
| William P. Robinson, MD |
11/19/2025 4:44 PM |
30 |
Presenter |
Short Chronic Occlusions (CTOs) <5cm When Treated Endovascularly For IC Are Associated With Poor Outcomes: Current Classification Systems Underestimate The Detrimental Impact Of Any CTO And Do Not Accurately Guide The Treatment Of IC: How Should They Be Changed |
| William P. Robinson, MD |
11/18/2025 5:36 PM |
16 |
Presenter |
Catastrophic Vascular Complications Of Anterior Spine Exposures; How To Avoid Them And How To Salvage The Situation If They Occur |
| William P. Robinson, MD |
11/18/2025 5:42 PM |
22 |
Presenter |
How Should Patient Age Impact The Choice Of Bypass vs Endovascular Therapy For CLTI: An Analysis Of The Outcomes Of The BEST CLI Trial According To Patient Age |
| William P. Robinson, MD |
11/22/2025 |
108, |
Session
Moderator |
AORTIC TOPICS TOO IMPORTANT TO MISS AND SPINE EXPOSURE |
| Caron B. Rockman, MD |
11/19/2025 2:24 PM |
36 |
Presenter |
The Burden Of Iatrogenic Vascular Injury To The Vascular Surgery Workforce At A Tertiary Care Center: What Can And Should Be Done To Offset This Problem: An Uncommitted Surgeon Of The Day May Help: Financial Implications |
| Caron B. Rockman, MD |
11/19/2025 8:18 AM |
32 |
Presenter |
How To Manage Patients With Recent Coronary DESs Who Require Vascular Operations Or Interventions: What To Do About Antiplatelet Medications: How Long To Wait Before Stopping Safely: What To Do With Urgent Or Emergent Cases To Avoid DES Thrombosis |
| Caron B. Rockman, MD |
11/18/2025 |
20, |
Session
Moderator |
MORE HOT NEW TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE AND ITS TREATMENT – EVALUATING ARTERIAL ANATOMY AND TREATMENT OUTCOMES WITH CLTI
|
| Caron B. Rockman, MD |
11/19/2025 |
31, |
Session
Moderator |
ADVANCES IN MEDICAL DIAGNOSIS AND TREATMENTS IN VASCULAR PATIENTS; NEW ANTI-ATHEROGENIC DRUGS AND LIPID MANAGEMENT
|
| Caron B. Rockman, MD |
11/21/2025 |
93, |
Session
Moderator |
MEDICAL AND ADJUNCTIVE (DRUG AND CELL) TREATMENTS IN VASCULAR PATIENTS; RARE VASCULAR DISEASES; VASCULAR PROCEDURES TO FACILITATE OTHER SURGERIES |
| Sean P. Roddy, MD |
11/19/2025 3:34 PM |
37 |
Presenter |
In 2026 What Will Happen With Global Reimbursement For OBLs And Component Reimbursement In ASCs: When And Where Should Surgeons Do Procedures To Gain Good Reimbursement For Their Work |
| Sean P. Roddy, MD |
11/19/2025 4:28 PM |
38 |
Presenter |
What Will Happen With CPT Codes And Physician Reimbursement In Late 2025 And 2026: What's Good And What's Bad |
| Sean P. Roddy, MD |
11/19/2025 |
38, |
Session
Moderator |
UPDATES AND ISSUES IMPORTANT TO ALL VASCULAR SURGEONS AND SPECIALISTS: FUTURE REIMBURSEMENT; IMPROVING VASCULAR CARE QUALITY; FIXING FALSE TESTIMONY; FLAWED PEER REVIEW; FDA IMPROVEMENTS; LEARNING HEALTH SYSTEMS |
| Sonia Ronchey, MD, PhD |
11/19/2025 10:46 AM |
42 |
Presenter |
Comparison Of All Iliac Branched Endovascular Devices (IBDs): Advantages And Limitations Of Each |
| Sonia Ronchey, MD, PhD |
11/20/2025 8:30 AM |
56 |
Presenter |
Comparison Of Cook And Treo (Terumo) Fenestrated Devices For Juxta- And Pararenal AAAs: Results, Advantages And Limitations Of Both |
| Eric E. Roselli, MD |
11/18/2025 7:32 AM |
1 |
Presenter |
Progress In Endovascular Treatment Of Type A Aortic Dissections (TAADs) In 2025: What Is Here And What Is Coming: Experience With Ascending Aortic Endografting Including The Gore Device In The ARISE Clinical Trials |
| Kenneth Rosenfield, MD |
11/18/2025 11:10 AM |
18 |
Presenter |
Balloon Pulmonary Angioplasty For Chronic Thromboembolic Pulmonary Hypertension: Has This Become Mainstream |
| Kenneth Rosenfield, MD |
11/18/2025 11:37 AM |
18 |
Panelist |
Challenging The Experts: Interactive Q&A |
| Kenneth Rosenfield, MD |
11/19/2025 7:04 AM |
23 |
Presenter |
An Interventional Cardiologist's Perspective On The Primary And Secondary Outcomes Of BEST-CLI: Why Does It Differ From The Perspective Of Most Vascular Surgeons |
| Rachel Rosovsky, MD, MPH |
11/18/2025 7:45 AM |
17 |
Presenter |
Testing For Cancer And Other Hypercoagulable States In PE: Why, When, And What Tests |
| John R. Ross, Sr., MD |
11/22/2025 11:33 AM |
112 |
Presenter |
Strategies For Access Placement In Patients With Chronic Congestive Heart Failure |
| John R. Ross, Sr., MD |
11/22/2025 3:38 PM |
115 |
Presenter |
Should AV Fistula Aneurysm Repair Include Simultaneous Inflow Or Outflow Revision |
| Joris Rotmans, MD |
11/22/2025 1:59 PM |
114 |
Presenter |
Dynamic AV Fistulas: A Promising Solution In The Making |
| Vincent L. Rowe, MD |
11/18/2025 3:30 PM |
21 |
Presenter |
Decreased Renal Function And Dialysis Dependent Renal Failure (ESRD) Are Negative Factors In The Outcomes Of Limb Salvage Surgery In CLTI Patients: These Must Be Acknowledged But Are Not A Contraindication To Endo Or Open Procedures |
| Vincent L. Rowe, MD |
11/18/2025 |
19, |
Session
Moderator |
HOT NEW TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE AND ITS TREATMENTS: “NO OPTION” FOR LIMB SALVAGE ISSUES IN CLTI
|
| Maria A. Ruffino, MD, EBIR, FCIRSE |
11/18/2025 11:00 AM |
12 |
Presenter |
New Large Balloon Intravascular Lithotripsy Catheter L6 (Shockwave-J&J) Facilitates The Treatment Of Isolated Aortic Lesions And Reduces The Need For Stents And Covered Stents |
| Maria A. Ruffino, MD, EBIR, FCIRSE |
11/20/2025 1:30 PM |
59 |
Presenter |
Pros And Cons Of Re-Entry Devices In Treating CTOs: Why, Where And When To Use Them: Are They Worth The Cost And Have Other Techniques Like Retrograde Access Largely Replaced Them |
| Maria A. Ruffino, MD, EBIR, FCIRSE |
11/20/2025 4:55 PM |
63 |
Presenter |
Increased Procedural Efficacy And Decreased Cost Are Associated With Use Of Computed-Assisted Vacuum Thrombectomy (Penumbra Indigo And Lightning Flash) To Treat ALI: Is Open Thrombectomy Ever Required |
| Theodore F. Saad, MD |
11/22/2025 11:25 AM |
112 |
Presenter |
Management Of Patients With Recurrent Access Thrombosis |
| Hazim J. Safi, MD |
11/18/2025 11:12 AM |
4 |
Presenter |
With Post-Dissection TAAAs When Is Open Repair The Best Treatment Option And Why: What Qualifications Will Be Needed To Do These Procedures, And How To Attain Them: Will There Be Qualified Surgeons In The Future |
| Hazim J. Safi, MD |
11/18/2025 |
1, |
Session
Moderator |
PROGRESS IN TRANSCATHETER VALVE REPLACEMENT AND TREATMENT OF ASCENDING AORTIC DISEASE |
| Natzi Sakalihasan, MD, PhD |
11/19/2025 1:36 PM |
43 |
Presenter |
What Is The Relationship Between AAAs, Inflammation (On PET/CTs), Cancer And Mortality: How Should These Variables Influence Treatment |
| Clifford M. Sales, MD, MBA, FACS |
11/22/2025 |
114, |
Session
Moderator |
NOVEL TECHNOLOGIES IN HEMODIALYSIS ACCESS |
| Russell H. Samson, MD, DFSVS, RVT, FACS |
11/22/2025 1:24 PM |
113 |
Presenter |
Establishing Protocols For Precertification For Dialysis Access Interventions |
| Russell H. Samson, MD, DFSVS, RVT, FACS |
11/19/2025 4:16 PM |
37 |
Presenter |
The Endovascular Revolution Is Responsible For Unnecessary And Inappropriate Treatments: Have We All Been Drinking The Kool-Aid: What Can Vascular Surgeons And Others Do About It |
| Russell H. Samson, MD, DFSVS, RVT, FACS |
11/21/2025 |
87, |
Session
Moderator |
POPLITEAL DISEASE TOPICS RELATED TO ANEURYSM TREATMENT, ENTRAPMENTS, ADVENTITIAL CYSTIC DISEASE AND TRAUMA |
| Luis A. Sanchez, MD |
11/20/2025 10:52 AM |
58 |
Presenter |
Current Status In The US Of The Relay Branched Endovascular Graft (Terumo) For Endo Repair Of Aortic Arch Lesions: How Many Branches Can And Should Be Revascularized: Advantages, Limitations And Clinical Experience To Date |
| Luis A. Sanchez, MD |
11/19/2025 |
33, |
Session
Moderator |
PROGRESS IN MANAGING ENDOLEAKS: UNDERSTANDING THEIR CONSEQUENCES AND PREDICTING, PREVENTING AND TREATING THEM
|
| Prof. Dr. med Wilhelm Sandmann, MD |
11/18/2025 4:18 PM |
15 |
Presenter |
Current Optimal Treatment Of SMA Compression Of The Duodenum (Wilke Syndrome) With Or Without Left Renal Vein Compression (Nutcracker Syndrome) |
| Timur P. Sarac, MD |
11/19/2025 11:12 AM |
34 |
Presenter |
Vascular Surgery's Identity And Role Is Usually In A Subservient Position Within A Heart And Vascular Center: What Should Be Done To Correct This Inequity In The Interest Of Better Patient Care |
| Timur P. Sarac, MD |
11/20/2025 |
53, |
Session
Moderator |
EXCITING NEW OR UPDATED CONCEPTS, TECHNIQUES AND TREATMENTS |
| Pierre G. Sarradon, Docteur |
11/19/2025 2:49 PM |
28 |
Presenter |
Percutaneous Extravascular FemPop PTFE Bypasses Without Traversing The Vein: Technique And 7-Year Experience In Patients: Are Others Doing The Procedure |
| Sal Scali, MD |
11/20/2025 2:06 PM |
52 |
Presenter |
New Developments In The Management Of Ruptured AAAs With Aorto-Enteric Fistulas: How To Improve Survival |
| Sal Scali, MD |
11/18/2025 5:06 PM |
16 |
Presenter |
Open SMA Bypass After Failed Endovascular Interventions: Patient Selection, Technical Tips And Long-Term Outcomes |
| Sal Scali, MD |
11/22/2025 7:42 AM |
106 |
Presenter |
Why Dementia In Patients With CLTI Is Important To Evaluate: How Should It Influence Treatment And Will It Change Outcomes |
| Sal Scali, MD |
11/22/2025 9:29 AM |
110 |
Presenter |
Does Preoperative Exercise Or Heat Therapy Improve AV Fistula Remodeling And Reduce Hemodialysis Access Induced Hand Ischemia |
| Robert Schainfeld, DO |
11/18/2025 10:30 AM |
18 |
Presenter |
How To Best Use The Direct Oral Anticoagulants—What Are the Tips |
| Robert Schainfeld, DO |
11/18/2025 11:37 AM |
18 |
Panelist |
Challenging The Experts: Interactive Q&A |
| Andres Schanzer, MD |
11/18/2025 8:20 AM |
2 |
Presenter |
Total Endovascular Aortic Arch Repair Is Complicated But A 3 Retrograde Branch Design Is Safest And Simplest When Reinforced Steerable Sheaths Are Used Entirely Via Transfemoral Access: Which Devices Are Best And Technical Tips |
| Andres Schanzer, MD |
11/20/2025 8:20 AM |
48 |
Presenter |
Late Results Of F/EVAR For Failed EVAR Are Excellent: When Should It Be The Procedure Of Choice For EVAR Failures: Technical Tips Including Use Of A F/EVAR Device With An Integrated Bifurcation To Facilitate The Procedure |
| Andres Schanzer, MD |
11/19/2025 9:24 AM |
33 |
Presenter |
How To Treat Type 1 Endoleaks After EVAR: When Cuff, When F/EVAR, When Chimney, When Open Conversion: What About Embolization |
| Andres Schanzer, MD |
11/20/2025 9:50 AM |
49 |
Presenter |
Aortic Research Consortium (ARC) Quality Analysis Over Time Shows Improving F/B/EVAR Outcomes Despite Growing Disease Complexity: Key Technical Tips And Reasons For Improvement |
| Andres Schanzer, MD |
11/19/2025 |
46, |
Session
Moderator |
MORE HOT NEW TOPICS RELATED TO AORTC DISEASE AND ITS TREATMENT |
| Dori R. Schatell, MS |
11/22/2025 10:26 AM |
111 |
Presenter |
Helping Patients Overcome Needle Fear |
| Dori R. Schatell, MS |
11/22/2025 8:06 AM |
110 |
Presenter |
The Importance Of Talking To Your Patients About Dialysis Options |
| Dierk Scheinert, MD |
11/19/2025 1:30 PM |
35 |
Presentation
Moderator |
PROGRAM TO BE DETERMINED |
| Dierk Scheinert, MD |
11/19/2025 |
26, |
Session
Moderator |
NEW DEVELOPMENTS IN DRUG COATED BALLOONS (DCBs) AND DRUG ELUTING STENTS (DESs): UPDATES ON PACLITAXEL TOXICITY, RANDOMIZED CONTROLLED TRIALS
(RCTs) AND BTK LESION TREATMENTS WITH DCBs AND DESs
|
| Larry A. Scher, MD |
11/19/2025 11:48 AM |
34 |
Presenter |
How Vascular Guidelines Can Be Used To Support Unjustified Malpractice Claims: What Can Be Done About It |
| Larry A. Scher, MD |
11/22/2025 8:00 AM |
110 |
Presenter |
Introduction |
| Larry A. Scher, MD |
11/22/2025 |
110, |
Session
Moderator |
IMPORTANT ISSUES IN HEMODIALYSIS ACCESS |
| Larry A. Scher, MD |
11/22/2025 |
112, |
Session
Moderator |
MINISYMPOSIUM: MANAGEMENT OF THE COMPLEX HEMODIALYSIS PATIENT |
| Larry A. Scher, MD |
11/22/2025 |
113, |
Session
Moderator |
POLITICAL, ECONOMIC AND LEGAL ISSUES IN HEMODIALYSIS ACCESS |
| Larry A. Scher, MD |
11/22/2025 |
115, |
Session
Moderator |
UPDATE ON CLINICAL CHALLENGES IN HEMODIALYSIS ACCESS |
| Marc L. Schermerhorn, MD |
11/22/2025 11:32 AM |
109 |
Presenter |
Impact Of Antiplatelet Regimens On CAS Outcomes: Plavix Alone May Be As Safe As Plavix And Aspirin (DAPT) But Not Aspirin Alone; What Is The Optimal Timing And Dosage: What About Resistance To Plavix |
| Marc L. Schermerhorn, MD |
11/19/2025 2:00 PM |
27 |
Presenter |
Not So Fast: Results With DVA May Not Be As Good Universally As Reported In The PROMISE And Other Trials: DVA May Have Some Downsides Leaving Room For Other Treatments Of "No Option" CLTI Patients |
| Marc L. Schermerhorn, MD |
11/21/2025 8:24 AM |
80 |
Presenter |
DEBATE: Comparative Contemporary Performance And Risks Of TCAR And CEA, Show Them To Be Superior To Transfemoral CAS (TFCAS) For The Treatment Of Carotid Artery Stenosis |
| Marc L. Schermerhorn, MD |
11/20/2025 8:26 AM |
48 |
Presenter |
F/EVAR After Failed EVAR: It Works But Long-Term Results Are Worse Than For Standard F/EVAR: Why This May Be: Technical Tips To Facilitate The Procedure |
| Marc L. Schermerhorn, MD |
11/21/2025 |
80, |
Session
Moderator |
NEW DEVELOPMENTS IN THE TREATMENT OF CAROTID STENOSIS: UPDATE ON MESH COVERED STENTS AND TCAR (TRANSCERVICAL CAROTID ARTERY REVASCULARIZATION)
|
| Andrej Schmidt, MD |
11/19/2025 1:30 PM |
35 |
Presentation
Moderator |
PROGRAM TO BE DETERMINED |
| Andrej Schmidt, MD |
11/19/2025 7:28 AM |
23 |
Presenter |
Local Anesthetic Injection Into A Lesion Site Facilitates Angioplasty (PTA) And Stent Placement By Decreasing Patient Pain And Movement: How To Do It |
| Andrej Schmidt, MD |
11/19/2025 |
23, |
Session
Moderator |
GENERALITIES IN THE TREATMENT OF LOWER EXTREMITY OCCLUSIVE DISEASE, CLTI AND THEIR MEDICAL TREATMENT: SOME NEW CONCEPTS
|
| Darren B. Schneider, MD |
11/20/2025 10:38 AM |
49 |
Presenter |
Aneurysm Sac Changes After F/B/EVAR For TAAAs: Why They Are Important Prognostically: What Beside Endoleaks Can Cause Enlargement: When And How Should Enlargement Be Treated |
| Peter A. Schneider, MD |
11/19/2025 10:18 AM |
26 |
Presenter |
Increased Amputation Rates From Use Of Paclitaxel Coated Devices May Be Real Or A Methodological Artifact: Other Paclitaxel Coating Effects Like Embolization Or Post Atherectomy Aneurysm Formation Deserve Further Study |
| Peter A. Schneider, MD |
11/19/2025 10:36 AM |
26 |
Presenter |
Long-Term Results Of An RCT Comparing SurVeil DCBs (Surmodics) With In.Pact DCBs (Medtronic) For Treating FemPop Lesions: From The TRANSCEND Trial: How Do The Two Devices Differ |
| Peter A. Schneider, MD |
11/19/2025 1:00 PM |
27 |
Presenter |
What Presently Defines A No Option Or Desert Foot Before Or After Failed Endo Or Open Treatments: Can Better Arterial Imaging Help And How To Do It |
| Peter A. Schneider, MD |
11/19/2025 7:34 AM |
23 |
Presenter |
Use Of Intraoperative Pedal Duplex To Detect Embolization During Complex Lower Extremity Revascularization: How To Do It, What Are The Causes And How To Prevent It |
| Peter A. Schneider, MD |
11/19/2025 |
24, |
Session
Moderator |
NEW DEVELOPMENTS IN ATHERECTOMY AND STENTS (UNCOATED AND COATED) |
| Peter A. Schneider, MD |
11/22/2025 |
106, |
Session
Moderator |
LOWER EXTREMITY TOPICS TOO IMPORTANT TO MISS |
| Andrew Schulick, MD |
11/18/2025 5:24 PM |
16 |
Presenter |
Anterior Lumbar Spine Exposures: Variation Of Standard Approaches, Tips, Tricks, And Tools For Dealing With Difficult Circumstances: Causes And Management Of Unexpected Venous Injury |
| Geert Willem H. Schurink, MD, PhD |
11/21/2025 6:58 AM |
79 |
Presenter |
Update On Value Of MEPs: How Can They Guide Treatment To Decrease SCI With Endo And Open TAAA Repairs |
| Eric A. Secemsky, MD, MSc |
11/18/2025 11:37 AM |
18 |
Panelist |
Challenging The Experts: Interactive Q&A |
| Eric A. Secemsky, MD, MSc |
11/19/2025 8:05 AM |
24 |
Presenter |
The Available Atherectomy Devices: Which One Is Best For What Lesions: What Is The Solid Evidence That Atherectomy Is Effective: From A Systematic Review And Meta-Analysis |
| Eric A. Secemsky, MD, MSc |
11/18/2025 8:45 AM |
17 |
Presenter |
Pharmacomechanical Thrombolysis With The Bashir Catheter: Unique And Differentiated Approach |
| Carlo Setacci, MD |
11/21/2025 1:00 PM |
83 |
Presenter |
CAS vs CEA: Why The Debate Will Never End: Bias And Self Interest Overwhelms Facts And Logic And Often Influences How Good Trials And Even RCTs Are Misinterpreted |
| Carlo Setacci, MD |
11/21/2025 3:00 PM |
93 |
Presenter |
Update On Autologous Cell And Gene Therapy For Chronic Limb Threatening Ischemia (CLTI): Do They Really Work And Future Prospects |
| Carlo Setacci, MD |
11/19/2025 9:06 AM |
33 |
Presenter |
Major Systemic Trauma Can Cause Type 1 Endoleaks Anytime After EVAR With Or Without Fixation Elements: How Should Such Endoleaks Be Treated |
| Carlo Setacci, MD |
11/19/2025 |
35, |
Session
Moderator |
RECORDED LIVE CHALLENGING CASES AND INNOVATIVE TECHNIQUES FROM THE PLINIO ROSSI AND LINC COMPONENTS
|
| Julien G. Sfeir, MD |
11/18/2025 2:58 PM |
6 |
Presenter |
Inflammatory AAAs: When Can Medical Treatment Be Effective As Endo Or Open Invasive Treatment: From Results Of A 5-Year Study |
| Robert Shahverdyan, MD |
11/22/2025 1:51 PM |
114 |
Presenter |
The Rise And Fall And Future Of Endovascular AV Fistulas |
| Robert Shahverdyan, MD |
11/22/2025 9:13 AM |
110 |
Presenter |
Clinical Applications Of Volume Flow Measurement In Hemodialysis Access |
| Sherene Shalhub, MD, MPH |
11/19/2025 2:12 PM |
44 |
Presenter |
Why And How Should AAAs And Iliac Pathology Be Treated Differently In Patients With Heritable Vascular Syndromes (Marfan, Loeys-Dietz And Ehlers-Danlos [EDS]) |
| Murray L. Shames, MD |
11/18/2025 11:36 AM |
1 |
Presenter |
Physician And Industry Responsibility In Overuse Of Technology (Atherectomy, CAS, EVAR, Etc.): What Is Happening To Correct This Overuse Especially Important In View Of The Recent Media Spotlight On This Issue |
| Murray L. Shames, MD |
11/18/2025 3:00 PM |
14 |
Presenter |
Impact Of EVAR On Resident/Fellow Experience In Open AAA Repair Experience And Competence: What To Do About It |
| Murray L. Shames, MD |
11/19/2025 5:22 PM |
38 |
Presenter |
Why Do We Not Have More FDA Approved Devices For F/B/EVAR In The US: Is The FDA Failing Or Doing Its Job |
| Murray L. Shames, MD |
11/18/2025 7:26 AM |
9 |
Presenter |
The Cydar System And Its AI Modifications Allows Image Fusion For F/B/EVAR Even With Mobile C-Arms And Enhances Fusion Accuracy As Intravascular Hardware Modifies Vascular Anatomy: How Does The System Work: Advantages And Limitations |
| Murray L. Shames, MD |
11/20/2025 8:12 AM |
56 |
Presenter |
In Choosing Industry Made Endovascular Devices, How Important Is Corporate Reputation, Device Quality, Service By Representatives And Cost |
| Rashid Sharaf, MD |
11/22/2025 8:38 AM |
110 |
Presenter |
Evolving Algorithms Of Care In AV Access Creation And Maintenance |
| Aditya Sharma, MD |
11/18/2025 7:15 AM |
17 |
Presenter |
The Basics Of Pulmonary Embolism Diagnosis: What Is The Role Of The History, Exam, Biomarkers |
| Palma M. Shaw, MD, MBA, FACS, RPVI, DFSVS |
11/18/2025 5:00 PM |
22 |
Presenter |
Why Intravascular Lithotripsy (IVL - Shockwave-J&J) Is A Game Changer In The Treatment Of BTK Vascular Lesions: What Is The Evidence, What Are The Indications And Techniques |
| Surendra Shenoy, MD, PhD |
11/22/2025 11:17 AM |
112 |
Presenter |
Hemodialysis Access In Patients With Chronic Hypotension |
| Surendra Shenoy, MD, PhD |
11/22/2025 |
115, |
Session
Moderator |
UPDATE ON CLINICAL CHALLENGES IN HEMODIALYSIS ACCESS |
| Chang Shu, MD |
11/18/2025 9:50 AM |
3 |
Presenter |
Comparison Of Indication And Results For Treatment Of Aortic Arch Lesions With Branched Endografts, Fenestrated Endografts, Parallel Stent Grafts, Hybrid Repairs, Or Open Repairs |
| Anton N. Sidawy, MD, MPH |
11/19/2025 4:52 PM |
38 |
Presenter |
Update On The SVS/ACS Vascular Verification Program (VVP) To Assure Quality Vascular Care In Outpatient And Inpatient Programs: What Is It And How Will It Help Vascular Surgery |
| Anton N. Sidawy, MD, MPH |
11/19/2025 |
37, |
Session
Moderator |
MORE ISSUE-RELATED TOPICS IMPORTANT TO VASCULAR SURGEONS AND VASCULAR SPECIALISTS; ISSUES RELATED TO OUTPATIENT CENTERS OR OFFICE BASED LABS (OBLs) AND AMBULATORY SURGERY CENTERS (ASCs) |
| Anton N. Sidawy, MD, MPH |
11/19/2025 |
38, |
Session
Moderator |
UPDATES AND ISSUES IMPORTANT TO ALL VASCULAR SURGEONS AND SPECIALISTS: FUTURE REIMBURSEMENT; IMPROVING VASCULAR CARE QUALITY; FIXING FALSE TESTIMONY; FLAWED PEER REVIEW; FDA IMPROVEMENTS; LEARNING HEALTH SYSTEMS |
| Anton N. Sidawy, MD, MPH |
11/22/2025 |
110, |
Session
Moderator |
IMPORTANT ISSUES IN HEMODIALYSIS ACCESS |
| Anton N. Sidawy, MD, MPH |
11/22/2025 |
113, |
Session
Moderator |
POLITICAL, ECONOMIC AND LEGAL ISSUES IN HEMODIALYSIS ACCESS |
| Adnan H. Siddiqui, MD, PhD |
11/21/2025 10:48 AM |
82 |
Presenter |
The Role Of Intravascular Lithotripsy (IVL) And Next Generation Stents In TFCAS And TCAR |
| Adnan H. Siddiqui, MD, PhD |
11/18/2025 8:50 AM |
10 |
Presenter |
If Optimal Skills For Performing CEA, CAS And TCAR Are Available And Invasive Treatment Is Justified, How To Select The Optimal Procedure: This Algorithm Helps |
| Adnan H. Siddiqui, MD, PhD |
11/18/2025 9:40 AM |
11 |
Presenter |
With Acute Strokes, What Is New With Endovascular Intracranial Techniques And Indications For Arterial Clot Removal: Do The Recent Trials Expand Treatment Options: They Do Not For More Distal Clot Removal Or Intracranial Thrombolysis: Why Must Stroke Patients Be Kept Flat |
| Adnan H. Siddiqui, MD, PhD |
11/18/2025 9:52 AM |
11 |
Presenter |
Optimal Current Management Of Acute Embolic Stroke From Carotid Bifurcation Disease: Approach And Sequence Of The Treatment With Removal Of Intracranial Clot And Stenting Of The Carotid Lesion: Equipment And Training Needed |
| Horst Sievert, MD |
11/19/2025 7:42 AM |
32 |
Presenter |
An Update On Renal Denervation For Resistant Hypertension: It Really Works As Shown By RCTs: What Are The Techniques And Devices: When Should They Be Used |
| Horst Sievert, MD |
11/19/2025 8:24 AM |
32 |
Presenter |
Expanding Endovascular Renal Artery Denervation To Multiorgan Arterial Denervation: What Are Its Potential Benefits In Treating Human Diseases: What Is The Supporting Evidence |
| Michael B. Silva, Jr., MD |
11/22/2025 11:20 AM |
109 |
Presenter |
Endovascular Emergency Treatment Of Carotid Blowout From Head And Neck Cancer Or Carotid Patch Infections: Planning, Preparation And Technical Tips Are Essential |
| Michael B. Silva, Jr., MD |
11/20/2025 |
47, |
Session
Moderator |
EXCITING NEW OR REDISCOVERED TECHNIQUES, DEVICES, CONCEPTS |
| Michael B. Silva, Jr., MD |
11/21/2025 |
81, |
Session
Moderator |
MORE CAROTID HOT TOPICS RELATED TO TCAR, CAS AND EFFECTS OF INTERVENTIONS ON COGNITIVE FUNCTION
|
| Rossi M. Silva, MD |
11/20/2025 |
55, |
Session
Moderator |
NEW OR IMPROVED DEVICES FOR INFRARENAL AAA AND COMPLEX AAA REPAIR |
| Michael J. Singh, MD |
11/21/2025 1:44 PM |
92 |
Presenter |
How Anterior Scalene And Pectoralis Minor Blocks Can Simplify The Diagnostic Dilemma With Neurogenic TOS: What Agent To Use, Technique And How It Directs Treatment |
| Michael J. Singh, MD |
11/21/2025 2:08 PM |
92 |
Presenter |
Arterial TOS In Patients With Connective Tissue Disorders: How The Latter Influences The Vascular Pathology And Should Change Treatment Strategies |
| Michael J. Singh, MD |
11/21/2025 4:36 PM |
86 |
Presenter |
How To Prevent And Treat Complication Of Large Bore Arterial Access: Comparative Analysis of Manta, Prostar XL And Perclose ProGlide Devices |
| Michael J. Singh, MD |
11/21/2025 |
92, |
Session
Moderator |
NEW DEVELOPMENTS IN THE TREATMENT OF THORACIC OUTLET SYNDROMES (TOSs)
|
| Niten Singh, MD |
11/19/2025 2:25 PM |
28 |
Presenter |
For Primary Treatment Of CLTI What Is The Current Role And Proportion Of Patients Needing An Open Bypass In The Endovascular Era: What Percentage Of CLTI Patients Will Need An Open Bypass At Some Time In Their Course: What Percentage Of These Bypasses Will Have To Be Done With A PTFE Graft |
| Niten Singh, MD |
11/19/2025 4:18 PM |
29 |
Presenter |
Why CLTI Patients At Many Hospitals Could Not Be Included In The BEST-CLI Trial: Why This Weakens The Trial's Conclusions And Make Them Non-Applicable To Much Real-World Practice: What To Do About It |
| Jeffrey J. Siracuse, MD, MBA, FACS |
11/22/2025 8:26 AM |
107 |
Presenter |
Axillo-Unifemoral And Axillo-Bifemoral Bypasses Have Equal Patency For More Than A Year: Why The Bilateral Procedure Should Only Be Used When Bilateral Ischemia Exists |
| Jeffrey J. Siracuse, MD, MBA, FACS |
11/22/2025 9:37 AM |
110 |
Presenter |
Strengths And Weaknesses Of Using VQI And Other Administrative Data Bases To Assess Hemodialysis Access Outcomes |
| Pasqualino Sirignano, MD, PhDS |
11/18/2025 3:24 PM |
21 |
Presenter |
Endovascular PTA And Stenting Of Deep Femoral Artery (DFA) Lesions Is Possible And Effective: How To Do It, Limitations, And Results |
| Pasqualino Sirignano, MD, PhDS |
11/21/2025 3:54 PM |
94 |
Presenter |
Emergency Management Of Major Arterial And Venous Injuries During Interventional Cardiology Procedures: Diagnosis, Technical Tips, And Outcomes |
| Christopher J. Smolock, MD |
11/18/2025 11:24 AM |
12 |
Presenter |
Redo AIOD Interventions After Failed Stenting Or Aorto-Bifem Procedures: How To Recanalize Native Vessels And Salvage With A CERAB Procedure |
| Christopher J. Smolock, MD |
11/18/2025 9:02 AM |
10 |
Presenter |
Optimal Current Treatment Of Tandem Extracranial Carotid Lesions: Techniques And Sequence Of Treatment To Include Flow Reversal Cerebral Protection |
| J. David Spence, MD |
11/21/2025 1:36 PM |
83 |
Presenter |
Whatever The RCTs Show, Invasive Treatments May NOT Be Better Than BMT Because Of Flaws In The Trials: What Are These Flaws And How To Remedy Them |
| J. David Spence, MD |
11/19/2025 7:16 AM |
31 |
Presenter |
The Importance Of LDL-C Lowering During A Lifetime And In Decreasing Dementia Risk: How Low To Strive For With Intensive Drug Therapy: How Young To Start If High; How Old To Continue Statins: Why And How Often Should LDL-C Levels Be Measured |
| J. David Spence, MD |
11/18/2025 8:32 AM |
10 |
Presenter |
What Is The Best Medical Therapy For Patients With Carotid Stenosis: Diet (What Should And Shouldn't Be Eaten) Is Very Important: What Drugs And Dosage Should They Be On And Should They Be Titrated Against LDL Levels: When And How Should Homocysteine Levels Be Reduced |
| Francesco Speziale, MD |
11/18/2025 4:38 PM |
7 |
Presenter |
Coral Reef Aorta: Indications For Invasive Treatment; When Open Surgery, When Endo: Technical Tips |
| Francesco Spinelli, MD |
11/21/2025 2:14 PM |
92 |
Presenter |
Minimally Invasive Transaxillary First Rib Resection For TOS Under Local And Regional Anesthesia: How To Do It Safely: What Are The Limitations |
| Francesco Spinelli, MD |
11/18/2025 2:28 PM |
20 |
Presenter |
What Has Been The Impact Of The BEST-CLI And BASIL 2 RCTs On The Treatment Of CLTI In European Practices |
| Francesco Spinelli, MD |
11/22/2025 8:32 AM |
107 |
Presenter |
Technical Tips For Performing BK Popliteal To Distal Leg Or Foot Artery Bypasses: Advantages And Results |
| Lars Stangenberg, MD, PhD |
11/18/2025 1:12 PM |
13 |
Presenter |
How To Develop A Robotic Vascular Surgery Practice And How It Can Benefit A Vascular Surgeon: What Is The Future Of Robotic Vascular Surgery |
| James C. Stanley, MD |
11/18/2025 2:18 PM |
14 |
Presenter |
The Direct And Indirect Value Of The ABS Vascular Board Becoming An ABMS Approved Independent American Board Of Vascular Surgery: Why does Vascular Surgery Not Have An Independent Board While One Exists In Every Other Civilized Country |
| James C. Stanley, MD |
11/20/2025 3:40 PM |
53 |
Presenter |
What Are The Best Arterial Grafts To Treat Aortic Pathology Including AAAs In Children And Infants |
| James C. Stanley, MD |
11/18/2025 4:06 PM |
15 |
Presenter |
Current Optimal Treatment Of Gastroduodenal And Pancreaticoduodenal Artery Aneurysms In Patients With Occlusion Of The Celiac Axis: Open Or Endovascular |
| James C. Stanley, MD |
11/18/2025 |
14, |
Session
Moderator |
ISSUES IMPORTANT TO VASCULAR SURGERY’S INDEPENDENCE, IDENTITY, WELL BEING AND TRAINING
|
| James C. Stanley, MD |
11/18/2025 |
15, |
Session
Moderator |
PROGRESS IN THE TREATMENT OF RENAL AND VISCERAL ARTERY DISEASE |
| Benjamin W. Starnes, MD |
11/18/2025 2:30 PM |
14 |
Presenter |
Why The SVS Has Been Reluctant To Support An Independent American Board Of Vascular Surgery When So Many Membership Polls Have Shown Overwhelming Support For Such A Board Over The Past Two Decades |
| Benjamin W. Starnes, MD |
11/20/2025 8:42 AM |
56 |
Presenter |
What Is The TREO-Fit Platform And How Does It Work To Standardize PMEG Repairs OF Juxta And Para-Renal AAAs: Advantages And Results |
| Johnny Steuer, MD, PhD |
11/20/2025 7:56 AM |
47 |
Presenter |
Long-Term (Up To 20-Years) Follow-Up Of 95 TEVAR Patients With Non-Compliant Endografts For Blunt Traumatic Aortic Injury (BTAI): All Major Complications Requiring Reintervention Occurred Within 18 Months: Was There A Detrimental Effect On The BP Or Heart In These Patients |
| Scott L. Stevens, MD |
11/19/2025 11:42 AM |
34 |
Presenter |
How Human Behavior – Even With Vascular Surgeons/Specialists – Is Controlled By Biases And Rationalizations: How To Overcome These And Perform Better |
| David H. Stone, MD |
11/18/2025 1:12 PM |
5 |
Presenter |
Size Thresholds For Repair Of AAAs Are Wrong On The Low Side: Data From Medicare And The VQI Indicate That Rupture Risk Only Increases With AAAs Over 6-6.9 cm |
| Patrick A. Stone, MD |
11/19/2025 2:12 PM |
36 |
Presenter |
How To Prevent Problems With Overlapping Surgical Procedures For A Single Surgeon With A Covering Surgeon Policy: Is It Good For Patients |
| Michael C. Stoner, MD |
11/19/2025 2:18 PM |
36 |
Presenter |
How A Vascular Surgery Service With A Large Volume Of Emergent Patients Can Handle Them Without Disrupting Elective Schedules And Clinical Practices: A Committed Surgeon Of The Day Without Other Responsibilities Is The Answer |
| Michael C. Stoner, MD |
11/21/2025 8:54 AM |
80 |
Presenter |
How To Manage Safely Heavily Calcified Carotid Lesions With TCAR And Without IVL (Shockwave) |
| Michael C. Stoner, MD |
11/21/2025 9:08 AM |
88 |
Presenter |
Arterial Graft Infections Can Be Treated With Local Antibiotic Beads To Downgrade Infection Virulence And Allow For Graft Preservation: How To Do It And When Does It Work |
| Martin Storck, MD, PhD |
11/21/2025 2:24 PM |
84 |
Presenter |
With Asymptomatic Carotid Stenosis (ACS) Are There Gender Specific Differences In Treatment Outcomes Or Are Any Observed Differences Related To Vessel Size: Gender Should Never Preclude Treatment |
| Bjoern D. Suckow, MD, MS |
11/19/2025 3:30 PM |
45 |
Presenter |
PMEGs Outside Of IDE Trials: What Is The FDAs Position And Will CMS Reimburse For Them: How Can A Vascular Surgeon Get An IDE For PMEGs |
| Bjoern D. Suckow, MD, MS |
11/19/2025 3:42 PM |
45 |
Presenter |
Technical Improvements For PMEGs To Facilitate Diameter Reduction And Branch Access Covered Stent Delivery |
| Bjoern D. Suckow, MD, MS |
11/21/2025 9:52 AM |
89 |
Presenter |
How To Pick The Best Hybrid OR/Suite For Your Institution: Advantages, Disadvantages, Accessories And Determinants Of Cost Of The Three Main Systems (GE, Siemens, Philips) |
| Sherif A.H. Sultan, MD, FRCS, EBQS-VASC, PhD, FACS |
11/19/2025 1:06 PM |
27 |
Presenter |
Progress In The Treatment Of Supposed "No Option" CLTI Patients: With Better Arterial Imaging, Inframalleolar PTA Or Bypass Or Deep Vein Arterialization (DVA) May Be The Best Treatment: How To Do This Better Imaging With Direct Arterial Injection, DSA, CTA And MRA And What They Can Show |
| Sherif A.H. Sultan, MD, FRCS, EBQS-VASC, PhD, FACS |
11/18/2025 1:12 PM |
19 |
Presenter |
The ArtAssist Self Applied Intermittent Compression Device To Treat CLTI Patients: How Does It Work: When Is It Indicated And When Is It Not: Results |
| Wilson Y. Szeto, MD |
11/18/2025 10:24 AM |
4 |
Presenter |
Use Of A Bare Stent (AMDS – Artivion) In The Aortic Arch After Open Ascending Aortic Repair Of DeBakey Type 1 Dissection To Alleviate End Organ Malperfusion: How Does It Work And Promising Mid-Term Results |
| Wilson Y. Szeto, MD |
11/19/2025 11:40 AM |
42 |
Presenter |
Role Of Bare Metal AMDS Stents (From Artivion) For Repair Of Acute DeBakey Type 1 Dissections: How Do They Work, Indications And Advantages |
| Piotr Szopinski, MD, PhD |
11/20/2025 1:36 PM |
51 |
Presenter |
AAA Rupture After EVAR Behaves Differently From De Novo Rupture: How Should Treatment Be Modified In Patients With Ruptures After EVAR |
| Piotr Szopinski, MD, PhD |
11/20/2025 7:06 AM |
55 |
Presenter |
The Adaptive Sealing Ring Polymer Technology Of The ALTO Endograft (Endologix) Is Optimal To Treat Patients With Complex Proximal Neck Anatomy And Narrow Or Tortuous Iliac Arteries: Advantages, Limitations And Results |
| Piotr Szopinski, MD, PhD |
11/20/2025 7:48 AM |
55 |
Presenter |
Current Status And Value Of The AFX 2 For The Treatment Of AAAs And Aorto-Iliac Occlusive Disease |
| TBD |
11/18/2025 10:10 AM |
11 |
Presenter |
TBD |
| TBD |
11/22/2025 10:12 AM |
108 |
Presenter |
TBD |
| TBD |
11/18/2025 10:16 AM |
11 |
Presenter |
TBD |
| TBD |
11/20/2025 10:38 AM |
57 |
Presenter |
TBD |
| TBD |
11/22/2025 11:44 AM |
109 |
Presenter |
TBD |
| TBD |
11/20/2025 11:49 AM |
50 |
Presenter |
A New Hemostatic Agent (Cresilon [Trauma Gel]) Topical Application To Control Traumatic Hemorrhage |
| TBD |
11/20/2025 1:42 PM |
59 |
Presenter |
TBD |
| TBD |
11/20/2025 2:54 PM |
60 |
Presenter |
TBD |
| TBD |
11/21/2025 3:24 PM |
93 |
Presenter |
TBD |
| TBD |
11/21/2025 3:30 PM |
93 |
Presenter |
TBD |
| TBD |
11/22/2025 3:46 PM |
115 |
Presenter |
TBD |
| TBD |
11/19/2025 5:34 PM |
38 |
Presenter |
TBD |
| Michael G. Tal, MD, MBA |
11/19/2025 10:48 AM |
33 |
Presenter |
Catheters, Guidewires, Balloon Innovations That Have Changed IR: Advice From A Serial Innovator |
| Apostolos K. Tassiopoulos, MD |
11/18/2025 1:54 PM |
13 |
Presenter |
How Can AI Improve Treatment Strategies Before And After AAA Procedures: Will It Improve Outcomes And Be Widely Available |
| Apostolos K. Tassiopoulos, MD |
11/20/2025 4:18 PM |
62 |
Presenter |
Endoanchors (Heli-FX – Medtronic) Offer Durable Protection Of EVAR Proximal Seal Zones In Patients With Hostile Neck Anatomy: What Is The Evidence And How Durable Is The Seal |
| Gunnar Tepe, MD |
11/19/2025 10:30 AM |
26 |
Presenter |
2-Year Results Of The SPORTS RCT – Comparing DESs (Eluvia – Boston Scientific) vs Bare Metal Stents (BMSs) vs DCBs: Which Device Is Best And In What Circumstances |
| Gunnar Tepe, MD |
11/19/2025 2:55 PM |
28 |
Presenter |
What Are The Best Treatment Options For Restenosis After DCBs And How They Differ From Restenosis After Angioplasty And Stenting |
| Gunnar Tepe, MD |
11/18/2025 5:12 PM |
22 |
Presenter |
Update On The Advantages Of The Chocolate Wire Constrained Uncoated Balloon (From Medtronic) For Treating Popliteal And BTK Lesions: Advantages Including Prevention Of Vessel Recoil: Updated Results (From The CHOCO CABANA Trial) |
| Katherine A. Teter, MD |
11/21/2025 2:20 PM |
92 |
Presenter |
Robotic Approach To Thoracic Outlet Decompression: Equipment Required And How To Do It: Advantages, Limitations And Results |
| Bryan W. Tillman, MD, PhD. |
11/20/2025 7:32 AM |
47 |
Presenter |
Progress With The Retrievable Rescue Stent-Graft To Control Massive Aortic Or Caval Bleeding: How Does It Work, How Is The Device Retrieved And When Will It Be Widely Available |
| Bryan W. Tillman, MD, PhD. |
11/19/2025 7:40 AM |
23 |
Presenter |
The Retrievable "Infuse" Drug Delivery Stent-Graft: How Does It Work And Will It Render Drug Coated Balloons (DCBs) Obsolete |
| Carlos H. Timaran, MD |
11/18/2025 10:54 AM |
4 |
Presenter |
Updated Experience With Endovascular Thermal Septotomy Of The Dissection Flap With An Electrocautery Activated Guidewire To Treat Subacute And Chronic TBADs: How Does It Optimize Landing Zones: Technical Tips And How To Avoid Pitfalls And Complications |
| Carlos H. Timaran, MD |
11/18/2025 7:32 AM |
9 |
Presenter |
Improved Fiberoptic Based Radiation Free Imaging With The FORS Lumiguide System (Philips): Fiberoptic Sensors Within A Guidewire And A Special 3D Hub Allow Imaging Guidance With Any Catheter: How Does It Work And Experience |
| Carlos H. Timaran, MD |
11/19/2025 9:16 AM |
41 |
Presenter |
Endovascular Treatment Of Post-Dissection TAAAs By F/B/EVAR: Challenges, Technical Tips, Optimal Devices And Long-Term Outcomes |
| Carlos H. Timaran, MD |
11/20/2025 |
57, |
Session
Moderator |
NEW OR IMPROVED DEVICES FOR THORACOABDOMINAL ANEURYSM (TAAA) REPAIRS AND THORACIC AORTIC LESION REPAIRS (TEVAR)
|
| Giovanni Tinelli, MD, PhD |
11/19/2025 6:50 AM |
39 |
Presenter |
TEVAR In Patients With Compromised Distal And Proximal Landing Zones: Strategies For Success: The Value Of Scallops And Endoanchors |
| Giovanni Tinelli, MD, PhD |
11/19/2025 8:33 AM |
40 |
Presenter |
Long-Term Stroke Risk In Total Aortic Arch Branched Endovascular Repairs: What Are The Etiologies, Why Is It An Unresolved Problem And How Can It Be Solved |
| Giovanni B. Torsello, MD |
11/20/2025 10:26 AM |
49 |
Presenter |
Impact Of Aortic Remodeling On Main Graft And Bridging Stent Stability After B/EVAR And F/EVAR: How Harmful Is It, How Can It Be Prevented And How Should It Influence Treatment |
| Giovanni B. Torsello, MD |
11/18/2025 4:32 PM |
7 |
Presenter |
The Value Of Endovascular Treatment Of Thoracoabdominal Coral Reef Aorta: Technical Tips, Results And When And How Can It Be Used |
| Giovanni B. Torsello, MD |
11/21/2025 |
91, |
Session
Moderator |
CHALLENGING RECORDED LIVE CASES FROM MÜNSTER, GERMANY |
| Margaret Tracci, MD, JD |
11/18/2025 10:30 AM |
12 |
Presenter |
New Developments In The Treatment Of External Iliac Artery Endofibrosis In Committed Cyclists: Pathogenesis And Why There Is No Role For Endovascular Therapy |
| Margaret Tracci, MD, JD |
11/21/2025 2:02 PM |
92 |
Presenter |
Arterial And Venous TOS Disorders In Overhead Throwing Athletes: What Are These Disorders And How Should They Best Be Treated |
| Margaret Tracci, MD, JD |
11/18/2025 2:12 PM |
14 |
Presenter |
What New Initiatives Should The SVS Be Engaged In To Improve The Status Of Vascular Surgery And The Well Being Of Vascular Surgeons: Why Hasn't The SVS Been Able To Do More |
| Margaret Tracci, MD, JD |
11/18/2025 4:54 PM |
16 |
Presenter |
What Is The Role Aorto-Iliac Endarterectomy In The Endovascular Era: When And Why Is It The Best Treatment |
| Margaret Tracci, MD, JD |
11/20/2025 |
56, |
Session
Moderator |
NEW OR UPDATED EVAR DEVICES FOR AAAs, COMPLEX AAAs OR TAAAs |
| Santi Trimarchi, MD, PhD |
11/20/2025 11:46 AM |
58 |
Presenter |
Computational Modeling Is A New Paradigm For Outcomes Improvement In TEVAR |
| Santi Trimarchi, MD, PhD |
11/19/2025 8:03 AM |
40 |
Presenter |
Expert Consensus (ESVS) On The Use Of TEVAR For Ascending Aortic Disease: Optimal Devices And Results For Complicated And Uncomplicated Aortic Dissections And Other Pathologies: When Is It Indicated And When Not |
| Patrick Troy, MD |
11/18/2025 10:40 AM |
18 |
Presenter |
Your Referring Docs Think Heparin Is All They Need To Offer For PE—How To Tell The Intervention Story |
| Patrick Troy, MD |
11/18/2025 11:37 AM |
18 |
Panelist |
Challenging The Experts: Interactive Q&A |
| Yamume Tshomba, MD |
11/18/2025 3:56 PM |
7 |
Presenter |
Open Repair Of Chronic Type B Dissection: What Is The Role For Open Repair; Technical Tips |
| Nikolaos Tsilimparis, MD, PhD |
11/20/2025 11:22 AM |
58 |
Presenter |
Preloaded Fenestrated Endografts With A Modified Biport Handle (From Cook): A Way To Make F/EVAR Easier: How Does It Work And Results From An International Multicenter Study |
| Nikolaos Tsilimparis, MD, PhD |
11/20/2025 2:12 PM |
52 |
Presenter |
T-Branch (Cook - OTS) Treatment Of Ruptured TAAAs: The Value Of Local Anesthesia And Why Axillary Access And The BeFlare Covered Stent Are Important Adjuncts: Advantages And Contraindications |
| Nikolaos Tsilimparis, MD, PhD |
11/18/2025 8:38 AM |
2 |
Presenter |
Multibranched Arch Endografts Are Not Harmless And Can Have Several Complications: What Are They And How Can They Be Minimized |
| Gilbert R. Upchurch, MD |
11/19/2025 10:10 AM |
41 |
Presenter |
Hybrid Repair Of A TAAA (Proximal TEVAR With Distal Open Repair -- The Upchurch Procedure): When Is It Indicated; What Are The Advantages And Updated Results |
| Gilbert R. Upchurch, MD |
11/19/2025 |
41, |
Session
Moderator |
OPEN AND ENDO TREATMENT OF COMPLEX AAAs (JUXTA, PARA- AND SUPRA-RENAL) AND TAAAs; INTERESTING NEW DEVICES FOR THEIR TREATMENT |
| Gilbert R. Upchurch, MD |
11/21/2025 |
94, |
Session
Moderator |
ADVANCES IN THE ENDO AND OPEN TREATMENT OF VASCULAR TRAUMA |
| Marco V. Usai, MD |
11/20/2025 5:31 PM |
63 |
Presenter |
Comparison Of Endovascular Thrombectomy Devices For Acute Mesenteric Ischemia: Indications, Contraindications, Which Device Works Best And Results: When Is Open Treatment Necessary |
| Marco V. Usai, MD |
11/21/2025 |
91, |
Session
Moderator |
CHALLENGING RECORDED LIVE CASES FROM MÜNSTER, GERMANY |
| Alexander Ushinsky, MD |
11/22/2025 2:23 PM |
114 |
Presenter |
Is There A Role For Intravascular Lithotripsy In Hemodialysis Access |
| Claude D. Vaislic, MD |
11/18/2025 10:30 AM |
4 |
Presenter |
The Multilayered Uncovered Allay Aortic Stent (Intressa Vascular) To Treat TBADs: Indications For Use, Advantages, Precautions And Results |
| Claude D. Vaislic, MD |
11/19/2025 11:22 AM |
42 |
Presenter |
Flow Modulating Bare Stents (Allay From Intressa) Are Not Showing Long-Term Benefit For The Treatment Of Complex AAAs And TAAAs Based On An Updated Review Showing Their Limitations: However Results Show They Have Value In The Treatment Of TBAD Patients With Or At High Risk Of End Organ Malperfusion |
| Domenico Valenti, DMChir, PhD, FRCS, FRCS(Ed), FEBVS |
11/18/2025 4:12 PM |
15 |
Presenter |
Open Surgery For The Management Of Visceral Aneurysms In The Endovascular Era: When Is It Best Especially In The Treatment Of Giant Pancreaticoduodenal Aneurysms |
| S. Rao Vallabhaneni, MD, FRCS |
11/18/2025 3:22 PM |
6 |
Presenter |
Failure Rates Are High For Endo Repairs Of Juxtarenal And Complex AAAs In A 7-Year Follow-Up From The UK-COMPASS Trial: Would A Wider Use Of Open Repair Remedy This |
| Isabelle Van Herzeele, MD, PhD |
11/20/2025 1:42 PM |
51 |
Presenter |
Selection Of Patients With Ruptured AAAs For Noninvasive (Comfort) Care Based On Scoring Systems Or Advanced Age Is NOT Appropriate And Unfair To Some Patients |
| Ramon L. Varcoe, MBBS, MS, FRACS, PhD, MMed (ClinEpi) |
11/20/2025 2:36 PM |
60 |
Presenter |
Early Experience With A New Bioresorbable Stent Scaffold (Efemoral From Efemoral Medical) To Treat FemPop Disease Ramon L. Varcoe, MBBS, MS, PhD, MMed |
| Ramon L. Varcoe, MBBS, MS, FRACS, PhD, MMed (ClinEpi) |
11/19/2025 8:59 AM |
25 |
Presenter |
3-Year Results Of The Esprit (Abbott) Drug Eluting Resorbable Stent (DERS) In The LIFE-BTK RCT Comparing It With Plain Old Balloon Angioplasty (POBA): DERSs Make A Difference |
| Ramon L. Varcoe, MBBS, MS, FRACS, PhD, MMed (ClinEpi) |
11/19/2025 |
24, |
Session
Moderator |
NEW DEVELOPMENTS IN ATHERECTOMY AND STENTS (UNCOATED AND COATED) |
| Ravi K. Veeraswamy, MD |
11/22/2025 11:02 AM |
109 |
Presenter |
AI Based Auto Image Analysis Systems To Evaluate Aortic And Carotid CT Scans To Determine Lesion Progression And Aneurysm Risk Factors: Will It Work And Current Status |
| Ravi K. Veeraswamy, MD |
11/18/2025 1:24 PM |
13 |
Presenter |
How AI Can Improve Automated Image Analysis And Be Helpful To All Vascular Surgeons And Specialists |
| Ravi K. Veeraswamy, MD |
11/19/2025 3:54 PM |
45 |
Presenter |
How To Navigate The Many Choices Of Endografts For Pararenal And Type IV TAAAs: TAMBE, Fen Plus (ZFEN Cook), In Situ Laser F/EVARs, PMEGs Or Parallel Grafts |
| Ravi K. Veeraswamy, MD |
11/20/2025 5:40 AM |
54 |
Presenter |
New Developments In Improving Radiation Safety By Room Mitigation And Personal Protection |
| Ravi K. Veeraswamy, MD |
11/20/2025 5:40 PM |
54 |
Presenter |
New Developments In Improving Radiation Safety By Room Mitigation And Personal Protection |
| Frank J. Veith, MD |
11/19/2025 10:42 AM |
33 |
Presenter |
How The First US EVAR Changed The Vascular World |
| Frank J. Veith, MD |
11/18/2025 7:00 AM |
17 |
Presenter |
Introduction To The Symposium |
| Frank J. Veith, MD |
11/18/2025 7:04 AM |
1 |
Presenter |
Opening Remarks |
| Frank J. Veith, MD |
11/19/2025 |
29, |
Session
Moderator |
FOOT PERFUSION EVALUATION METHODS; LOWER EXTREMITY RCTs: NEW CONCLUSIONS PRO AND CON |
| Frank J. Veith, MD |
11/20/2025 |
47, |
Session
Moderator |
EXCITING NEW OR REDISCOVERED TECHNIQUES, DEVICES, CONCEPTS |
| Frank J. Veith, MD |
11/20/2025 |
51, |
Session
Moderator |
PROGRESS IN THE TREATMENT OF RUPTURED INFRARENAL AAAs |
| Frank J. Veith, MD |
11/21/2025 |
82, |
Session
Moderator |
MORE CAROTID RELATED NEW TOPICS RELATED TO GUIDELINES, TCAR, CAS, CEA, NEW DEVICES, MESH COVERED STENTS, DEALING WITH DISTAL (HIGH) CAROTID LESIONS, MINI-INCISION CEA AND TREATMENT OF POST PROCEDURAL STROKES |
| Frank J. Veith, MD |
11/22/2025 |
109, |
Session
Moderator |
AORTIC AND CAROTID TOPICS TOO IMPORTANT TO MISS |
| Maarit Venermo, MD, PhD |
11/19/2025 3:30 PM |
29 |
Presenter |
Pedal Pulse Acceleration Time (PAT) Is The Best Method To Assess Circulatory Improvement After Revascularizations For CLTI: How To Do It And Why It's Better Than Other Methods |
| Maarit Venermo, MD, PhD |
11/19/2025 5:12 PM |
46 |
Presenter |
DEBATE: Routine Inferior Mesenteric Artery (IMA) Embolization Prior To EVAR Is NOT Beneficial: Based On An Analysis Of Over 700 Patients |
| Maarit Venermo, MD, PhD |
11/20/2025 5:34 PM |
54 |
Presenter |
How Can C-Arm System Settings Be Used To Minimize Radiation Exposure |
| Maarit Venermo, MD, PhD |
11/18/2025 |
6, |
Session
Moderator |
MORE ABOUT AAAs AND EVAR, STANDARD AND COMPLEX: UPDATES ON PHYSICIAN MODIFIED ENDOGRAFTS (PMEGs) AND GUIDELINES
|
| Gian Franco Veraldi, MD |
11/22/2025 10:24 AM |
108 |
Presenter |
Bare vs Covered Stents To Treat Aorto-Iliac Occlusive Disease (AIOD): Advantages And Limitations Of Each And When Is Each Proven To Be The Best Treatment: A Systematic Analysis |
| Hence J.M. Verhagen, MD, PhD |
11/19/2025 3:00 PM |
44 |
Presenter |
DEBATE: Large Flow Luminal Space In An AAA Sac With Minimal Mural Thrombus Is Associated With Adverse Events After EVAR: It Is More Important Than AAA Sac Size: Thrombus May Be Protective |
| Hence J.M. Verhagen, MD, PhD |
11/18/2025 3:16 PM |
6 |
Presenter |
What Are The New ESVS Guideline For Surveillance After EVAR And Do They Lead To Unsafe Practices |
| Hence J.M. Verhagen, MD, PhD |
11/18/2025 5:26 PM |
8 |
Presenter |
The Science Behind The High Risk Features Of Uncomplicated Acute Type B Dissections (uTBADs) Is Shaky At Best: They Should Not Be Used As An Excuse To Treat These Patients Invasively (As Some Guidelines Suggest) Until We Have Better Evidence: Until Then An RCT Will Be Difficult Or Impossible |
| Hence J.M. Verhagen, MD, PhD |
11/20/2025 8:54 AM |
56 |
Presenter |
New Insights From The 10-Year Results Of The ENGAGE EVAR Registry: What Does It Tell Us About EVAR Durability |
| Hence J.M. Verhagen, MD, PhD |
11/19/2025 9:36 AM |
33 |
Presenter |
Most Type 2 Endoleaks After EVAR Should Be Left Alone Because Treatments Have Poor Results, Have Complications And Do Not Improve Outcomes: What Are The Exceptions |
| Eric L.G. Verhoeven, MD, PhD |
11/20/2025 10:32 AM |
49 |
Presenter |
Longer-Term Outcomes Of Inner Branches To Address Visceral Target Arteries In F/EVAR And B/EVAR: What Are The Correct Indications For Them And Does The Bridging Stent-Graft Matter |
| Eric L.G. Verhoeven, MD, PhD |
11/20/2025 10:44 AM |
49 |
Presenter |
The Begraft And Begraft Plus (Bentley) As Bridging Covered Stents For F/B/EVAR: Advantages And Mid-Term Outcomes: What Is The New Beflared Covered Stent And Why Is It Better |
| Eric L.G. Verhoeven, MD, PhD |
11/18/2025 11:24 AM |
4 |
Presenter |
Updated Experience With F/B/EVAR For Post TBAD TAAAs: Technical Tips And The Value Of Inner Branched Devices: Value Of The BeBack Catheter (Bentley) To Cross The Dissection Flap |
| Eric L.G. Verhoeven, MD, PhD |
11/18/2025 |
4, |
Session
Moderator |
MORE NEW DEVELOPMENTS IN THE TREATMENT OF AORTIC DISSECTIONS, THORACIC AORTIC DISEASE AND THORACOABDOMINAL ANEURYSMS (TAAAs)
|
| Eric L.G. Verhoeven, MD, PhD |
11/20/2025 |
55, |
Session
Moderator |
NEW OR IMPROVED DEVICES FOR INFRARENAL AAA AND COMPLEX AAA REPAIR |
| Todd R. Vogel, MD, MPH |
11/18/2025 11:12 AM |
12 |
Presenter |
For Aorto-Iliac Occlusive Disease (AIOD): A Unibody Stent-Graft (AFX From Endologix) Offers Durable Outcomes Comparable To Traditional Aortobifemoral Bypass Or Stents (Bare Or Covered) |
| Todd R. Vogel, MD, MPH |
11/19/2025 7:53 AM |
24 |
Presenter |
The Many Devices For Atherectomy: Advantages And Limitations Of Each: Which Is The Best And Why: When Is Atherectomy Solidly Indicated And When Is It Overused |
| Reese A. Wain, MD |
11/21/2025 3:54 PM |
85 |
Presenter |
Asymptomatic Patients With A Carotid Lesion That Cannot Be Serially Followed Or The Severity Of Which Cannot Be Assessed: When Is It A Valid Indication For Carotid Intervention: Why Not Just BMT For All |
| Ron Waksman, MD |
11/19/2025 7:22 AM |
31 |
Presenter |
The Importance Of Decreasing Inflammation (As Reflected By C-Reactive Protein Levels) With Old And New Drugs; New Information On The Effect Of Elevated Lp(a) And Elevated Triglycerides: What Drugs Can Lower Them (Mulvalapin And Zerlasiran; Vascepa) |
| Ron Waksman, MD |
11/19/2025 9:11 AM |
25 |
Presenter |
Bioresorbable Magnesium Scaffold (Stent — BIOTRONIK) Has Been Improved For Lower Extremity And Coronary Lesions: Current Status, Advantages And Limitations |
| Ron Waksman, MD |
11/19/2025 |
32, |
Session
Moderator |
CATHETER BASED TREATMENTS FOR RESISTANT HYPERTENSION; MANAGEMENT OF CARDIAC PROBLEMS, CORONARY DESs, SMOKING AND TRANSFUSION IN VASCULAR SURGERY PATIENTS; PREVENTING VASCULAR AND CARDIAC COMPLICATIONS
|
| Craig M. Walker, MD |
11/19/2025 3:01 PM |
28 |
Presenter |
Atherectomy Followed By DCB To Treat Severe In-Stent Restenosis (ISR): Why Is Excimer Laser The Best Atherectomy Tool: Technical Tips And Late Results |
| Craig M. Walker, MD |
11/19/2025 8:11 AM |
24 |
Presenter |
Optimal Treatment For Calcified Fem-Pop Lesions: Why Intravascular Lithotripsy (IVL - Shockwave-J&J) And When Aperta High Pressure PTA Balloon (Braun): What About Atherectomy - Their Limitations And Advantages |
| Craig M. Walker, MD |
11/19/2025 |
24, |
Session
Moderator |
NEW DEVELOPMENTS IN ATHERECTOMY AND STENTS (UNCOATED AND COATED) |
| Grace J. Wang, MD, MSCE |
11/18/2025 1:06 PM |
5 |
Presenter |
Should We Reconsider AAA Size Threshold For Infrarenal AAA: Why Many Patients With AAAs >5cm In Diameter Should NOT Have Any Invasive Treatment: Should The Guidelines Be Changed |
| Grace J. Wang, MD, MSCE |
11/18/2025 |
5, |
Session
Moderator |
NEW DEVELOPMENTS IN ABDOMINAL AORTIC ANEURYSM (AAA) ETIOLOGY, DETECTION, TREATMENT AND EVAR |
| ShenMing Wang, MD, PhD |
11/19/2025 |
42, |
Session
Moderator |
PROGRESS IN TREATING ILIAC ANEURYSMS; ILIAC BRANCHED DEVICES (IBDs); UPDATE ON FLOW MODULATING AND BARE STENTS FOR TREATING ANEURYSMS AND DISSECTIONS |
| Anders Wanhainen, MD, PhD |
11/22/2025 10:00 AM |
108 |
Presenter |
Management Of Congenital AAAs In Infants With And Without Rupture: What Is The Best Graft And Long-Term Prognosis |
| Anders Wanhainen, MD, PhD |
11/19/2025 2:18 PM |
44 |
Presenter |
Endovascular (Endograft) Treatment Of Complex Aortic Diseases In Patients With CTDs: When Is It Indicated And When Is It Not: From The Results Of An International Multicenter Study Including Marfan, Vascular EDS And Loeys-Dietz Syndromes |
| Anders Wanhainen, MD, PhD |
11/20/2025 2:48 PM |
52 |
Presenter |
Rapid In Situ Laser Fenestration For Endovascular Treatment Of Ruptured Complex AAAs: How To Do It With Minimal SMA And Renal Ischemia And Results |
| Anders Wanhainen, MD, PhD |
11/21/2025 7:56 AM |
88 |
Presenter |
Current Concepts In Treatment Of Aortic Graft And Endograft Infections, Including EVAR, F/EVAR, TAAA And Arch Endografts: From The GRANDPA Registry |
| Haimanot (Monnie) Wasse, MD, MPH, FASN |
11/22/2025 |
111, |
Session
Moderator |
MORE IMPORTANT ISSUES IN HEMODIALYSIS ACCESS |
| Haimanot (Monnie) Wasse, MD, MPH, FASN |
11/22/2025 |
114, |
Session
Moderator |
NOVEL TECHNOLOGIES IN HEMODIALYSIS ACCESS |
| Fred A. Weaver, MD, MMM |
11/20/2025 |
53, |
Session
Moderator |
EXCITING NEW OR UPDATED CONCEPTS, TECHNIQUES AND TREATMENTS |
| Mitchell D. Weinberg, MD |
11/18/2025 8:55 AM |
17 |
Presenter |
Percutaneous Mechanical Thrombectomy Without Lytics: The Flowtriever System |
| Rodney A. White, MD |
11/18/2025 7:26 AM |
1 |
Presenter |
Challenges And Successes With Endografts In The Treatment Of Ascending Aortic Dissections (TAADs), Penetrating Ulcers And Pseudoaneurysms |
| Rodney A. White, MD |
11/18/2025 9:44 AM |
3 |
Presenter |
Technical Aspects To Enhance Successful Distal Dissection Stents In Petticoat And STABILISE Configurations To Treat Aortic Dissections: How To Assure Precise Stent Deployment, Avoid Aortic Injury, And Maximize Late Remodeling |
| Rodney A. White, MD |
11/18/2025 |
1, |
Session
Moderator |
PROGRESS IN TRANSCATHETER VALVE REPLACEMENT AND TREATMENT OF ASCENDING AORTIC DISEASE |
| Rodney A. White, MD |
11/19/2025 |
42, |
Session
Moderator |
PROGRESS IN TREATING ILIAC ANEURYSMS; ILIAC BRANCHED DEVICES (IBDs); UPDATE ON FLOW MODULATING AND BARE STENTS FOR TREATING ANEURYSMS AND DISSECTIONS |
| Rodney A. White, MD |
11/20/2025 |
58, |
Session
Moderator |
NEW OR IMPROVED DEVICES FOR THE AORTIC ARCH OR NEAR THE ARCH, TAAAs AND TEVAR |
| Michael H. Wholey, MD, MBA |
11/21/2025 9:12 AM |
80 |
Presenter |
Why We Need An RCT Comparing TCAR With TFCAS, Transradial CAS And Best Medical Treatment For Asymptomatic And Symptomatic Carotid Stenosis |
| Michael H. Wholey, MD, MBA |
11/21/2025 |
85, |
Session
Moderator |
MORE HOT AND CONTROVERSIAL CAROTID TOPICS |
| David M. Williams, MD |
11/19/2025 4:48 PM |
46 |
Presenter |
The Femoral Flag Concept With TBADs: How Can The Femoral Arteries On Presenting CT Indicate Vulnerable Visceral Artery Anatomy And How Should This Influence Treatment |
| Willem Wisselink, MD |
11/20/2025 1:06 PM |
51 |
Presenter |
Long-Term Results Of The AJAX RCT Comparing EVAR With Open Repair For Ruptured AAAs Has Flaws: What Are They: Despite These Flaws, EVAR Wins In The End – Especially In Older Patients |
| Willem Wisselink, MD |
11/18/2025 1:36 PM |
13 |
Presenter |
Why Randomized Controlled Trials (RCTs) In Vascular Surgery Are Obsolete And Unethical In The Era Of Artificial Intelligence |
| Willem Wisselink, MD |
11/18/2025 7:14 AM |
9 |
Presenter |
What New Developments In Vascular Robotics Will Lead To Their Comeback: How Can Single Port Robotic Surgery Help: What Does The Future Hold |
| Willem Wisselink, MD |
11/18/2025 |
9, |
Session
Moderator |
PROGRESS IN VASCULAR ROBOTICS AND IMAGING AND GUIDANCE SYSTEMS WITH LESS RADIATION AND CONTRAST
|
| Mathew D. Wooster, MD, MBA |
11/20/2025 11:04 AM |
58 |
Presenter |
Aortic Arch Repair With A Transfemoral, Modular, Off-The-Shelf Design That Avoids Arch Manipulation: How Does It Minimize Cerebral Ischemia |
| I-Hui Wu, MD, PhD |
11/18/2025 10:48 AM |
4 |
Presenter |
How Best To Treat TBADs Extending Into The Arch, Its Branches Or Ascending Aorta; When Open, When Endo, When Hybrid |
| I-Hui Wu, MD, PhD |
11/18/2025 4:00 PM |
15 |
Presenter |
Isolated Dissection Of The Celiac Axis Or Superior Mesenteric Artery (SMA) May Be Symptomatic Or Asymptomatic: Natural History And When Is Anticoagulation Or Invasive Treatment Needed |
| Herrick Wun, MD |
11/22/2025 8:46 AM |
110 |
Presenter |
Deep Learning Analysis Of Blood Flow Sounds To Detect AV Fistula Stenosis |
| Wayne F. Yakes, MD |
11/20/2025 10:56 AM |
50 |
Presenter |
How General Dan "Razin" Caine Orchestrated The Taking Out Of ISIS During Trump's First Presidential Term |
| Wayne F. Yakes, MD |
11/20/2025 |
50, |
Session
Moderator |
A TRIBUTE TO OUR MILITARY AND MILITARY PHYSICIANS: SOME MILITARY HISTORY; TREATMENT OF MILITARY AND CIVILIAN VASCULAR INJURIES AND CONTROL OF HEMORRHAGE; UPDATE ON REBOA |
| Kak Khee Yeung, MD, PhD |
11/18/2025 1:42 PM |
13 |
Presenter |
The VASCUL-AID Platform: Using AI To Predict Cardiovascular Disease Progression In AAA Patients And Lower Extremity Arterial Occlusive Disease: What Does It Show After 6 Years Of Study And How Does It Improve Patient Care |
| Kak Khee Yeung, MD, PhD |
11/20/2025 5:10 PM |
54 |
Presenter |
The Zero Radiation Project: MRI Can Replace Radiation In The Diagnosis, Treatment And Follow-Up Of EVAR Treated AAA Patients: How To Do It And Validation |
| Kak Khee Yeung, MD, PhD |
11/21/2025 6:52 AM |
79 |
Presenter |
Prediction Of SCI With AI: What Factors Are Evaluated And How Accurate Is It: Should It Be An Indication For CSF Drainage |
| Kak Khee Yeung, MD, PhD |
11/18/2025 |
13, |
Session
Moderator |
NEW CONCEPTS; MACHINE LEARNING AND ARTIFICIAL INTELLIGENCE (AI); TO DECREASE RADIATION (SEE ALSO SESSIONS 9 AND 90)
|
| Kak Khee Yeung, MD, PhD |
11/21/2025 |
90, |
Session
Moderator |
AUGMENTED REALITY (AR), MIXED REALITY AND ARTIFICIAL INTELLIGENCE (AI): HOW WILL THEY IMPROVE VASCULAR IMAGING AND ENDOVASCULAR DEVICE GUIDANCE WHILE MINIMIZING RADIATION |
| Christopher K. Zarins, MD |
11/19/2025 |
23, |
Session
Moderator |
GENERALITIES IN THE TREATMENT OF LOWER EXTREMITY OCCLUSIVE DISEASE, CLTI AND THEIR MEDICAL TREATMENT: SOME NEW CONCEPTS
|
| Hany M. Zayed, MD |
11/18/2025 1:06 PM |
19 |
Presenter |
Optimal Vessel Preparation For Drug Coated Balloon (DCB) Treatment Of Fem-Pop Lesions: Atherectomy, IVL Or POBA: Is It Lesion Or Previous Intervention Dependent |
| Hany M. Zayed, MD |
11/19/2025 1:36 PM |
27 |
Presenter |
Long Term Outcomes Of Transcatheter Arterialization Of The Deep Veins (DVA) Using The LimFlow System (Inari-Stryker): From A Multicenter UK Study: Indications, Advantages And Limitations |
| Hany M. Zayed, MD |
11/19/2025 1:42 PM |
27 |
Presenter |
Intraoperative Optimization Of DVA (LimFlow) For No Option CLTI: Flow Volume In The Lateral Plantar Vein Is A Crucial Parameter To Measure And Modulate For DVA Success: How To Do It And How To Use It |
| Clark J. Zeebregts, MD, PhD |
11/18/2025 8:20 AM |
10 |
Presenter |
Should The Amount Of Calcium Play A Role In Decision Making Of Carotid Interventions For ACS: How To Quantitate It And How Does It Influence Outcomes |
| Clark J. Zeebregts, MD, PhD |
11/20/2025 8:24 AM |
56 |
Presenter |
Cook Zenith Fenestrated Endovascular Aneurysm Repair With Distal Inverted Contralateral Iliac Limb: When To Use It: Advantages And Limitations |
| Clark J. Zeebregts, MD, PhD |
11/21/2025 9:46 AM |
89 |
Presenter |
What Conditions Can Cause Increased 18F FDG (Fluorodeoxyglucose) Uptake In Positron Emission CT: How Reliable Is It In Diagnosing Aortic And EVAR Graft Infection And Predicting AAA Rupture |
| Thomas Zeller, MD |
11/19/2025 10:54 AM |
26 |
Presenter |
Directional Atherectomy As Vessel Prep For DCB Use For FemPop Lesions: For Which Lesion Characteristics Is It The Best Treatment: What Is The Evidence For Its Superiority |
| Thomas Zeller, MD |
11/22/2025 7:24 AM |
106 |
Presenter |
Comparison Of Atherectomy And DCB Treatment With Open Surgery For Symptomatic Deep Femoral Artery Lesions: When Is Each Indicated |
| Thomas Zeller, MD |
11/19/2025 8:41 AM |
24 |
Presenter |
Updated Results With The Spur Spiked Temporary Stent System For Drug Delivery (Reflow Medical) With And Without DCB Angioplasty: Data From The DEEPER OUS And DEEPER REVEAL Trials |
| Sara L. Zettervall, MD |
11/19/2025 9:58 AM |
41 |
Presenter |
Optimal Volume Thresholds For Surgeons And Institutions Doing F/B/EVAR: Pros And Cons Of Regionalization |
| Wayne W. Zhang, MD |
11/21/2025 11:06 AM |
82 |
Presenter |
A System For Percutaneous TCAR With Reversal Of Flow Protection: How Does It Work And Clinical Experience To Date |
| Wayne W. Zhang, MD |
11/20/2025 8:18 AM |
56 |
Presenter |
A Novel EVAR Endograft System Dedicated To Prevention Of Type II Endoleaks: How Does It Work And Experience To Date |
| Wayne W. Zhang, MD |
11/18/2025 |
12, |
Session
Moderator |
PROGRESS IN THE TREATMENT OF AORTIC AND AORTOILIAC OCCLUSIVE DISEASE (AIOD) |
| Wei Zhou, MD |
11/21/2025 10:11 AM |
81 |
Presenter |
DEBATE: Invasive Treatment Of Asymptomatic Carotid Stenosis (ACS) Improves Cognitive Function |
| Wei Zhou, MD |
11/21/2025 |
82, |
Session
Moderator |
MORE CAROTID RELATED NEW TOPICS RELATED TO GUIDELINES, TCAR, CAS, CEA, NEW DEVICES, MESH COVERED STENTS, DEALING WITH DISTAL (HIGH) CAROTID LESIONS, MINI-INCISION CEA AND TREATMENT OF POST PROCEDURAL STROKES |
| R. Eugene Zierler, MD, RPVI |
11/19/2025 1:54 PM |
43 |
Presenter |
The Role Of Contrast-Enhanced Ultrasound After EVAR: When Can It Replace Contrast CT For Surveillance: Advantages And Limitations |
| R. Eugene Zierler, MD, RPVI |
11/21/2025 3:42 PM |
85 |
Presenter |
What Are The Various Duplex Ultrasound Criteria For Determining High Grade (>80%) Carotid Artery Stenosis: Which Is Most Accurate: How Often Are They Misleading: Confirmatory Imaging Should Precede Any Invasive Procedure |
| Gert J. de Borst, MD, PhD |
11/21/2025 11:48 AM |
82 |
Presenter |
Current Best Treatment For Strokes Apparent During Or Right After CEA, CAS Or TCAR: Best Diagnostic Modalities And Treatments: Who Should Be Involved And What Skills Are Needed |
| Gert J. de Borst, MD, PhD |
11/21/2025 1:30 PM |
83 |
Presenter |
The 2nd European Carotid Surgery Trial (ECST-2): Current Status And What It Tells Us About BMT vs Invasive Therapy |
| Gert J. de Borst, MD, PhD |
11/18/2025 8:14 AM |
10 |
Presenter |
New Developments In Carotid Plaque Imaging (Duplex, CT, MRI): Can It Predict Stroke Risk Reliably In ACS Patients To Facilitate Highly Selective Invasive Treatment |
| Gianmarco de Donato, MD |
11/20/2025 7:00 AM |
55 |
Presenter |
Update On The Polymer O-Ring Based ALTO Endograft (Endologix): Advantages And Limitations |
| Jean-Paul de Vries, MD, PhD |
11/19/2025 1:42 PM |
43 |
Presenter |
3D Geometric Analyses Of CTAs: What Are They, How To Do Them And How Can They Help To Predict, Prevent Or Treat Endoleaks With EVAR And F/EVAR |
| Jean-Paul de Vries, MD, PhD |
11/20/2025 4:12 PM |
62 |
Presenter |
Long-Term Results Of Heli-FX Endoanchors: (Medtronic) Fixation To Prevent And Treat EVAR Complications Including Type 1A Endoleaks: From The Global ANCHOR Registry: Can Virtual Techniques Predict The Need For Endoanchors |
| Jean-Paul de Vries, MD, PhD |
11/21/2025 8:02 AM |
88 |
Presenter |
New Developments In The Treatment Of Aortic Graft Infection After EVAR And Open Repair: What Is The Best Current Treatment And Mid-Term Results: From A Multi-Center Study |
| Joost van Herwaarden, MD, PhD |
11/20/2025 8:45 AM |
48 |
Presenter |
Ch/EVAR For Juxtarenal AAAs: Results From A Single Center With The Longest Available Follow-Up Confirm Long-Term Safety And Effectiveness: Technique Is Vital And How To Do It |
| Marc R.H.M. van Sambeek, MD, PhD |
11/20/2025 1:18 PM |
51 |
Presenter |
The Role Of Intraluminal Thrombus In AAA Growth And Rupture: What Mechanism Makes Thrombus Harmful |
| Marc R.H.M. van Sambeek, MD, PhD |
11/21/2025 2:06 PM |
83 |
Presenter |
Photoacoustic Imaging (With Laser And Ultrasound Derived Information) To Assess Carotid Plaque Vulnerability: How Does It Work And Does It Help |
| Jos C. van den Berg, MD, PhD |
11/18/2025 2:10 PM |
20 |
Presenter |
The Value Of Distal Angiography, Selective And Subselective, In The Treatment Of Lesions Causing CLTI: Technical Tips On How To Do It |
| Jos C. van den Berg, MD, PhD |
11/21/2025 7:10 AM |
87 |
Presenter |
Given A Patient With CLTI And A Popliteal Aneurysm: How To Assess And How To Treat: Endo vs Open |
| Jos C. van den Berg, MD, PhD |
11/21/2025 7:28 AM |
87 |
Presenter |
Dynamic MRI To Assess Popliteal Artery Entrapment Syndrome: How Can It Influence Diagnosis And Treatment |
| Jos C. van den Berg, MD, PhD |
11/22/2025 8:38 AM |
107 |
Presenter |
Treatment Of Dissections After PTA Of Lower Extremity Lesions: What Techniques Are Available: When Is Treatment Necessary And When Is It Not |
| Jos C. van den Berg, MD, PhD |
11/22/2025 9:14 AM |
107 |
Presenter |
Technical Tips For Overcoming Recoil After PTA In BTK Interventions: When And How To Do It |
| Arno von Ristow, MD |
11/19/2025 11:28 AM |
42 |
Presenter |
While Flow Modulating Bare Stents (Allay From Intressa) Do Not Always Seem To Prevent Aneurysm Enlargement And Rupture With TAAAs, They May Be Effective Treatment For Peripheral And Visceral Aneurysms: What Are The Indications |
